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ABSTRACT OF THE DISSERTATION 
MODULATING ADIPOGENESIS: KEY ROLE OF RAS-RELATED PROTEIN 
RAB5 AND ITS EFFECTORS 
by 
Yongjun Huang 
Florida International University, 2018 
Miami, Florida 
Professor Alejandro Barbieri, Major Advisor 
The formation of adipocytes is a complicated process in which insulin and IGF-
1 signaling pathways and numerous transcription factors control the conversion of 
precursor cells to mature fat cells. The Rab5 protein acts as a rate-limiting protein 
during receptor-mediated endocytosis by switching between a GDP-bound 
inactive form and a GTP-bound active form. The inactivation and activation of 
Rab5 are regulated by several Rab5 GTPase activating proteins (GAPs) and Rab5 
guanine nucleotide exchange factors (GEFs), respectively.  
This dissertation demonstrated that the activity of the small GTPase Rab5 and 
its regulators are essential for the differentiation of 3T3-L1 pre-adipocytes. 
Specifically, it showed that Rab5 activation is detrimental to the differentiation 
process. The overexpression of a dominant-negative Rab5:S34N mutant, but not 
an active counterpart (Rab5:Q79L), stimulated the differentiation of 3T3-L1 pre-
adipocytes. Consequently, the expression of Rab5:S34N increased the expression 
of two adipogenic-specific transcriptional factors, PPARγ and C/EBPα. siRNA-
mediated depletion of Rab5 inhibited the differentiation of 3T3-L1 pre-adipocytes, 
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providing further evidence for the requirement of Rab5 in the process of 
adipogenesis.  
A dramatic decrease of the Rab5-GTP level is also observed during the 
differentiation of 3T3-L1 pre-adipocytes. Consistent with these observations, I 
found that the expression of Rab5 GEFs (i.e., RIN1, Rabex-5, and RAP6), which 
increased the GTP-bound form of Rab5, blocked the differentiation process. In 
contrast, the expression of Rab5 GAPs (i.e., RN-tre and RabGAP-5), which 
decreased the GTP-bound form of Rab5, stimulated differentiation of 3T3-L1 pre-
adipocytes.  
I also found a novel interaction between the VPS9 domain of the Rab5 GEFs 
and the activated insulin receptor. This interaction is specific since the VPS9 
domain did not interact with the catalytic inactive mutant of the insulin receptor and 
the Rab5 GAPs (no VPS9 domain) did not bind to the activated insulin receptor. 
The data point out that a reduction on the GTP-bound form of Rab5 is required 
for the rapid differentiation of 3T3-L1 pre-adipocytes, identifying Rab5 inactivation 
as an important contributor of adipogenesis. Also, these observations suggest a 
novel cellular mechanism of Rab5 activity in the adipogenesis process in 
connection with the insulin receptor, the Rab5 GAPs, and the Rab5 GEFs.  
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CHAPTER I 
I. Introduction 
Adipose tissue includes a diversity of cell types, including endothelial cells, 
blood cells, fibroblasts, pre-adipocytes, and macrophages, with mature adipocytes 
as the main cell type. 
Adipogenesis is an insulin receptor-driven signaling cascade that promote 
pre-adipocytes to differentiate into mature (brown and white) adipocytes through 
the participation of some key transcription factors (Lowe et al., 2011). Specifically, 
adipogenesis is a programmed and highly-regulated process that requires factors 
like peroxisome proliferator-activated receptor γ (PPARγ) and other transcription 
factor families, including CCAAT/enhancer-binding proteins (C/EBPs), signal 
transducers and activators of transcription (STATs), and Kruppel-like factor (KLF) 
proteins (Ali et al., 2013). 
On the other hand, the intracellular membrane trafficking of the insulin 
receptor is an extremely complex process during which the receptor encounters 
its adaptor proteins as well as a variety of enzymes. One of them, the small 
GTPase Rab5, acts as a rate-limiting protein and governs the early stage of insulin 
receptor-mediated endocytosis. How this cellular process is regulated by the small 
GTPase Rab5 and its effectors during adipogenesis is not clearly understood. The 
specific roles of these intracellular factors, including the transcription factors, Rab5, 
and Rab5 regulators, their targets and the corresponding signaling events will be 
described. Thus, the working hypotheses and specific aims are proposed and 
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discussed on the basis of the current knowledge and the information provided in 
this chapter. 
 
I.1 Adipogenesis: the mystery of obesity 
Along with the development of the society and the more comfortable and 
convenient accessibility of food source, obesity, as one of the most severe global 
health problems, receives attention all around the world. Meanwhile, adipogenesis 
has been extensively studied in the past four decades because of the increase in 
the number of obese people.  
I.1.1 Obesity: a global health problem 
I.1.1.1 Obesity in history and modern life: from a symbol of beauty to 
the threaten of health 
Obesity is a medical condition in which excessive fat is formed and 
accumulated in the body with a body-mass index (BMI) ≥30kg/m2 (Haslam & 
James, 2005). Rather than be treated only as a metabolic disorder, obesity 
nowadays has been recognized as a multifactorial disease. Type 2 diabetes, high 
blood pressure, osteoarthritis, stroke, congenital disabilities, and menstrual 
disorders are related to the increase of body weight (Haslam & James, 2005). 
Besides, animal and human data show that high glucose/fat food consumption 
sabotage the appetite control by impairing hippocampal-dependent memories, 
which suggests obesity is a threat to the central nervous system (Morris et al., 
2015). What is more, the comorbidities not only reduce life expectancy and 
increase the economic burden of the society, but also are associated with 
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increased incidence and mortality of multiple types of cancers, including liver, 
colon, bladder, endometrium, and breast cancer (Ezzati et al., 2004; Giovannucci 
et al., 2010)  
Obesity is derived from the Latin word obesitas. The ancient Greeks and 
Egyptians were the first ones on record to recognize obesity as a medical disorder 
(Heitmann et al., 2012).  In the 6th century B.C., an Indian surgeon Sushruta 
related obesity with diabetes and heart disorders (Dwivedi & Dwivedi, 2007). 
During the Middle Ages and the Renaissance (~1300 A.D. to 1700 A.D.), obesity 
was a sign of wealth and prosperity and the symbol of beauty, not only in Europe 
but also in Asian (Bloomgarden, 2003). The values towards beauty can be 
represented by the artistic works at that time, such as the Portrait of Alessandro 
del Borro, a Tuscan nobleman and soldier, who fought in the wars against Ottoman 
Empire, was painted as a confident and over obese man; the Madonna with the 
Christ Child and St. John the Baptist, in which Madonna and Jesus were 
represented as overtly obese woman and child; and the Venus at a Mirror and the 
Woman at the well, in which women were drawn as overweight (Ferrucci et al., 
2010). During the 19th century, both height and weight of human bodies increased 
in the developed world, which was believed to be associated with the efficient and 
sufficient access to food and accumulated society wealth as a result of the 
Industrial Revolution (Caballero, 2007). However, it happened quite recently 
(around the 1980s) that obesity attracted the sight of the public and started being 
extensively studied by researchers, and it was only until the 20th century that 
obesity was recognized to associate with mortality increase (Eknoyan, 2006). 
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Since the beginning of the 20th century, public’s view towards ideal body weight 
and the relationship between obesity and wealth changed dramatically. The 
change is supported by the data that the height of pageant winners of Miss 
American increased less than 2%, but the trend of BMI decreased from 22 to 17.5, 
which even belongs to the range of undernutrition defined by the World Health 
Organization (WHO) (Rubinstein & Caballero, 2000).  
Nowadays, increasing evidence demonstrates that obesity is becoming a 
global disease. According to the National Health and Nutrition Examination Survey 
(NHANES), in the U. S., during 1999-2002, 86.3% and 84.2% of men and women 
who were diagnosed as diabetes were obese or overweight with 53% and 58% of 
them being obese, respectively (Report, 2004). Studies also found that nearly 29% 
of the world population was overweight or obese in 2013, and nearly two out of 
three of the obese population lived in developing countries (Mckay, 2014). What is 
worse, the data of Behavioral Risk Factor Surveillance System (BRFSS) from 1990 
to 2008, show that obesity prevalence increased by 33% and severe obesity 
prevalence increased by 130%. Researchers predicted that by the year 2030, 42% 
of the population will be obese with a severe obesity (BMI≥40kg/m2) prevalence of 
11% (Finkelstein et al., 2011). 
 
I.1.1.2 Adipose tissue: not only a fat storehouse 
Obesity, as the name implies, always happen with the symptom of a gain of 
body weight. The gain of body weight, however, mostly attributes to the increase 
in the mass of adipose tissue.  
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Adipose tissue is loose connective tissue containing adipocytes, which are 
also the dominant component of adipose tissue; stromal vascular fraction (SVF), 
which includes adipocyte precursors, mesenchymal stem cells (MSCs), and 
endothelial precursor cells; and immune cells such as adipose tissue macrophages 
(Riordan et al., 2009). The MSCs resemble fibroblasts morphologically and have 
the capacity to differentiate into adipocytes, chondrocytes, myocytes and 
osteocytes under proper stimulation (Zuk et al., 2001). The endothelial precursor 
cells are capable of stimulating angiogenesis either directly or indirectly by 
secreting insulin-like growth factor 1 (IGF-1), hepatocyte growth factor 1 (HGF-1), 
and vascular endothelial growth factor (VEGF) (Rehman et al., 2004; Sumi et al., 
2007). The adipose tissue macrophages are responsible for the production of the 
majority of tumor necrosis factor alpha (TNF-α), which affects glucose 
homeostasis in adipocytes, promotes lipolysis and inhibit lipogenesis, and has 
been shown to relate with insulin resistance and type 2 diabetes (Cawthorn & Sethi, 
2008).  Three types of adipocyte precursors, preadipocytes, the CD34+/CD31- cell 
population, and the human multipotent adipose tissue-derived stem cells, were 
found in the SVF of human adipose tissue (Symonds, 2012). These adipocyte 
precursors, which have the capacity to differentiate into adipocytes, resident in 
adipose tissue during adult life, undergo self-renewal to produce adipocytes, and 
allow the adipose tissue to expand as much as 15-fold as a result of a constant 
excess of fat intake (Symonds, 2012).  
Researchers mainly focused on the regulation of lipolysis and lipogenesis 
since adipose tissue was only considered to be an energy storage organ in the 
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past. They started realizing the importance and complexity of adipose tissue in the 
recent 20~25 years when adipose tissue was widely and extensively studied 
because of the increasing prevalence of obesity. Adipose tissue is crucial and 
multifunctional in the body. It is 1) the primary energy storage site, where excessive 
fat that surpasses the requirement of body will be stored; 2) the insulating layer, 
which reduces heat loss and maintains the body temperature; 3) the protect and 
support structure of some organs; 4) an endocrine organ that secretes numerous 
endocrine mediators, including hormones (adipokines), cytokines, and lipids; 5) an 
immune organ that helps in the removal of debris and apoptotic cells, and the 
maintenance of tissue homeostasis (Mraz & Haluzik, 2014; Vegiopoulos et al., 
2017).  
However, the functions of adipose tissue have been found to be different 
and, to some extent, harmful to obese individuals. Adipose tissue changes 
histologically, functionally, and metabolically in the obese microenvironment. In 
obese patients, most adipose depots visibly expand in size, adipocytes increase 
in numbers and sizes, while the proportions of other types of cells also changed. 
Specifically, the expanded volume of adipose tissue and increased adipocytes cell 
number are principally the result of the reduced removal rate of triacylglycerol 
(TAG), the main component of fat in adipocytes (Arner et al., 2011). Additionally, 
excessive accumulation of fat leads to an increase of number and activity of some 
immune cells, such as macrophages, but a decrease of some others (Cildir et al., 
2013). The elevated number of macrophages increases the secretion of TNF-α in 
both adipose tissue and the circulatory system, which is related to insulin resistant 
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in vitro (Plomgaard et al., 2005). Besides, adipose tissue of obese patients has 
relatively reduced blood vessels and neural structure, which form a hypoxic 
microenvironment in adipose tissue, and are thought to be responsible for insulin 
resistant of obese patients (Coppack, 2005). In response to the hypoxia stress, 
adipocytes activate the p38 mitogen-activated protein kinases (p38 MAPKs) and 
the Jun N-terminal kinases (JNKs), which correlate with glucose uptake and insulin 
sensitivity (M. Bluher, 2013). The dysregulated secretion of TNF-α, hypoxia 
microenvironment, and the stress-induced changes in signaling pathways attribute 
to an obesity-induced specific type of inflammation named chronic low-grade 
sterile inflammation. This type of inflammation is characterized by the increase of 
immune factors in the circulatory system and the absence of clinical signs of 
inflammation. It is also believed to play a crucial role in the development of insulin 
resistance in obese individuals (Medzhitov, 2008; Oliver et al., 2010). Overall, 
adipose tissue is crucial for energy control and the homeostasis of the human body. 
Its dysfunction in obese patients is the leading cause of the obesity-related 
diseases. 
 
I.1.1.3 White, brown, and beige: different colors with different 
functions? 
The two functionally distinct types of adipose tissue found in mammals are 
classified as the white adipose tissue (WAT) and the brown adipose tissue (BAT), 
where the white adipocytes and the brown adipocytes cluster, respectively. It is 
generally believed that under specific situations, the white adipocytes undergo a 
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“browning” process and gain the features of brown adipocytes. These white-
original brown adipocytes are named beige, or brite adipocytes. However, 
evidence also shows that the beige cells could be a distinct type of adipocytes 
which arise from unique precursor cells that are different from the white or brown 
(J Wu et al., 2012). The introduction of this dissertation will only focus on 
discussion of the universally brief of beige origin. 
The WAT, taking up the majority of the adipose tissue, could be found both 
subcutaneously and viscerally, and is one of the most abundant tissues in the 
human body. The abnormal expansion/hypertrophy of WAT is the dominant factor 
to contribute to the weight gain and dysfunction of adipose tissue during obesity 
progression because of the fact that the WAT is poorly vascularized with relatively 
rare neural structures (Vazquez-Vela et al., 2008). White adipocytes, the main 
component of WAT, manage the primary functions of WAT, such as rapid 
accumulation and release of fatty acids, lipogenesis, lipid storage, and regulation 
of insulin sensitivity (Symonds, 2012). Adipocytes arise from the mesoderm during 
fetal development (Enerback, 2009). The development of white adipocytes, for a 
long time, is believed to derive from a myogenic factor 5 (Myf5)-negative lineage 
(Timmons et al., 2007). However, developmental studies challenged the view by 
providing evidence of the existence of Myf5-positive precursors in WAT (Figure 1). 
The mature white adipocytes are round-shaped cells variable in size from 25μm to 
200μm. They contain a single giant lipid droplet in the cytoplasm and a flattened, 
peripherally located nucleus (Table 1). The content and function of mitochondria 
are one of the main differences between the white and brown adipocytes. 
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Mitochondria in white adipocytes are, like in other tissues, the main source of ATP, 
thin and spindle in shape, and though variable, still relatively few in numbers (Table 
1). The dysfunction of mitochondria could cause the imbalance between 
production and decomposition of reactive oxygen species (ROS), which is thought 
to play a role in the metabolic dysregulation of obesity (Cedikova et al., 2016).  
The BAT was thought to only exist in infants and small animals to defend 
cold temperature and maintain body temperature in the past (Rothwell & Stock, 
1979). But it has been found to locate in supraclavicular, paravertebral, and neck 
regions and been suggested to play a potential role in the treatment of obesity in 
the past three decades. As the name of BAT implies, the brown adipocytes 
comprise the main portion of it. The brown adipocytes, derive from the Myf5-
positive cell lineage, are relatively smaller (size from 15μm to 60μm) polygonal 
cells with multiple scattered lipid droplets in the cytoplasm and a round, 
eccentrically, yet not peripherally, located nucleus (Table 1). Mitochondria in brown 
adipocytes are bigger and contain more cristae than the ones in white adipocytes. 
These mitochondria have unique elliptical shape, exist in the cytoplasm with 
enormous numbers, and exclusively express a transmembrane protein, 
uncoupling protein 1 (UCP1) (Figure 1). Together with high vascularization, the 
cytochromes of numerous mitochondria give the BAT the visible brown color 
(Table 1). Unlike the WAT whose regulation is principally controlled by insulin, the 
BAT is primarily innervated by the sympathetic nervous system (SNS), which 
responses to energy defect or increased energy expenditure, via activating of 
numerous-expressed β3-adrenergic receptors (β3-AR) on the membrane of 
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mature brown adipocytes (Table 1). The activation of β3-AR enhances the 
expression of UCP1 and hormone-sensitive lipase (HSL), and eventually promotes 
lipolysis and thermogenesis (Geerling et al., 2014).  
Figure 1. Origins and characteristics of white and brown adipocytes.  
The white adipocytes are predominantly derived from Myf5- cells while the brown 
adipocytes are derived from Myf5+ cells. Mature white adipocytes are round 
shaped cells containing a single giant lipid droplet in the cytoplasm, few 
mitochondria, and a flattened, peripherally located nucleus. Mature brown 
adipocytes are polygonal cells with multiple scattered lipid droplets in the 
cytoplasm, and a round, eccentrically, yet not peripherally, located nucleus. Brown 
adipocytes contain more mitochondria, which are bigger in size and have more 
cristae than the ones in white adipocytes. 
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Table 1. Similarities and diversities of white, brown, and beige adipose 
tissue.  
(Barneda et al., 2013; Cedikova et al., 2016; Kajimura et al., 2015; Saely et al., 
2012; Sanchez-Gurmaches et al., 2012; Seale et al., 2008; Szentirmai & Kapas, 
2017; Vargas et al., 2015). 
Features White Brown Beige 
Development 
Mesenchymal 
stem cell; 
Predominantly 
Myf-negative 
precursor cells 
Mesenchymal 
stem cell;  
Myf-positive 
precursor cells 
Mesenchymal 
stem cell; 
Predominantly 
Myf-negative 
precursor cells 
Develop time Primarily after birth At neonatal stage 
Upon WAT 
development 
Vasculature Poorly developed Few capillaries Highly developed N/A 
Nervous structure Poor innervation High innervation N/A 
Cell shape Round Polygonal Round 
Cell size 25μm ~ 200μm 15μm ~ 60μm 
Variable 
depending on 
stimulation 
Nucleus 
Flattened, 
peripherally 
located 
Round, 
eccentrically 
located 
Depend on 
stimulation 
Lipid droplets 
(LDs) One giant LD 
Multiple small 
LDs 
Multiple variable 
sized LDs 
Mitochondria Few Thin and spindle 
High amount 
Large and 
elliptical or round 
Variable 
depending on 
stimulation 
UCP1 expression Undetectable High 
Variable 
depending on 
stimulation 
Endoplasmic 
reticulum Normal amount Poor 
Depend on 
stimulation 
Main function Fat storage Thermogenesis 
Adjust to cold 
exposure; 
thermogenesis 
Location Subcutaneous and visceral 
Cervical, 
supraclavicular, 
paravertebral 
Within WAT 
Role in obesity Positive Negative Negative 
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The discovery and study of beige (or brite) adipocytes came up quite 
recently when researchers observed the trans-differentiation of brown-like 
adipocytes from white adipocytes in WAT depots after chronic cold exposure 
(Barbatelli et al., 2010). The first usage of the term “beige” to define the brown-like 
white adipocytes, to my knowledge, was in the comments to a published paper 
discussing de novo recruitment of brown adipocytes in 2010 (Vegiopoulos et al., 
2010; Ishibashi & Seale, 2010). The trigger of the browning process has not been 
fully elucidated but appears to be affected by the excitement of the SNS, levels of 
hormones, the tension of physical exercises, and time and extent of cold exposure 
(Poekes et al., 2015). Many studies support the decisive role of β3-AR in white 
adipocyte browning (Bartness & Ryu, 2015). But controversial views came up 
towards the necessarily of the activation of β3-AR, either by the norepinephrine or 
the β3-adrenergic agonist, in the browning process. The passive role of β3-AR is 
supported by evidence that the β3-AR is dispensable for the browning process (de 
Jong et al., 2017). Since the beige cells are transdifferentiated from the white 
adipocytes, it is predictable that they share some features in morphology and 
function with the white adipocytes, such as sharing the same precursors as well 
as the same locations (Table 1). Upon the browning process, the beige cells will 
show intermediate features between the two types of adipocytes and generally 
transform towards the brown ones. The changes include increased expression of 
UCP1 in mitochondria, increased number but decreased size of lipid droplets and 
mitochondria, increased sensitivity of β3-AR, increased innervation and 
vascularization (Table 1). Recently, the beige cells attract a broad interest from 
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scientists as a result of its exercise- and temperature-inducible characteristics. 
More will be discussed in the next unit.   
 
I.1.1.4 Current therapies of obesity: a long way to go  
As one of the most severe and prevalent diseases raised recently, variable 
treatments towards obesity are offered for obese patients to choose from. Basic 
strategies of weight control include diet to control the total intake of calories, 
physical activities/exercises to consume energy, and behavior change/lifestyle 
therapies (Kushner, 2014). Multiple drugs, such as phentermine, orlistat, lorcaserin, 
and certain combinations such as phentermine/topiramate, functioning as either 
appetite suppressors or lipogenesis inhibitors, have been approved by the Food 
and Drug Administration (FDA) for the treatment of obesity. The most effective 
treatment for obesity may be bariatric surgery. However, only severe patients or 
patients with severe complications should be considered as surgery candidates. 
The decision to undergo surgery must be made on the basis of a comprehensive 
assessment evaluating both risks and benefits (Mechanick et al., 2013). As a 
consequence of the low patient compliance with physical therapies, unavoidable 
side effects of current medicines, restrict applicability of surgery, researchers and 
doctors are still looking for effective and safe ways to treat obesity. 
 Several studies have been done to detect the potential possibility of 
recruiting and activating the BAT and beige cells in obese patients for weight 
control because of the negative role of BAT and beige in obesity. Gene transgenic 
mice with ablated BAT were associated with insulin resistance and non-insulin-
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dependent diabetes mellitus, reduced rate of energy consumption, and 
considerable obesity even with a regular diet (Hamann et al., 1988). Besides, 
human studies showed that the BAT activity is negatively related with BMI and 
body fat percentage, but was positively associated with cold-induced 
thermogenesis (Vijgen et al., 2011; van Marken Lichtenbelt & Daanen, 2003). 
Though some in vitro studies showed that activating β3-AR promotes lipolysis and 
thermogenesis of both brown and beige adipocytes as described above, the usage 
of β3-AR agonists for obesity treatment received disappointing results in humans 
so far (S Qian et al., 2015).  
Bone morphogenetic protein 4 (BMP-4) agonist and BMP-4 inhibitors have 
recently been recommended as a potential medicine or drug target, respectively, 
for obesity treatment. An animal study showed that BMP-4 transgene mice 
exhibited a reduced WAT mass, decreased number of white adipocytes, and 
increased beige cells and SVF (SW Qian et al., 2013). Conversely, the BMP-4-
knockout mice had depressed UCP-1 expression, decreased mitochondria size, 
and increased lipogenesis along with diminished insulin sensitivity (SW Qian et al., 
2013). Human studies showed that silencing of Gremlin-1, a potent BMP-4 inhibitor, 
dramatically increased both beige and BAT markers, while the silencing of chordin 
and chordin-like-1, a BMP-4 binding protein, markedly reduced adipogenesis 
markers, such as peroxisome proliferator-activated receptor-gamma (PPARγ) and 
fatty acid binding protein 4 (FABP4) (Gustafson et al., 2015). However, since 
BMPs have a broad range of functions not only on adipocytes but also on 
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angiogenesis and bone formation, the usage of BMP agonists on obese treatment 
needs to be intensely studied before being used on humans. 
Other factors like IGF-1, fatty acids, glucocorticoids, macrophage colony 
stimulating factor, and prostaglandins, have been identified as stimulators of the 
adipogenesis process (MacDougald & Mandrup, 2002). While some other factors, 
such as proteins from the Wnt family, transforming growth factor beta (TGF-β), 
interleukin 1 (IL-1), TNF-α, and epidermal growth factor (EGF), all showed 
inhibitory role in adipogenesis (MacDougald & Mandrup, 2002). However, it is 
difficult to use these intracellular or extracellular factors as targets since the 
stimulation or inhibition of them could result in complex cellular and systematic 
responses.  
Quite recently, Gomisin N, a physiological lignan extracted from Schisandra 
chinensis, showed inhibitory effects on pre-adipocyte differentiation (Jang et al., 
2017). But whether this lignan functions appropriately in vivo and whether it will 
induce severe side effect in the human body remain unknown. 
In summary, to find a thorough and secure treatment for obesity still requires 
more lab work and clinical tests to be done. 
 
I.1.2 Process of adipogenesis in vitro: the lipids factory under precise 
regulation 
Adipogenesis is the formation of mature adipocytes differentiated from 
fibroblast-like pre-adipocytes. Thus, when considering obesity from a molecular 
level, the essential cause could be viewed as a result of the formation and 
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accumulation of adipocytes both subcutaneously or/and viscerally. Besides, 
adipogenesis is a continuously happened normal physiological process that not 
only store lipids for energy expenses, but also regulate body metabolism and 
homeostasis. 
The highly-controlled process of adipocyte differentiation, especially the 
white adipocyte differentiation, has been extensively studied in the past 30 years. 
Two types of in vitro experimental models have been used. One is the pre-
adipocyte cell lines, such as the 3T3-L1 and the 3T3-F442A cell line, which is 
isolated from the Swiss 3T3 cell line. These pre-adipocyte cell lines only have the 
ability to differentiate into adipocytes. The other is the multipotent stem cell lines, 
such as the C3H10T1/2 cell line from C3H mouse embryonic stem cell precursors 
and the adipose-derived stem cells from human adipose tissue. These multipotent 
cell lines have the potential to commit to different lineages, including adipose, bone, 
and muscle lineage (Moreno-Navarrete & Fernández-Real, 2012).  
To achieve a successful differentiation into mature adipocytes, morphology, 
transduction of signals, and protein expression of the pre-adipocytes change 
dramatically through a regulated process. All mature adipocytes are characterized 
by the existence and accumulation of big lipid droplets (comparing to other type of 
cells) in the cytosol, high expression of adipogenic transcription factors (such as 
PPARγ and CCAAT/enhancer-binding proteins (C/EBPs)) and adipogenic markers 
(such as acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), and fatty acid 
binding protein 4 (FABP4)). However, the stimulation of differentiation and the 
 
 
17 
adipogenesis process for the three types of adipocytes – the white, brown and 
beige cells – are not the same.  
 
I.1.2.1 Lipids and lipid droplets in adipocytes 
Lipid droplets (LDs) are lipid-rich cellular organelles that can be found in all 
eukaryotic organisms and even some prokaryotic cells (Grant & Donaldson). The 
formation of lipid droplets in the cytosol, with a variable range from less than 1μm 
to more than 100μm, is the main characteristic of mature adipocytes (Suzuki et al., 
2011). Thus, it is of great importance to understand the structure and metabolism 
of the LDs (Figure 2). 
In adipocytes, LDs are observed as round structures under the microscope. 
The lipid droplets are isolated from other organelles and the aqueous intracellular 
environment by a monolayer of phospholipid embedded or adhered by several 
types of proteins, including the perilipin (Plin) family proteins (Plin1~5), the cell 
death-inducing DFF45-like effector (Cide) family proteins (Cidea, Cideb, Cidec), 
adipose triglyceride lipase (ATGL), and some membrane-trafficking proteins 
(Barneda et al., 2013; Guo et al., 2009). The Plins stabilize the lipid droplets and 
govern lipolysis. The Cides regulate the size of LDs. The adipose triglyceride lipase 
hydrolyzes the first fatty acid of triacylglycerol (TAG) to start lipolysis. Membrane-
trafficking proteins, such as the Rab proteins, govern the fission and fusion of 
vesicles, deliver proteins to different cellular compartments, and regulate the signal 
transduction. With the phospholipid layer surrounded, the hydrophobic core of LDs 
in white adipocytes are predominately made up of triacylglycerols (TAGs) (Figure 
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2.A). Thus, the formation and growth of LDs require the production and 
transportation of the core lipids (mainly TAGs with a small amount of sterol esters), 
the surface phospholipid monolayer and the lipid-related proteins. Several models 
have been proposed to describe the life cycle of LDs, but none of the models was 
successfully and sufficiently supported by current data. The following introduction 
will build on studies conducted on 3T3-L1 pre-adipocytes cell line in vitro or/and 
mice/human adipose tissue in vivo. 
Generally, the life cycle of the LDs starts with fatty acids. The fatty acids 
can diffuse into the cell through fatty acid transporter (FAT, CD36) or fatty acid 
transport proteins (FATPs, especially the FATP1) that are located on the cell 
membrane. The fatty acids can also be synthesized through de novo lipogenesis 
that takes place in the cytoplasm (Figure 2.B). De novo lipogenesis normally 
contributes about 20% of the total adipose TAG formation. But this de novo 
lipogenesis process is able to provide all necessary fatty acids for adipogenesis 
process (Strawford et al., 2004; JM Collins et al., 2011). The fatty acid transport 
protein type 1 (FATP1) is highly expressed on the membrane of both WAT and 
BAT initially (Schaffer & Lodish, 1994). Though insulin stimulation does not change 
the expression of FATP1, it facilitates the translocation of FATP1 to the plasma 
membrane from an intracellular compartment in the 3T3-L1 pre-adipocytes (Stahl 
et al., 2002). During de novo lipogenesis, palmitate (C16:0) is constructed by 
continuously adding malonyl-CoA to acetyl-CoA (Figure 2). Two key enzymes are 
involved in the process: ACC and FAS (JM Collins et al., 2011). First, acetyl-CoA, 
an intermediate product of glycolysis, is carboxylated into malonyl-CoA by ACC 
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(Wakil & Abu-Elheiga, 2009). Acetyl-CoA carboxylase (ACC) is a complex 
multifunctional biotin-containing enzyme system that performs the carboxylation 
reaction through two steps: 1) ACC acts as a biotin carboxylase in an ATP-
dependent manner; 2) ACC acts as a carboxyl transferase to transfer the carboxyl 
group from biotin to acetyl-CoA to form malonyl-CoA (Gurr et al., 2016). Next, the 
condensation reaction is conducted by FAS to form 16-carbon palmitate using 
acetyl-CoA and malonyl-CoA as substrates (Currie et al., 2013). The FAS is a giant 
multifunctional enzyme system formed by homodimer of two identical monomers 
(Berg et al., 2015). Each monomer has seven covalently linked catalytic sites, 
which are divided into three domains, to produce palmitate (Chirala & Wakil, 2004). 
The chemically inert FAs, either diffuse into the cell or be generated endogenously, 
need to bind to cytosolic FABP4 and be esterified with CoA. The esterification is 
an ATP-dependent two-step reaction conducted by acyl-CoA synthetase (ACS) — 
to enter the bioactive pool in the form of fatty acyl-CoA (FA-CoA) that binds to the 
acyl-CoA-binding protein (ACBP) (Figure 2.B). Fatty acid binding protein 4 (FABP4) 
belongs to the FABP family and is highly expressed in adipocytes. It is a ~15 kDa 
small protein, which acts as intracellular lipid carrier and transporter, to regulate 
lipid trafficking and targeting (Furuhashi et al., 2014).  
The majority of TAGs are generated through the glycerol 3-phosphate (G3P) 
pathway at the endoplasmic reticulum (ER) membrane where the synthesis 
process is conducted by enzymes either permanently or transiently located (Pol et 
al., 2014). More specifically, the TAGs are formed and deposited between the 
leaflets of the ER membrane (Kohlwein et al., 2013). As the triose sugar backbone 
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of TAG, G3P is mainly generated through 3 metabolic processes:                                   
1) gluconeogenesis, in which dihydroxyacetone phosphate is reduced to G3P by 
G3P dehydrogenase during glycolysis, 2) phosphorylation of glycerol via glycerol 
kinase, and 3) glyceroneogenesis, in which G3P is formed from non-
glycerol/glucose precursors, such as pyruvate, amino acids, and lactate (Reshef 
et al., 2003). Gluconeogenesis can be upregulated in obese individuals since the 
activity of G3P dehydrogenase from lean individuals is only half of that from the 
morbidly adipose tissue of obese individuals (Swierczynski et al., 2003). Under 
insulin stimulation, the PPARγ-mediated increased expression and activity of 
glycerol kinase allow glycerol to be a direct source of G3P (Guan et al., 2002). 
However, by using the tritium ([3H2]0) to track body water, glyceroneogenesis was 
found to be the quantitatively dominant source of G3P in adipose tissue of rats 
(Nye et al., 2008).  
Triacylglycerol synthesis is the esterification of the alcoholic groups of G3P 
in a row. Several reactions happen successively and are conducted by specific 
enzymes, including G3P acyltransferase (GPAT), 1-acylglycerol-3-phosphate 
acyltransferase (AGPAT), phosphatidate phosphohydrolase (PAP), and 
diacylglycerol acyltransferase (DGAT) (Figure 2.B). First, GPAT and AGPAT 
transfer acyl groups to G3P stepwise. Then PAP catalyzed the dephosphorylation 
reaction, and DGAT converts the generated diacylglycerol (DAG) to TAG 
(Saponaro et al., 2015). DGAT is one of the most important enzymes in the process. 
The expression and activity of DGAT can be upregulated by both insulin and 
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glucose. However, the deletion of DGAT in adipocytes leads to depleted DGAT 
activity, TG synthesis, and LD formation (Harris et al., 2011; Meegalla et al., 2002). 
Figure 2. Structure and formation of lipid droplets (LD) in adipocytes.  
A. LD structure. LD is observed as round structure with a hydrophobic core mainly 
made up of TAGs. LD is surrounded by a monolayer of phospholipid embedded or 
adhered by several types of proteins, including the Plins, the Cides, ATGL, Rab5, 
and Rab18. B. Formation of LDs. Fatty acids from the diet were either transported 
into adipocytes through FAT and FATP located on the plasma membrane or 
synthesized de novo in the cytosol from acetyl-CoA. The inert fatty acids will be 
activated by ACS to form FA-CoA. Then on the membrane of ER, TAG will be 
synthesized using G3P and FA-CoA as substrates via a chain of reactions 
mediated by GPAT, AGPAT, PAP, and DGAT.  
(ACBP: acyl-CoA-binding protein; ACS: acyl-CoA synthetase; AGPAT: 1-
acylglycerol-3-phosphate acyltransferase; ATGL: adipose triglyceride lipase; Cide: 
cell death-inducing DFF45-like effector; DAG: diacylglycerol; DGAT: diacylglycerol 
acyltransferase; ER: endoplasmic reticulum; FA-CoA: fatty acyl-CoA; FAT: fatty 
acid transporter; FATP: fatty acid transport protein; G3P: glycerol 3-phosphate; 
GPAT: glycerol 3-phosphate acyltransferase; PAP: phosphatidate 
phosphohydrolase; Plin: perilipin; TAG: triacylglycerol.) (JM Collins et al., 2011; 
Ehehalt et al., 2006; Garrett & Grisham, 2017; Pol et al., 2014; Gurr et al., 2016; 
Fujimoto & Parton, 2011) 
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Though it is widely believed that the TAGs are synthesized between the 
leaflets of the ER membrane, how the neutral lipids and LD-associated proteins 
are assembled, how and whether the mature LDs separate from the ER membrane 
remain incompletely understood (Hashemi & Goodman, 2015). The exact 
pathways of LDs expansion and how much each possible pathway contribute to 
LDs expansion also remain unclear. Nevertheless, it is widely accepted that LDs 
can grow in size. One possibility is that the neutral lipids and phospholipids were 
transported to the LDs through LD-ER contact sites (Yang et al., 2012). The 
assumption was supported by electron and immunoelectron microscopy data 
showing that the small LDs (around 1μm in diameter) were surrounded by several 
layers of ER (Heid et al., 2014). Another possibility is that the neutral lipids and 
phospholipids were synthesized directly on the LDs membrane. This scenario is 
supported by localization of neutral lipids synthesis related proteins – such as 
GPATs, AGPATs, and DGATs – and phospholipid related proteins – such as 
CTP:phosphocholine cytidylyltransferase (CCT) – on the LDs membrane (Guo et 
al., 2008; Wilfling et al., 2013). Fusion of smaller LDs into bigger LDs also seems 
to contribute to the growth of LDs. The fusion event is rare in normal conditions but 
happens quite often in the 3T3-L1 pre-adipocytes upon insulin treatment (Guo et 
al., 2008; Ariotti et al., 2012).  
In summary, the formation of LDs is a multistep process that is conducted 
by a series of enzymes whose expression and activity can be regulated by 
extracellular stimuli – such as insulin and glucose.  
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I.1.2.2 Insulin, dexamethasone, 3-isobutyl-1-methylxanthine: the three 
musketeers 
As is mentioned above, adipocyte differentiation is a highly regulated and 
complicated process in which numerous hormones, proteins, and signaling 
pathways function together and successively. Commonly, scientists mimic the 
trigger of pre-adipocyte differentiation by adding a hormone combination 
containing insulin, dexamethasone (DEX), and 3-isobutyl-1-methylxanthine (IBMX) 
in vitro. These three “musketeers” work together to help d'Artagnan – the pre-
adipocytes – undergoing a regulated differentiation process. Though how exactly 
these hormones regulate adipogenesis is not fully explored, some basic functions 
will be discussed below. 
Insulin is a major regulator of cell metabolism and also the most potent 
hormone among the three “musketeers” to initiate adipogenesis (Klemm et al., 
2001). It is a hormone secreted by B cells of the pancreas and performs its function 
of regulating carbohydrate metabolism by activating the insulin receptors (IRs) and 
the IGF receptors (IGFRs) located on the plasma membrane (details of the IR, the 
IGFR, the insulin signaling pathways, and how the pathways affect adipogenesis 
will be discussed later in another section). The human circulating (biological active) 
insulin is a monomer made up of two chains: an A chain with 21 amino acids and 
a B chain with 30 amino acids (De Meyts, 2004). In general, insulin alters body 
metabolism by affecting glucose transport and glycolysis, fatty acids and TAG 
synthesis, the rate of protein synthesis, and the expression of adipocyte 
differentiation-associated proteins (Dimitriadis et al., 2011).  
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The capability of insulin to govern the transportation of glucose, which is 
essential for adipocyte differentiation as the source of energy and TAGs, mostly 
relays on its regulatory role towards the glucose transporter type 4 (GLUT4). The 
GLUT4, an insulin-sensitive glucose transport protein, is uniquely expressed on 
the plasma membrane of adipocytes (James et al., 1988). Under the normal state 
(without insulin stimulation), only a small portion of GLUT4s are found on the cell 
surface, while the majority of GLUT4s stay on specific intracellular compartments–
the specialized GLUT4 storage vesicles (GSVs)–which locate peripherally close to 
the plasma membrane (Leto & Saltiel, 2012). Insulin augments the cell surface 
GLUT4 of adipocytes by increasing exocytosis of the GSVs and decreasing 
endocytosis of GLUT4 on the plasma membrane (Czech & Buxton, 1993; Jhun et 
al., 1992). These GLUT4 transporters were endocytosed into the cell through both 
clathrin-mediated endocytosis and the cholesterol-dependent endocytosis (Lajoie 
& Nabi, 2010). During internalization, small GTPases (e.g., Rab5), guide the 
GLUT4-containing vesicles towards the cell interior (Huang et al., 2001). Upon the 
stimulation of insulin, several intracellular signaling cascades are initiated, 
including the extracellular signal regulated kinase (Erk)1/2 signaling cascade, and 
the phosphatidylinositide 3-kinase (PI3K)/Akt signaling cascade (Zarich et al., 
2006). However, the former cascade has been found to be unimportant for glucose 
transportation (Lazar et al., 1995). Instead, the insulin signaling pathway 
significantly increases the exocytosis of GSVs by controlling the activation states 
of small GTPases via activating the PI3K/Akt signaling cascade (Leto & Saltiel, 
2012). Once is recruited and activated, Akt phosphorylates and inactivates two 
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GAPs, the AS160 – for vesicle translocation, and the RAL–GAP complex (RGC) – 
for vesicle targeting (Leto & Saltiel, 2012). Thus, insulin is able to regulate glucose 
uptake by increasing the GLUT4 level and the duration of GLUT4 remains on the 
plasma membrane. Besides, studies also show that the 3T3-L1 pre-adipocytes, 
once they reach confluence, become more sensitive to insulin stimulation. Under 
the pre-confluent state, the cell surface GLUT4 level of 3T3-L1 cells was increased 
by 70% upon insulin stimulation; while under confluent state, the surface 
transporter level of 3T3-L1 cells was increased by 270% upon insulin stimulation 
(Govers et al., 2004).  
Dexamethasone is a synthetic glucocorticoid that performs an anti-
inflammatory role in the body. It triggers the differentiation of primary MSCs into 
osteocytes and adipocytes in vitro. With either an increased concentration of DEX 
in media or an extended incubation time with DEX, the MSCs prefer adipogenic 
differentiation than osteogenic differentiation (Yin et al., 2006). 3-isobutyl-1-
methylxanthine (IBMX) is one of the most potent and competitive, non-specific 
inhibitor of phosphodiesterases that enhance the intracellular cyclic adenosine 
monophosphate (cAMP) and activate protein kinase A (PKA) (Schroeder et al., 
2012). Since the PKA signaling pathway is required for the transcriptional 
activation of PPARγ, IBMX performs a regulatory role in the gene expression 
during differentiation. A study has shown that treatment of IBMX on the 3T3-L1 
cells does not drive the pre-adipocytes towards adipogenic differentiation. But that 
did not represent a final fate of the pre-adipocytes. Indeed, treatment of DEX on 
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IBMX pre-treated cells followed by an additional 48 hours of IBMX treatment 
triggered the differentiation process (Pantoja et al., 2008).  
In conclusion, the three hormones, insulin, DEX, and IBMX, ensure the 3T3-
L1 pre-adipocytes to enter and complete the differentiation process properly. 
Insulin promotes the adipogenesis process by regulating the GLUT4 levels on the 
plasma membrane and the sensitivity of the cells to respond to insulin stimulation. 
Dexamethasone, in combination with IBMX, increase the expression of PPARγ, 
C/EBPδ, and C/EBPβ, which are important adipogenic transcription factors for 
adipocyte differentiation (Cao et al., 1991).  
 
I.1.2.3 Adipogenesis in vitro: the mitotic clonal expansion phase and 
the morphological change/terminal differentiation phase 
As is mentioned above, two different kinds of in vitro models are used in the 
study of adipocyte differentiation: the pre-adipocyte cell lines and the multipotent 
stem cell lines. Some cell types undergo a proliferative phase called the mitotic 
clonal expansion (MCE) phase before terminal differentiation, while some other 
cell types directly enter the differentiation phase. Here, I will discuss the 3T3-L1 
(pre-adipocyte cell line) adipogenesis process. 
In the process of 3T3-L1 pre-adipocytes differentiation, insulin action, 
glucose uptake, lipid transportation and synthesis, transcription factors (e.g., 
PPARγ and C/EBPα), cell cycle proteins (e.g., CDK2 (Cyclin-dependent kinase 2), 
cyclin D1 and retinoblastoma (Rb)), adipocyte-associated proteins (e.g., ACC and 
FAS), and activation of signaling cascades (e.g., the insulin signaling pathway) are 
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required (Koppen & Kalkhoven, 2010). Before hormone activation, the pre-
adipocytes stop proliferation once they reach cell confluence. The treatment of 
hormone cocktail (combination of insulin, DEX, and IBMX) will trigger the cells to 
enter the fate of differentiation, which includes two phases: the MCE phase and 
the morphological change/terminal differentiation phase (Figure 3). The former 
phase consists of two rounds of post-confluence mitosis, and the latter phase, 
including the transition to a round cell shape from an elongated cell shape and to 
contain large globules of fat in the cytoplasm, is the morphological change of pre-
adipocytes into adipocytes, (Figure 3). 
In the MCE phase (usually occupies the first 48 hours after hormone 
treatment), a group of cell cycle proteins are periodically expressed and degraded 
to ensure proliferation through mitosis. Cyclin D1 is a protein expressed 
periodically in the G1 phase of the cell cycle, and it is required for the transition 
from G1 phase to S phase. cAMP elevates the expression of cyclin D1 during the 
first few hours of adipogenesis, which is induced by IBMX and insulin (Fox et al., 
2008). CDK2 belongs to a family of protein kinases that regulated the cell cycle. 
The expression of CDK2 is required during the G1/S transition because of its 
catalytic role in the cyclin-dependent protein kinase complex (Peng et al., 2016).  
Retinoblastoma is phosphorylated by the cyclin-dependent protein kinase complex, 
which promotes transcriptional activation of the cell cycle required genes to drive 
the cells enter S phase (Berthet et al., 2006). 
Meanwhile, adipogenic specific proteins (e.g., C/EBPs and PPARγ) are 
regulated transcriptionally, which will be discussed in the next section. 
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Figure 3. The process of adipogenesis.  
Pre-adipocytes are fibroblast-like elongate-shaped cells with a round, centrally 
located nucleus. Upon the stimulation of hormone cocktail (combination of insulin, 
IBMX and DEX), pre-adipocytes undergo a ten-day process of differentiation 
named adipogenesis. Two phases are involved in this process. The clonal 
expansion phase, which happens in the first 48hs of adipogenesis, allows pre-
adipocytes to go through two cycles of mitosis to quadruple the cell. In the latter 
terminal differentiation phase, lipid droplets will be generated, accumulated, and 
fused in the cytoplasm and eventually form a large lipid vacuole. (Rosen & 
Spiegelman, 2000) 
 
 
I.1.2.4 The adipogenic markers: C/EBPs (C/EBPα, C/EBPβ, and 
C/EBPδ) and PPARγ 
A series of changes happen simultaneously and successively in 
transcriptional level during adipogenesis (Figure 4). The C/EBP family members 
share the characteristics of C-terminal leucine zipper domain for dimerization and 
a DNA-binding domain for transactivation activity. Three of the family members, 
C/EBPα/β/δ, have established roles in adipogenesis. During the first 24 hours after 
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hormone treatment, a transient, fast, and dramatic accumulation of C/EBPβ and 
C/EBPδ will appear within the MCE phase (Figure 4). The expression of C/EBPβ 
is critical for adipogenesis, which is supported by a study showing that mouse 
embryo fibroblasts from C/EBPβ (–/–) mice never enter the MCE phase and cannot 
differentiate into adipocytes (Tang et al., 2003). Once is hyperphosphorylated by 
the mitogen-activating protein kinase (MAPK) and glycogen synthase kinase 3β 
(GSK-3β), C/EBPβ acquires its DNA-binding activity and transactivate both 
C/EBPα and PPARγ (Tang et al., 2005). Though C/EBPβ appears within 2 hours 
after hormone induction, it only gains DNA-binding activity after a long lag when 
the cells enter S phase during the mitotic clonal expansion phase (MCE) (Figure 
4). An in vivo study shows that newborn C/EBPβ(–/–)·δ(–/–) mice does not 
accumulate droplets, and ependymal fat pad weight of adult C/EBPβ(–/–)·δ(–/–) 
mice is significantly reduced (Tanaka et al., 1997). The growth of C/EBPδ deficient 
pre-adipocytes are dramatically depressed under hormone induction (Hishida et 
al., 2009). However, the overexpression of C/EBPβ, not C/EBPδ, is sufficient to 
induce adipogenesis, which indicates a regulatory, but less important role of 
C/EBPδ in adipogenesis (Yeh et al., 1995). The expression of C/EBPβ and 
C/EBPδ both peak shortly after hormone induction and experience a sudden 
decrease together with the expression of low levels of C/EBPα and PPARγ. 
C/EBPα and PPARγ can then initiate the expression of each other in a positive 
feedback loop, perform proliferation inhibition activity, regulate adipogenic genes 
and proteins, and remain continuously elevated during adipogenesis (Figure 4). 
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Figure 4. The regulation of transcription factors during adipogenesis.   
A transient and dramatic increase of C/EBPβ and C/EBPδ takes place within the 
first 2 hours after hormone treatment and experience a sudden decrease at the 
end of the mitotic clonal expansion (MCE) phase. The expression of these two 
transcription factors transactivates both C/EBPα and PPARγ, which initiate the 
expression of each other in a positive feedback loop, when the cells cease the 
MCE phase. (Ramji & Foka, 2002; Rosen et al., 2002). 
 
The two key transcription factors, C/EBPα and PPARγ, emerge and 
dramatically increase in the second wave (the C/EBPβ and C/EBPδ are the first 
wave) of adipogenic transcription factors during the development of all types of 
adipose cells. A genomic study shows that PPARγ binds to 5299 genomic regions, 
where over 60% are also found to be bound by C/EBPα in the 3T3-L1 pre-
adipocytes (Lefterova et al., 2008). Another study reports C/EBPα to be 
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responsible for insulin-sensitive glucose transport and the regulation of several 
adipogenic related proteins, such as diacylglycerol acyltransferase 1 and 2 
(DGAT1/2) and ACC (Olofsson et al., 2008; Z Wu et al., 1999). Interestingly, 
PPARγ expression is necessary and sufficient to induce adipogenesis even in the 
lack of C/EBPα in mouse embryonic fibroblasts. In concordance, C/EBPα itself is 
not able to induce adipogenesis in the absence of PPARγ (Rosen & MacDougald, 
2006). The expression of the dominant negative mutant of PPARγ reduced the 
mRNAs of several adipogenic key enzymes – GLUT4, insulin receptor, and 
C/EBPα – in mature adipocytes (Tamori et al., 2002). So far, no other transcription 
factors have been found to successively induce adipogenesis in the absence of 
PPARγ, which indicates the importance and unique role of PPARγ in this process. 
Peroxisome proliferator-activated receptor gamma (PPARγ) exists in two isoforms, 
PPARγ1 and PPARγ2. The former one is more ubiquitously expressed while the 
latter one is exclusively expressed in adipocytes. Nevertheless, both isoforms are 
highly induced during adipogenesis (Siersbaek et al., 2010).  
In summary, the expression of PPARγ and C/EBPα is induced by C/EBPβ 
and C/EBPδ when the hormone-treated pre-adipocytes cease the MCE phase. 
Both PPARγ and C/EBPα are essential for the differentiation of pre-adipocytes. 
However, only PPARγ plays a unique and indispensable role in the differentiation 
process. 
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I.2 The receptor-mediated endocytosis 
I.2.1 Endocytosis 
All types of cells require fuel for metabolism. Eukaryotic cells, including the 
adipocytes, have the most complicated systems to communicate with the 
environment around them. Cells respond to changes and stimuli in the extracellular 
environment to mediate signal transduction, build interior trafficking structures, and 
secrete hormones to the extracellular environment (Alberts et al., 2007). To 
complete these missions, eukaryotic cells developed a high-efficient internal 
membrane trafficking system to transfer proteins (such as cell-surface receptors) 
between different membrane structures and to take up solutes, particles, or 
macromolecules from the external environment. By the process of exocytosis, the 
cells deliver proteins, hormones, and lipids either to the plasma membrane or the 
extracellular environment. Through the contrary process named endocytosis, the 
cells internalize certain particles/macromolecules by surrounding them with an 
area of the plasma membrane, removing the plasma membrane from the cell 
surface to form a vesicle structure, and delivering the vesicle structure to different 
intracellular compartments in an energy-consuming manner (Cooper, 2000). 
Compartments, such as the ER and Golgi apparatus, in the exocytosis process 
have recognizable shapes and certain localizations. In contrast, compartments in 
endocytosis process exist as vesicles that are usually isolated from large cellular 
structures. As a result, two endocytic compartments, the early endosomes and the 
late endosomes, are distinguished by their localization and time of formation during 
the endocytic process (Kornilova, 2014). Endocytosis can generally be divided into 
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three stages. First, the cargos (solutes, particles, and macromolecules) are 
internalized into the cell with part of the plasma membrane as intracellular vesicles. 
Second, the internalized vesicles are sorted and delivered to the early endosomes 
and then to different intracellular membrane compartments. At last, the cargos will 
reach the final destination, either the lysosome to be degraded or the plasma 
membrane to be reused (Sahay et al., 2010). 
There are multiple pathways for the solutes, particles, and macromolecules 
to enter the cells. Endocytosis has been broadly classified as phagocytosis and 
pinocytosis (Cooper, 2000). These two categories can be distinguished by the size 
of material been internalized and also by the dependence of phagocytosis on actin 
polymerization as a key step in particle ingestion (J Liu & Shapiro, 2003). The 
process of taking large particles (generally larger than 250 nm in diameter), such 
as cell debris, bacteria or even another cell, is named phagocytosis (Doherty & 
McMahon, 2009). Specific cell types, such as macrophages, monocytes, and 
neutrophils are well-known “professional phagocytes” that wipe out foreign 
material (bacteria and pathogens) as part of the immune system. The uptake of 
fluids and solutes (such as vitamins, some ions, and cholesterol, which are 
generally less than 150 nm in diameter), together with the macromolecules (such 
as transmembrane receptors, ion-channels, and cell-surface transporters) that 
they bind to, is called pinocytosis (Cooper, 2000). Different from phagocytosis that 
usually occurs in phagocytotic cells, pinocytosis exists in all cell types. At least two 
classifications of pinocytosis have been proposed: one considers the material been 
engulfed into the cell; the other one emphasizes on the proteins that participate in 
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the process of endocytosis (Sahay et al., 2010). The former one classified 
pinocytosis as receptor-mediated endocytosis, adsorptive endocytosis, and fluid-
phase endocytosis (Khalil et al., 2006). The fluid-phase endocytosis can occur by 
either micropinocytosis (vesicles less than 0.1 μm in diameter) or 
macropinocytosis (vesicles between 0.5 μm to 5 μm in diameter) (Kruth et al., 
2005). The latter one can further classify pinocytosis into two types: clathrin-
dependent endocytosis, also known as clathrin-mediated endocytosis (CME), and 
clathrin-independent endocytosis (Sahay et al., 2010).  
 
I.2.2 Mechanism of receptor-mediated endocytosis: how the initial signal 
is implemented – magnification V.S. quenching. 
I.2.2.1 The ligands and the receptor tyrosine kinases: the soulmates 
Receptor-mediated endocytosis (RME), which is characterized by selective 
uptake of specific macromolecules followed by internalization of ligand-receptor 
complexes, generally occur through a clathrin-dependent process (Lodish et al., 
2016). The categories of macromolecules been internalized through RME are 1) 
peptide signaling growth factors, cytokines, and hormones, such as EGF, FGF, 
and insulin; 2) cell metabolism-related macromolecules, such as transferrin and 
low-density lipoprotein (LDL); 3) toxins, such as Clostridium perfringens Iota and 
Clostridium botulinum C2; 4) viruses, such as measles virus (through Nectin 4 
receptor) and Rubella virus (through myelin oligodendrocyte glycoprotein, MOG); 
5) bacteria, such as Listeria monocytogenes (through E-cadherin and Met) and 
Yersinia pseudotuberculosis (β1-integrins) (Backovic & Rey, 2012; Cossart & 
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Helenius, 2014; Gibert et al., 2011; Kornilova, 2014). I will only discuss the entry 
of macromolecules from the first category in this chapter. 
Receptor-mediated endocytosis is controlled and regulated by a large 
number of specialized proteins to mediate fission and fusion of phospholipid 
membranes, engulfment of ligands and ligands binding proteins (the receptor 
tyrosine kinases, RTKs), movement and directing of ligand-receptor complexes 
containing vesicles towards different cellular structures (Doherty & McMahon, 
2009). The process of RME starts with the binding of the macromolecules and 
specific RTKs, which are a group of cell-surface receptors that consist of 58 
receptors divided into 20 subfamilies (Critchley et al., 2018). Receptors and ligands 
come in matched pairs. Each RTK only recognizes one or a few specific ligand(s), 
for instance, the insulin receptor (IR) specifically identifies insulin and insulin-like 
growth factors (IGFs), the epidermal growth factor receptor (EGFR) binds to EGF 
and transforming growth factor α (TGF-α), and fibroblast growth factor receptor 4  
(FGFR4, from the FGFR family) has high affinity to several ligands, including FGF-
1, 2, 4, 6, 8, 9, 16, 17, 18, and 19 (Lodish et al., 2016; Tiong et al., 2013). 
Meanwhile, a ligand can be picked up by only one or a few receptor(s), e. g., insulin 
can be recognized by both the IRs and the IGF receptors (IGFRs), FGF-1 can 
binds to FGFR1/2/3/4 (Sorkin & Puthenveedu, 2014; Tiong et al., 2013). 
However, the binding affinities between different ligands towards the same 
receptor or different receptors with the same ligand are quite diverse. In summary, 
despite the fact that one RTK can recognize one or several ligand(s) and one 
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ligand can bind to different RTKs with vary affinities, the bindings between ligands 
and RTKs are of high specificity and precision. 
 
I.2.2.2 The internalization of ligand-receptor complexes: engulfment 
does not mean suppression 
The binding of RTKs with specific ligand(s) will form the ligand-receptor 
complexes, which will be internalized into the cell with part of the plasma 
membrane where the RTKs locate through RME (Figure 5.B). The responsiveness 
of cells to the extracellular signal molecules depends on the number of ligand-
receptor complexes formed on the plasma membrane. Thus, the endocytosis of 
these complexes, which alters the distribution and concentration of RTKs on the 
plasma membrane, regulates the long-term homeostasis and sensitivity of the cell 
to specific ligands(s) (Lodish et al., 2016).  
Once the RTKs recognize the extracellular signal and form the ligand-
receptor complexes, the area of the plasma membrane that contains these 
complexes will be pinched off as clathrin-coated pits (Figure 5). The internalization 
process requires the participation of two proteins, the adaptor protein 2 (AP2) and 
clathrin. The former one, AP2 complex, which is formed by 4 subunits (the large α 
and β2 subunits, the medium-sized μ2 subunit, and the small-sized σ2 subunit) as 
a heterotetrameric structure, serves as bridges between the plasma membrane, 
RTK, and clathrin (Higgins & McMahon, 2002) Park, 2014 #1013). Knockout of 
AP2 in mice is embryonic lethal, indicating the crucial role of AP2 in embryonic 
development and cell homeostasis (Park & Guo, 2014). The latter one, clathrin, 
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has a triskelion structure with three clathrin heavy chains (CHC) stretched out from 
a central vertex that is made up by three tightly associated clathrin light chains 
(CLC) (Conner & Schmid, 2003; Royle, 2006). Knockout of the CHC in Hela cells 
results in diminished growth rate and impaired endocytosis (Hinrichsen et al., 
2003). To form the clathrin-coated pits, the first step is to “mark” the trans-
membrane receptors – the majority of which are RTKs – to be internalized. The 
marking is accomplished when cytoplasmic-located specific motifs of RTKs 
become exposed because of structural change under ligand binding (Pearse et al., 
2000). The well-characterized motifs include the tyrosine-based YXXΦ/NPXY 
motif and the dileucine-based [D/E]XXXL[L/I] motif (X is any amino acid, and Φ is 
a bulky hydrophobic amino acid, e.g., leucine, isoleucine, methionine, valine, and 
phenylalanine) (Bonifacino & Traub, 2003). The AP2 complex interacts with 
phosphatidylinositol-4,5-bisphosphate (PIP2) and phosphatidylinositol-3,4,5-
triphosphate (PIP3) through its α subunit and μ2 subunit. The interactions between 
the AP2 complex and PIP2/PIP3 are responsible for its localization on the plasma 
membrane (BM Collins et al., 2002). The AP2 complex also recognizes the 
exposed YXXΦ/NPXY motif through the μ2 subunit and the [D/E]XXXL[L/I] motif 
through μ2 and/or β2 subunit (Bonifacino & Traub, 2003). After binding to motifs 
located on the RTK, the AP2 complex undergoes a large conformational change 
from a locked state to an open state (Park & Guo, 2014). In the open state, AP2 
complex recruits clathrin to the plasma membrane through the “hinge” domains of 
its large α and β2 subunits and promotes the self-assembles of clathrin to build 
cage-like structures/lattice (Park & Guo, 2014). Hence, the curvature of the 
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membrane region that contains ligand-receptor complexes, the AP2 complexes, 
and the recruited clathrin is called the clathrin-coated pit. Through the action of 
other factors, such as endophilin and dynamin, the clathrin-coated pit further 
curves into the cell and finally will pinch off from the cell membrane (Figure 5.B). 
The mature pits – the pits dissociate entirely from the cell membrane – will 
be uncoated and fuse to an early endosome where the ligand-receptor complexes 
are sorted to lysosomes to be degraded or recycled back to the plasma membrane 
to be reused (Figure 5.B). The ratio between the recycled receptors and degraded 
receptors varies. For instance, the insulin receptors in the 3T3-L1 pre-adipocytes 
are efficiently recycled upon insulin stimulation at a concentration of 100ng/ml 
(Marshall, 1985). High concentration of EGF (over 100ng/ml) promotes the 
degradation of EGFR while low concentration of EGF (lower than 50ng/ml) favors 
recycling of EGFR (Sigismund et al. 2008). 
The role of RME involves both the rapid internalization of receptors following 
ligand binding and the subsequent sorting of the internalized ligand-receptor 
complexes (Goh & Sorkin, 2013). Thus, RME plays an essential role in controlling 
the functional activities of the RTKs.  
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Figure 5. The tyrosine kinase domain of RTKs and receptor-mediated 
endocytosis.  
A. The tyrosine kinase domain of RTKs contains a smaller N-lobe and a bigger C-
lobe. The cleft between the two lobes permits a specific site for ATP binding. B. 
Receptor tyrosine kinases are activated by binding with specific ligands followed 
by the formation of ligand-receptor complexes. The activated RTKs interact with 
AP2, which links to the plasma membrane and recruits clathrin. The ligand-
receptor complexes then clustered on the plasma membrane to form a growing 
curved clathrin-coated pit. The mature pit then buds off from the plasma membrane 
and becomes the clathrin-coated pit (CCP). The CCP will be uncoated in the 
cytosol and the uncoated vesicle will be delivered to early endosomes (EEs) to 
fuse with them. Some ligand-receptor complexes remain intact while some ligands 
dissociate from the receptors when reaching the early endosomes. The ligands 
and some of the receptors will be sorted to late endosomes and eventually, 
lysosomes to be degraded. However, some of the receptors will be recycled to the 
plasma membrane. (Sorkin & Puthenveedu, 2014; Casem, 2016; Kirchhausen et 
al., 2014; Cooper, 2000; Lemmon and Schlessinger, 2010). 
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As is mentioned above, the RME mediates the internalization and sorting of 
the RTKs. It is believed that the primary role of RME is to terminate the RTK 
signaling through ubiquitination and degradation upon vesicle sorting. However, 
several studies showed that the internalized ligand-receptor complexes continue 
functioning and mediate the full biological functions of the RTK signaling (von 
Zastrow & Sorkin, 2007). In other words, instead of just functioning as a delivery 
station, the endosomes that contain ligand-receptor complexes may also function 
as active signaling sites (Irannejad et al., 2015). For instance, activated EGFR has 
been found to co-localize with endosomes and downstream signaling molecules, 
including the adaptor protein – Src homology and collagen protein (Shc, Src stands 
for Rous sarcoma oncogene cellular homolog), the Ras guanine nucleotide 
exchange factor (GEF) – son of sevenless (SOS), and the docking protein – growth 
factor receptor-bound protein 2 (Grb2) – in vivo (Di Guglielmo et al., 1994). Besides, 
the internalized non-phosphorylated EGFR-ligand complex, which is induced by 
reversible inhibitors, could be activated in endosomes upon inhibitor wash-out and 
were able to perform its biological function by recruiting downstream signaling 
molecules (Pennock & Wang, 2003). Furthermore, the tropomyosin receptor 
kinase A (TrkA) receptors, once internalized upon nerve growth factor (NGF) 
binding, localize on the endocytic vesicles, remain phosphorylated, and are 
associated with phosphoinositide phospholipase C (PLC-γ1), which acts as an 
essential intracellular signaling transduction enzyme that catalyzes the formation 
of inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (Grimes et al., 1996). The 
TrkA-NGF complexes were also shown to move from the distal axon to the 
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neuronal cell body to carry the signal from the cell periphery to the nucleus (Cosker 
& Segal, 2014). Researchers also observed an accumulation of activated insulin 
receptors in the intracellular compartments in the presence of insulin (Kublaoui et 
al., 1995).  
In summary, the RTKs are internalized into the cell in the form of ligand-
receptor complexes through clathrin-mediated endocytosis. The engulfed 
receptors, in some cases, are not degraded immediately. Instead, these receptors 
appear to remain activated and functional in endosomal compartments after 
internalization. 
 
I.2.2.3 The small GTPase Rab proteins in the receptor-mediated 
endocytosis: the logistic company to control the delivery 
As is mentioned above, common procedures of RME include the budding 
of clathrin-coated pits from the plasma membrane into the cell, movement of 
vesicles in the cytosol, targeting of the vesicles to specific destinations, and 
eventually the fusion of vesicles to subcellular structures (Gonzalez & Scheller, 
1999). Numerous of proteins, including the Rab (Ras-related GTP-binding protein) 
family proteins, participate and act in the RME process to ensure the internalization, 
targeting, and fusion to take place precisely. The Rab proteins are a group of small 
GTPases (~20-30 kDa) belonging to the Ras superfamily and take part in the 
process of membrane trafficking (Grosshans et al., 2006). Over 70 Rab proteins 
are found to function in intracellular transport and are classified into 6 groups 
based on their function in different components of intracellular membrane 
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trafficking, such as vesicle budding, delivery, fusion, and localization of certain 
proteins on different membrane domains (Stenmark, 2009). Mutations and 
abnormal expression of Rabs have been found to relate with many diseases. For 
instance, mutations on the Rab27a gene are responsible for the Griscelli syndrome 
(Menasche et al., 2000). The G19V mutation of Rab38 leads to the Hermansky-
Pudlak syndrome (Loftus et al., 2002). Rab25, which belongs to the Rab11 
subfamily, is elevated expressed and has an oncogenic function in ovarian, breast, 
prostate, bladder, and gastric cancer (S Wang et al., 2017). Rab23, a negative 
regulator of the hedgehog signaling pathway that predominantly locates on the 
plasma membrane, has increased expression in hepatocellular carcinomas, 
diffuse-type gastric cancer, and follicular adenoma type of thyroid tumors (Evans 
et al., 2003; Lim & Tang, 2015). 
The Rab proteins function as molecular switches as they can be “turned off” 
to their GDP-bound form (inactive form) by GTPase activating proteins (GAPs) and 
“turned on” to their GTP-bound form (active form) by guanine-nucleotide exchange 
factors (GEFs) (G Li, 2015). By recycling between the two forms, the Rab proteins 
govern the receptor-mediated endocytosis by regulating membrane trafficking 
system, specifically, by recruiting Rab effector proteins to specific sites of the 
intracellular membrane structures. Every Rab protein has its unique localization on 
distinct membrane compartments to control the specificity of membrane structures 
and directionality of membrane trafficking (Zhen & Stenmark, 2015).  
The Rab proteins can be found both in the cytosol and on membrane 
structures. The Rab GDP dissociation inhibitor (GDI) specifically recognizes the 
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GDP-bound Rabs. Thus, GDI solubilizes the Rabs and removes inactive Rabs 
from membrane structures (Figure 6). The GDI displacement factor (GDF), which 
locates on the donor membrane, initiates the recruitment of Rabs by dissociating 
the GDI from Rabs and inserting the Rabs into the membrane of intracellular 
compartments (Figure 6). To gain the membrane association ability, Rabs require 
post-translational modification of two cysteine residues located on or near the C-
terminal (Leung et al., 2006). The Rab proteins are then activated by a group of 
membrane-bound proteins named guanine nucleotide exchange factors (GEFs) 
(Figure 6). The activated GTP-bound Rabs then recruit several specific Rab 
effectors to facilitate vesicle budding, vesicle movement/delivery, and vesicle 
tethering (Muller & Goody, 2018). For instance, Rab1 and Rab2 are found on ER 
and cis-Golgi to regulate ER-Golgi and Golgi-ER trafficking, respectively; Rab5 is 
found to locate on early endosomes, clathrin-coated vesicles, and the plasma 
membrane to mediate vesicle budding and early endosome fusion; Rab7 is found 
on late endosomes to regulate late endosome trafficking (Stenmark & Olkkonen, 
2001). Then the activated GTP-bound Rabs are converted to the inactive forms 
through hydrolysis of GTP, which is mediated by another group of proteins termed 
GTPase activating proteins (GAPs). As an end, the inactivated Rabs will be 
removed from the acceptor membrane by the GDIs to enter the cytosol. 
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Figure 6. Rab GTPases cycle.  
Rab GTPases exist both in cytosol and on membrane. GDF, which locates on the 
donor membrane, displaces GDI and inserts Rabs onto the donor membrane. 
GEFs, which also locate on the donor membrane, replace the GDP to GTP to 
activate Rabs. Activated Rabs can recruit specific Rab effectors to mediate 
different membrane trafficking processes. The activated GTP-bound Rabs are 
converted to the inactive forms through hydrolysis of GTP, which is mediated by 
GAPs. Then GDIs specifically recognize the GDP-bound Rabs and thus solubilize 
the Rabs and remove inactive Rabs from the acceptor membrane. (GDI: Rab GDP 
dissociation inhibitor; GEF: guanine nucleotide exchange factor; GAP: GTPase-
activating protein; GDF: GDI displacement factor). (G Li, 2015; Zhen & Stenmark, 
2015) 
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In conclusion, the small GTPase Rab proteins perform their functions in the 
RME process by switching between their active and inactive forms and recruiting 
specific Rab effectors to certain membrane compartments. 
 
I.2.3 Structure of the receptor tyrosine kinases  
The human genome encodes 58 RTKs divided into 20 subfamilies, and the 
majority of RTKs share similar structures (Karpov et al., 2015). Generally, an RTK 
is comprised of an extracellular domain for ligand binding, a single α-helix 
transmembrane domain, and an intracellular region that contains a juxtamembrane 
domain, a tyrosine kinase domain (TKD), and a C-terminal (Lemmon & 
Schlessinger, 2010). The extracellular domains of RTKs are quite diverse between 
different subfamilies, which ensures the high specificity of each RTK to recognize 
unique ligand(s) (Karpov et al., 2015). On the contrary, the intracellular regions are 
relatively conserved between different subfamilies. The tyrosine kinase domain of 
RTKs has an N-lobe and a C-lobe (Figure 5.A). The smaller N-lobe consists of a 
five-stranded β-sheet and one α-helix, while the bigger C-lobe mainly consists of 
α-helices (Huse & Kuriyan, 2002). Besides the big cleft between the two lobes that 
forms a specific site for ATP binding, a phosphate-binding loop, which contains a 
highly conserved Gly-rich (GXGXXG) motif, poses the γ-phosphate of ATP and 
allows ATP to fit beneath the loop (Taylor & Kornev, 2011). Another highly 
conserved construction, the activation loop, which usually contains around 20 to 
35 residues and is the primary site of regulatory phosphorylation, starts at the 
tripeptide Asp-Phe-Gly (DFG) motif and ends at another tripeptide Ala-Pro-Glu 
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motif (Svensson et al., 2016; Bayliss et al., 2015). The capacity of undergoing large 
conformational change allows the activation loop to switch between inactive and 
active states. In the inactive state, each TKD is stabilized in a unique auto-inhibition 
configuration by several particular intramolecular interactions between the 
juxtamembrane domain/C-terminal and the TKD (Lemmon & Schlessinger, 2010). 
Though the structures of inactive TKDs differ from receptor to receptor, which 
determines the diverse functions of RTKs, the active structures of all TKDs are 
very similar to each other (Nolen et al., 2004). Upon activation of TKD by specific 
ligands, the phosphorylated tyrosine residues in the activation loop then serve as 
sites for assembly of signaling molecules that contain Src homology 2 (SH2) or 
phosphor-tyrosine-binding (PTB) domains (Axel Ullrich & Schlessinger, 1990). The 
phosphorylation of these signaling molecules can be triggered either directly by 
phosphorylated RTKs themselves, or indirectly by docking proteins, which are 
recruited and phosphorylated by activated RTKs (Schlessinger & Lemmon, 2003). 
Then the recruited signaling molecules pass down the initial signal and regulate 
cell survival, proliferation, and differentiation. 
 
I.3 The insulin signaling pathways: the essential determinant of 
adipogenesis 
The insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) 
belong to the IR subfamily of RTKs. Both IR and IGF-1R have differ affinities to 
insulin and IGFs (IGF-1/-2), which are from the same structural-related insulin-
peptide superfamily (De Meyts et al., 2000-2013). The insulin signaling pathways 
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that are triggered by the activation of the IR and IGF-1R integrate the storage and 
release of nutrients through human lives. The outlines of the insulins signaling 
pathways have been well described, but many details of signal transduction still 
need to be elucidated. The two well-established and most essential signaling 
pathways been initiated by insulin/IGFs are the Erk1/2 signaling pathway and the 
PI3K/Akt signaling pathway (Zarich et al., 2006). The effects of insulin signaling 
pathways activation on adipocytes can be divided into three types: immediate 
effects, mid-term effects, and long-term effects. Immediate effects, such as the 
phosphorylation and dephosphorylation of specific enzymes and proteins, take 
place within several seconds after IR activation. Mid-term effects include the up- 
and down-regulated expression of specific proteins within 5-60 minutes after 
insulin stimulation. Long-term effects, e.g., cell proliferation and cell differentiation, 
will be detected from several hours to several days after insulin stimulation. Details 
of the effects of the insulin signaling pathways on adipocytes will be discussed 
later in this section. 
 
I.3.1 Insulin receptor and its structure 
The initiation of the insulin signaling pathways start with the binding of 
insulin or IGFs to the IR or the IGF-1R. Between the two receptors, IR is the 
primary site for insulin binding. The IR was first identified in 1971 by Cuatrecasas 
on adipocytes (Cuatrecasas, 1971). Through decades of research, the IR is proved 
to exist on the membrane of all types of mammalian cells with vary numbers from 
~40 on erythrocytes to ~200~300 × 103 on adipocytes (Watanabe et al., 1998). 
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Thus, dysregulation of cell metabolism happens when the IR is abnormally 
expressed on the cell surface. For instance, increased expression of the IR is often 
overserved in malignant cells. About 80% of the breast cancer cells have a 
significant higher IR content than the normal breast tissue cells. Besides, a higher 
level of IR expression predicts a poor survival in breast cancer patients (Vigneri et 
al., 2016). The IR knockout mice only survived a few days after birth. The “fat-
specific” IR knockout mice and adipocyte-specific IR knockout mice, though had a 
reduced fat mass and were protected from obesity-associated glucose intolerance, 
both suffered increased TAG accumulation in liver, hepatomegaly, and decreased 
lifespan (M.  Bluher et al., 2002; Eguchi et al., 2011; Joshi et al., 1996). 
As a member of the RTKs, the IR contains an extracellular domain for ligand 
binding, a transmembrane domain, and an intracellular region which includes a 
juxtamembrane domain, a tyrosine kinase domain, and a C-terminal (Figure 7). 
However, unlike the prototypical RTKs that exist as single-chain polypeptides, IR 
exists as a covalently-linked tetramer consists of two α-subunits and two β-
subunits (Weiss et al., 2014). The four subunits are disulfide-linked to form a ~350 
kDa structure. The α-subunit and 194 residues of the β-subunit together form the 
extracellular portion of the IR, while the rest of the β-subunit, which contains a 
single transmembrane part and a cytoplasmic portion (IR-β-tail) that permits the 
tyrosine kinase activity of the IR, is the intracellular portion (Belfiore et al., 2009). 
Upon ligand binding, the α-subunits of the IR will inhibit the kinase activity of the 
β-subunits by inducing a structural change of the IR molecule at first. Then, this 
conformational change of the IR molecule will bring the two β-subunits close 
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enough to each other to permit the kinase activity of the β-subunits (Boucher et al., 
2014). The activation of tyrosine kinase activity of the IR includes the 
autophosphorylation of three tyrosine residues, which are Y1158, Y1162 and 
Y1163 in the activation loop of the kinase domain (contains ~300 residues) (Figure 
7). Among the three tyrosine residues, the Y1162 is hydrogen-bonded to the 
catalytic loop that occludes the ATP-binding site in the absence of Mg2+-ATP and 
will be the first to undergo autophosphorylation during IR activation, followed by 
autophosphorylation of the other two residues (Wei et al., 1995). Mutations in these 
three residues not only affected the kinase activity of the IR but also impaired the 
biological function of the IR (Wilden et al., 1992). Besides the three tyrosine 
residues that permit the catalytic kinase activity, some other tyrosine residues, 
such as Y965 and Y972 in the juxtamembrane region (~35 residues; between the 
transmembrane helix and the tyrosine kinase domain) and Y1328 and Y1334 in 
the C-terminal (~70 residues) of the β-subunit, are also autophosphorylated upon 
ligand binding (Figure 7). Mutations on the tyrosine sites leads to decreased 
signaling transduction and/or diminished insulin sensitivity, glycogen synthesis, 
and nutrients uptake (Table 2). 
The IR has two isoforms: the IR isoform A (IR-A) without the exon 11, which 
codes a 12-amino acid segment at the C-terminal of α-subunit, and the IR isoform 
B (IR-B) with the exon 11 (Ebina et al., 1985; A. Ullrich et al., 1985). The two 
isoforms exhibit vary distribution in a tissue-specific manner and distinct cellular 
functional properties (Figure 7).  
 
 
50 
 Figure 7 The insulin signaling pathway.  
Insulin receptor (IR) is activated upon insulin binding. The activation of IR leads to 
the phosphorylation of several tyrosine kinases in the intracellular region of IR, 
including Y972 in the juxtamembrane region, Y1158, Y1162 and Y1163 in the 
tyrosine kinase domain and Y1328 and Y1334 in the C-terminal. The pY972 is 
responsible for the activation of IRS-1 and Shc through the phosphotyrosine-
binding domain (PTB domain), while Y1158, Y1162 and Y1163 activate IRS-2 after 
phosphorylation. In the PI3K/Akt pathway showing on the right of the figure, the 
activated IRS-1/2 can directly recruit the PI3K and eventually lead to the activation 
of Akt. Glucose uptake, glycogen synthesis and Glut4 translocation are up-
regulated upon Akt activation. In the Erk1/2 signaling pathway showing on the left, 
activated Shc recruits the Grb2-SOS complex, which mediates the GDP/GTP 
exchange of Ras. At the end, Erk1/2 will be activated and anticipates in the 
regulation of cell growth, gene expression and protein translation. (Cieniewicz et 
al., 2016; Papich & Riviere, 2009; Youngren, 2007; Taguchi & White, 2008; 
Boucher et al.; Hubbard, 2013). 
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The IR-B has high affinity to insulin and is predominantly expressed in 
differentiated tissues that contain a higher number of IRs on the cell surface and 
have an inadequate response to IGF-2, such as liver, kidney, adipose tissue, and 
muscle. In contrast, though the IR-A has similar affinity to insulin as the IR-B, it 
exhibits high affinity to IGF-2. Besides, the IR-A is primarily expressed in fetal and 
tumor tissues with comparatively greater rates of internalization and recycling than 
the IR-B (Escribano et al., 2017). Because of these differences, the IR-A activation 
is mainly associated with cell growth, cell proliferation, and cell survival, whereas 
the IR-B activation favors regulation of metabolism and differentiation. In the 32D 
cells, the IR-A preferentially sends mitogenic, antiapoptotic signals and translocate 
insulin receptor substrates (IRS-1) to the nucleus more effectively while the IR-B 
tends to send differentiation signals (Sciacca et al., 2003). In vascular smooth 
muscle cells, the overexpression of IR-A confers a stronger migratory capability 
(Beneit et al., 2016). The IR-A is also proved to be more efficient at increasing 
glycogen synthesis and storage and promoting glucose uptake than the IR-B 
(Diaz-Castroverde et al., 2016).  
The activation of the IR will induce the recruitment of downstream proteins 
that contain either a phosphotyrosine-binding domain (PTB domain) or an SH2 
domain (Figure 7). E.g., IRS-1/-2 and Shc (Src homology and collagen protein) 
have a PTB domain, while Shc and APS (adaptor protein with pleckstrin homology 
and Src homology 2 domains) contain an SH2 domain (Boucher et al., 2014; 
Taguchi & White, 2008). The PTB domain-containing proteins bind to pY972 
(phosphorylated-Y972), which creates a lower affinity docking site for the PTB 
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domain of IRS-1, but a much higher affinity docking site for the same domain of 
Shc (Chaika et al., 1999; SawkaVerhelle et al., 1996). Interestingly, the Y972 
belongs to the NPXY motif where the phosphorylation on the tyrosine site recruits 
the AP2 complex. In addition, pY972 is also the recruiting site for IRS-2. However, 
different from the IRS-1 that only interacts with the IR through one phosphorylated 
tyrosine (the pY972), the IRS-2 also interacts with the three tyrosines that located 
in the activation loop (Jensen & De Meyts, 2009; He et al., 1996). As 
consequences of IR activation, two major signaling pathways are activated: the 
Erk1/2 signaling pathway and the PI3K/Akt signaling pathway (Figure 7). The 
specific function and regulation of the two pathways will be discussed later.  
 
I.3.2 Insulin-like growth factor receptor 1 and its structure 
The complementary DNA for human IGF-1R was cloned and sequenced in 
1986 (A. Ullrich et al., 1986). It binds to IGF-1 with higher affinity than IGF-2 but 
does not recognize insulin efficiently. The IGF-1R is widely expressed in many cell 
types in fetal and postnatal tissues and plays a role in essential cellular processes, 
including cell growth, cell differentiation, and apoptosis (Arcaro, 2013). Mice with 
null mutants for the IGF-1R exhibit a severe growth deficiency (only 45% of normal 
size) and die invariably at birth because of respiratory failure (JP Liu et al., 1993). 
Non-malignant cells treated with IGF-1R nuclear translocation inhibitor or IGF-1R 
inhibitor display a decreased proliferation and migration rate than the untreated 
cells (Solomon-Zemler et al., 2017). In addition to the role of the IGF-1R during 
development and cell proliferation, evidence also suggests a vital role of it in 
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malignant transformation (Sachdev & Yee, 2007). For instance, data show that the 
increased expression of the IGR-1R is associated with malignancy behavior in 
familial pheochromocytomas and paragangliomas regardless of the age at 
diagnosis and the genetic aetiology (Fernandez et al., 2013). Evidence also shows 
that a disrupted activation of the IGF-1R results in inhibited growth and motility of 
a wide range of cancer cells in vitro and in mouse models (Sachdev & Yee, 2007). 
The IGF-1R and the IR are from the same subfamily of RTKs. Thus, the 
IGF-1R is highly structural homologous to the IR, sharing 45% to 65% amino acid 
identity in the ligand-binding domain, 65% to 85% identity in the tyrosine kinase 
and substrate recruitment domains, and nearly absolute conservation in the ATP 
binding pocket (Escribano et al., 2017). However, unlike the IR gene that is 
alternatively spliced to produce two isoforms, the IGF-1R gene is assembled 
without alternative splicing (Morris F. White, 2012). Similar to the IR, the IGF-1R is 
a tetramer consists of two α-subunits and two β-subunits. One α subunit and one 
β subunit form an αβ half-receptor monomer. Two monomers are assembled into 
heterotetramer complex through disulfide bonds, which can be induced by 
treatment of IGF-1 or Mn/MgATP in vitro (Treadway et al., 1989). Activation and 
signaling transduction of the IGR-1R is also quite similar to those of the IR. The 
three tyrosine residues locate on the activation loop of the tyrosine domain of IGF-
1R are Y1131, Y1135, and Y1136 (these three tyrosine residues resemble the 
functions of Y1158, Y1162, and Y1163 on the IR). The Y950 locates on the NYXP 
motif of the juxtamembrane domain of the IGF-1R has similar function as the Y972 
of the IR (Table 2). 
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Table 2. Locations and functions of essential amino acids on the β-subunit 
of the IR and the IGF-1R. 
 
A. Locations of essential amino acid residues on the β-subunit. 
Receptor Full Length 
Juxtamembrane 
Domain 
Tyrosine Kinase 
Domain C-Terminal 
IR-A1 1343 Y953, Y960 K1018, Y1146, Y1150, Y1151 
Y1316, 
Y1322 
IR-B2 1355 Y965, Y972 K1030, Y1158, Y1162, Y1163 
Y1328, 
Y1334 
IGF-1R3 1337 Y943, Y950 K1003, Y1131, Y1135, Y1136 
            
Y1316 
1 The numbering of amino acids of IR-A corresponds to the receptor of Ullrich et 
al. (A. Ullrich et al., 1985). 
2 The numbering of amino acids of IR-B corresponds to the receptor of Ebina et al. 
(Ebina et al., 1985). 
3 The numbering of amino acids of IGF-1R corresponds to the receptor of Ullrich 
et al. (A. Ullrich et al., 1986). 
 
B. Functions of essential amino acid residues on the β-subunit of the IR-B. 
Amino acid Function 
Y965 IR autophosphorylation site AP2 complex binding site15 
Y972 
IR autophosphorylation site 
AP2 complex binding site9 
PTB domain-containing protein binding site12 
IRS-1/2 binding site5 
K1030 ATP binding site6 
Y1158, Y1162, Y1163 
IR autophosphorylation sites 
Essential tyrosine residues on the activation 
loop14 
IRS-2 binding site9 
Y1328, Y1334 IR autophosphorylation sites 
5(He et al., 1996); 6(M. F.  White et al., 1988); 9(Bonifacino & Traub, 2003); 
12(Chaika et al., 1999); 14(Cieniewicz et al., 2016); 15(Y Xu et al., 2011). 
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C. Effects of essential amino acid residue mutants on the β-subunit of the 
IR-B. 
 
Mutant Effects of Mutant 
Y965F No effect on IR internalization or IR auto-phosphorylation11 
Y972F 
No interaction with IRS-14,5 
No effect on IRS-2 binding5 
No effect on IR auto-phosphorylation11 
Decreased insulin sensitivity6 and rate of glucose 
transport12 
Diminished glycogen synthesis and internalization8 
Y965A 
No effect on IRS-2 binding5 
No effect on IR auto-phosphorylation11 
Decreased IR internalization11 
Y972A No effect on IR auto-phosphorylation
11 
Decreased IR internalization11 
△966-977 
No effect on auto-phosphorylation of β-subunit8 
Diminished downstream signaling, glycogen synthesis, 
and IR internalization8 
K1030A No interaction with IRS-1/2
4,5 
Decreased IR internalization13 
K1030R Diminished glycogen synthesis, insulin sensitivity, MAP kinase activity, 
Y1158F No effect on IRS-2 binding
5 
Decreased IR internalization13 
Y1158, 
Y1162F, 
Y1163F 
Deduction of insulin-activated auto-phosphorylation16 
Decreased IR internalization13 
Diminished glucose uptake 
△1312-1355 No significant influence on kinase activities
7, 10 
No significant effect on IR internalization13 
4 (O’Neill et al., 1994); 5(He et al., 1996); 6(M. F.  White et al., 1988); 7(Backer, 
Schroeder, et al., 1992); 8(Backer et al., 1990); 9(Bonifacino & Traub, 2003); 
10(Myers et al., 1991); 11(Backer, Shoelson, et al., 1992); 12(Chaika et al., 1999); 
13(Carpentier et al., 1993); 14(Cieniewicz et al., 2016); 15(Y Xu et al., 2011); 16(Ellis 
et al., 1986). 
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I.3.3 Signaling transduction in adipocyte differentiation 
Because of the important function in cellular signaling transduction, the 
RTKs regulate several essential cellular processes such as proliferation, 
differentiation, and tissue homeostasis (Lemmon & Schlessinger, 2010; F Liu & 
Zhuang, 2016). For instance, RTKs regulate the liver regeneration through the 
Erk1/2 signaling pathway (J Li et al., 2011). In liver, the proliferation of hepatocytes 
(hepatocytes undergo two cell cycles) occur in the early 66 hours after partial 
hepatectomy (L Xu et al., 2010). The RTK à SHC à GRB2/SOS à RAS à RAF 
pathway is found to promote the progression of G1 phase during the proliferation, 
while the RTK à PLCγ à PKC à SRC/PYK2 à GRB2/SOS à RAS à RAF 
pathway participates in advancing the S phase and G2/M phase checkpoint (J Li 
et al., 2011). RTKs also regulate the differentiation of mesenchymal stem cells 
(MSCs) into neuronal cells (Tzeng et al., 2015). Upon the stimulation of growth 
factors such as FGF-8 (fibroblast growth factor 8) and FGF-2 (fibroblast growth 
factor 2), RTKs induce activation of both the Erk1/2 signaling pathway and the 
PI3K/Akt signaling pathway in MSCs (Trzaska et al., 2007). On the one hand, the 
phosphorylation of Erk in the former pathway phosphorylates the downstream 
protein GREB (cAMP response element-binding protein) and then leads to the up-
regulation of TrkB (tyrosine receptor kinase B, the receptor of BDNF) and the 
secretion of BDNF (brain-derived neurotrophic factor) (Tzeng et al., 2015). On the 
other hand, the activation of the later pathway plays a critical role in cell survival 
(Tzeng et al., 2015). Therefore, the importance of RTKs on intracellular trafficking 
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and cellular signaling, and how these receptors regulate proliferation and 
differentiation will allow us to understand the critical role of these receptors in the 
process of adipogenesis.  
Following up the functions of RTKs, the IR specifically activates two 
essential signaling pathways: the Erk1/2 signaling pathway and the PI3K/Akt 
signaling pathway (Figure 7). Through the two pathways, the activation of the IR 
regulates multiple biological processes: gene expression, protein translation, and 
cell growth via the Erk1/2 signaling pathway; and changes in metabolic function, 
such as glucose uptake, glycogen synthesis, and expression of necessary 
enzymes/proteins as acute metabolic response, through the PI3K/Akt signaling 
pathway (Taniguchi et al., 2006; Jensen & De Meyts, 2009). On the one hand, Shc 
is recruited and activated through the pY972 on the juxtamembrane domain of the 
IR. Then Grb2 will be recruited via the interaction between its SH2 domain and 
tyrosine phosphorylated Shc (Jameson et al., 2016). At last, SOS will be recruited 
and interacts with the two SH3 domains of Grb2 to form the Grb2-SOS complex, 
following the activation of RAS à RAF à MEK à Erk1/2 cascade (Zarich et al., 
2006). On the other hand, the phosphorylation on the Y972 recruits and activates 
both IRS-1 and IRS-2 whereas the Y1158, Y1162, and Y1163 on the activation 
loop of the IR are only responsible for IRS-2 recruitment and activation. Then PI3K 
will be recruited and activated based on its SH2 domains following IRS-1/2 
activation (Youngren, 2007). The activated PI3K finally leads to activation of Akt, 
which ensures the IRS-1/2 à PI3K à Akt cascade.  
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Besides the effects on normal cell processes, the IR signaling pathways are 
essential for the differentiation of the pre-adipocytes in specific aspects. First, the 
signaling pathway is triggered by activation of the IR and regulates the 
differentiation, proliferation, and growth of the fat cells (adipocytes) by stimulating 
the formation and storage of lipids in both pre-adipocytes and adipocytes (Saltiel 
& Kahn, 2001). Second, the invagination of the IR complexes is activated through 
the RME, which regulates the IR distribution on the plasma membrane, insulin 
sensitivity, and density of the IR biological activities (Morcavallo et al., 2014). 
Interestingly, the receptor signaling of IR complexes is not terminated after 
invagination, on the opposite, it can be magnified (Vieira et al., 1996). Since the 
internalized IR complexes are still active and continue triggering the downstream 
signaling, the process of internalization is essential for the regulation of signal 
transduction (Sorkin & Von Zastrow, 2002). As is discussed above, there are two 
fates for these internalized vesicles: 1) to merge with lysosomes and be degraded; 
2) to proceed to the recycling endosomes from where the IR is brought back to the 
cell surface to be used again (Marsh, 2001). The transport and sorting of early 
endosomes require the participation of Rab5 (Hunker et al., 2006). 
 
I.4 Regulating the function of Rab5 
I.4.1 The small GTPase Rab5: small but essential 
Rab5 is a Ras-like small GTPase (small GTP-binding protein) that not only 
shows a crucial regulatory role in controlling the RME of the IR but also plays a 
rate-limited role in early endosome fusion (Barbieri et al., 2004). Like the other 
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GTPases, Rab5 has two forms: the active form and the inactive form. The active 
form is also the Rab5 GTP-bound form, while the inactive form is also the Rab5-
GDP-bound form (Figure 8). The converting of the Rab5 GTP-bound form to the 
Rab5 GDP-bound form (inactivation of Rab5) is triggered by Rab5 GAPs while the 
activation of Rab5 is catalyzed by Rab5 GEFs (Figure 8). 
 
Figure 8. Rab5 regulation.  
As other GTPases, Rab5 has two forms: the active form and the inactive form. The 
active form is the Rab5 GTP-bound form while the inactive form is the Rab5 GDP-
bound form. The converting of the GTP-bound form to the GDP-bound form 
(inactivation of Rab5) is triggered by GAPs while the converse activation process 
of Rab5 is catalyzed by GEFs (Lundquist, 2006). The ribbon diagrams of 
GTP/GDP-bound form of Rab5 are modified from Zhu et al. (Zhu et al., 2004). The 
switch I/II (SW (I)/(II)) regions are shown in red and blue, respectively. GppNHp (a 
nonhydrolyzable GTP analog), GDP, and metal ions are shown in brown sticks and 
dots, respectively. (PL: phosphate-binding loop; GAP: GTPase activating protein; 
GEF: guanine exchange factor; GppNHp: guanosine-5’(β,γ)-imidotriphosphate.) 
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As the primary Rab protein to function in early endosome dynamics and 
probably the one that has the best-characterized effectors in mammalian studies, 
Rab5 presents on the plasma membrane and endocytic vesicles, but mainly 
locates on sorting endosomes (Woodman, 2000). Rab5 is also a membrane-
associated protein that undergoes a hydrophobic modification at the C-terminal 
(Woodman, 2000). The isoprenylation of C-terminal cysteines allow Rab5 to 
associate with the membrane of an organelle or transport vesicles in its GTP-
bound form (Pechlivanis & Kuhlmann, 2006). When in the Rab5-GDP binding form, 
Rab5 can be maintained in a soluble state, transferred, and efficiently recruited in 
the cytosol by forming a cytosolic complex with guanine nucleotide dissociation 
inhibitor (GDI) (Woodman, 2000). The GDI displacement factors (GDFs), which 
present on the membrane of the endocytic vesicles or the early endosome, then 
catalyze the localization of Rab5 to these membrane compartments and mediate 
the replacement of GDI (Blumer et al., 2013). A Rab5 GEF in the endosome 
membrane will then activate Rab5 by exchanging GDP to GTP (Alberts et al., 
2007). The activated Rab5 can activate PI3K, which synthesizes PI3P 
(phosphatidylinositol 3-phosphate). Together with PI3P, the activated Rab5 binds 
to a variety of Rab5 effectors to perform the biological effects of Rab5 on 
endosome fusion (Woodman, 2000). In addition, the activated Rab5 can recruit 
more Rab5 GEFs, thus creating a positive feedback loop to further enhancing 
Rab5 assembly. Interestingly, Rab5 is also reported to be required for the 
interaction between IRS-1 and p85α and the activation of Akt upon insulin 
stimulation (Su et al., 2006). 
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In summary, Rab5 activity is regulated by several Rab5 specific GEFs and 
GAPs, and more importantly, different Rab5 effectors are recruited by the GTP-
bound Rab5 to modulate particular intracellular pathways (Table 3). 
 
Table 3. Rab5 regulators and effectors. 
 
I.4.2 Guanine nucleotide exchange factors, GTPase-activating proteins, 
and effectors of Rab5: working cooperatively 
Rab5 GEFs, including Ras interference 1/2/3 (RIN1/2/3),  Rabaptin-5 
associated exchange factor for Rab5 (Rabex-5), , amyotrophic lateral sclerosis 2 
(ALS2/Alsin), GTPase activating protein and exchange factor for Rab5 (GAPex-5), 
 Regulator/Effector 
Rab5 GEF 
RIN1/2/3 
Rabex-5 
ALS2/Alsin 
RAP6/GAPex-5/RME-6 
Rab5 GAP 
RN-Tre 
RabGAP-5 
Rab5 effectors 
Rabaptin-5 
Vps34 
Rabenosyn-5 
EEA1 
APPL1/2 
PI3K 
Rabankyrin-5 
Huntingtin 
 
 
62 
and Ras interference-like (Rinl) are specialized by the highly conserved vacuolar 
protein sorting-associated protein 9 (VPS9) domain through which the inactivated 
Rab5 interacts with (Carney et al., 2006). The VPS9 domain-containing proteins 
are widely conserved in eukaryotic cells of different species, such as Vps9p and 
Muk1p from S. cerevisiae, RME-6, RABX-5, and CE23604 from Caenorhabditis 
elegans (C. elegans) and at least nine proteins from the human beings (Carney et 
al., 2006).  
Functions of the Rab5 GEFs have been extensively studied in the past four 
decades. The RIN family is composed of RIN1, RIN2, and RIN3. They are 
multifunctional proteins that, besides the VPS9 domain, contain another three 
domains: the RA (Ras association) domain, the PR (proline rich) domain, and the 
SH2 domain. The RIN proteins share similar structure of all the domains but are 
distinguished by the containing of a different number of the PH domain, which has 
one/two/three repeats in RIN1, RIN2 and RIN3, respectively. The RIN proteins can 
be activated by the IR through the SH2 domain and activate Rab5 through the 
VPS9 domain upon IR activation. Activation of RIN proteins leads to the activation 
of Rab5, thus promotes the early endosome fusion (Barbieri et al., 2004). The RA 
domain of the RIN proteins is responsible for the interaction with Ras, indicating 
RIN proteins to be Ras effectors that promote Rab5 activity. RIN1 is the most well-
characterized protein in the RIN family, existing in both the cytoplasm and the 
plasma membrane (Colicelli et al., 2012). Previous studies show that RIN1 
promotes EGFR and TGF-β receptor internalization through Rab5 activation 
(Barbieri et al., 2003; Colicelli et al., 2012). The expression of RIN1-SH2 domain, 
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however, impairs the EGFR internalization without affecting cargo endocytic 
receptors, such as transferrin (Barbieri et al., 2003). RIN1 also binds to 14-3-3 
proteins through a sequence containing serine 351. The binding with 14-3-3 
locates RIN1 to the cytoplasm and intracellular compartments whereas the 
mutation S351A shifts RIN1 localization to the plasma membrane (Y Wang et al., 
2002). RIN1:R94A mutant, which locates in the SH2 domain, showed a decreased 
interaction with EGFR upon EGFR activation (Barbieri et al., 2003). The 
RIN1:Y561F mutant, which locates in the VPS9 domain of RIN1, showed defective 
function in activation of Rab5 and dramatic inhibition of Rab5 function (Galvis et 
al., 2009). In addition, RIN1 has been found to be a breast tumor suppressor gene 
and undergoes a regulated expression in forebrain neurons and epithelial cells 
(Dzudzor et al., 2010; Milstein et al., 2007). RIN2 and RIN3 display same 
biochemical property as RIN1 that perform the guanine nucleotide exchange 
activity. However, both RIN2 and RIN3 can bind to amphiphysin II, whereas RIN1 
cannot. Besides this distinct interaction, RIN1 is dominantly expressed in brain and 
pancreas, RIN2 has its highest expression in heart and kidney, and RIN3 exhibits 
higher expression in human mast cells (Carney et al., 2006; Janson et al., 2012). 
RIN3 also exhibits a unique intracellular localization as it locates on Rab5-positive 
vesicles in the cytoplasm but does not colocalize with the essential early 
endosome marker early endosome antigen 1 (EEA1) (Kajiho et al., 2003). 
The Rinl was recently identified as a Rab5 GEF with high similarity to the 
RIN proteins but without an RA domain (Kajiho et al., 2012). It is ubiquitously 
expressed in all types of cells but with higher expression in lymphoid organs, such 
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as thymus and spleen, and specifically accumulates at neuromuscular synapses 
(Woller et al., 2011). It colocalizes with Rab5 in actin-rich membrane ruffles, which 
indicates a novel role of Rinl to recruit Rab5 to the cytoskeleton (Woller et al., 2011). 
Interestingly, the Rinl also activates Rab22 and even shows a higher catalytic 
activity for Rab22 compared to Rab5.  
The Rabex-5 protein structure is identified to be made up of an N-terminal 
domain, a membrane binding domain, a helical bundle (HB) domain, a VPS9 
domain, a coiled-coil (CC) domain, and a PR domain (Shin et al., 2012). The 
Rabex-5 activates Rab5 and thus recruits Rabaptin-5 (a Rab5 effector), which then 
binds to the GTP-bound Rab5 and recruits Rabex-5 in a positive loop. Interestingly, 
the GTP exchange activity of Rabex-5 is much higher when in the Rabex-5-
Rabaptin5 complex (Delprato et al., 2004). Besides, the VPS9 domain of Rabex-5 
alone shows a higher GTP exchange activity than the full-length Rabex-5 (Delprato 
et al., 2004).  
Alsin is a 183kDa protein that mainly expresses in brain. It is a 
multifunctional protein that contains a Ran GEF RCC1 (RCC1-like) domain, a 
tandem Dbl homology (DH) domain, a pleckstrin homology domain, several 
membrane occupation and recognition nexus (MORN) motifs, and a VPS9 domain 
(Carney et al., 2006). Alsin exhibits colocalization with Rab5 and its effector EEA1 
on the early endosomes in Hela cells (Otomo et al., 2003). Overexpression of the 
wild-type Alsin and the constitutive active form of Alsin both results in enlarged 
endosomes in cultured neuronal cells through the activation of Rab5 (Otomo et al., 
2003). Besides, Alsin-deficient mice exhibit a disturbance in endosome 
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transportation of IGF-1R but unaltered endocytosis of transferrin and dextran 
(Devon et al., 2006). 
Rab5-activating protein 6 (RAP6) is the human homolog of GAPex-5, which 
is also known as receptor-mediated endocytosis protein 6 (RME-6) as the C. 
elegans homolog, contains an N-terminal RasGAP domain and a C-terminal VPS9 
domain. Unlike the other Rab5 GEF proteins that colocalize with Rab5 on the early 
endosomes, RAP6 is primarily found on clathrin-coated pits (CCPs). In vivo, the 
expression of the dominant-negative form of Rab5 (Rab5-S34N, this mutant will 
be discussed later in other chapters) or small interfering RNA (siRNA)-mediated 
depletion of RAP6, reduced the uncoating efficiency of AP2 complex on the CCPs 
by increasing the steady-state levels of AP2 (Semerdjieva et al., 2008). 
Another group of proteins that regulate the Rab5 function are the GAPs, 
including the Rab5-specific GAP protein (RabGAP-5) and related to the N terminus 
of tre oncogene (RN-tre), which solubilize Rab5 by inactivating Rab5 from the 
acceptor membrane (Figure 6). The rate of GTP hydrolysis mediated by GAPs is 
relatively high since the basal rate is intrinsically slow (~1 min) (Scheffzek et al., 
1998).  
RN-tre localizes to Rab5-positive vesicles. Overexpression of RN-tre 
inhibits the Rab5-dependent internalization of transferrin and EGF but does not 
affect the membrane association of EEA1 (Haas et al., 2005; Palamidessi et al., 
2013). Removal of RN-tre increases the level of active Rab5 and significantly 
improves the cell migration of mouse embryo fibroblasts in vitro (Palamidessi et 
al., 2013).  
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The overexpression of RabGAP-5 results in a loss of Rab5 effector EEA1 
from early endosomes and impaired endocytosis (Haas et al., 2005). However, 
depletion of RabGAP-5 leads to similar phenotype as the expression of the 
constitutive active mutant of Rab5 (Rab5-S34N): level of endosome-localized 
EEA1 is increased, endosomes become larger, and trafficking of EGF is disrupted 
(Haas et al., 2005). 
In the processes of vesicle formation and delivery, Rab5 is also regulated 
by multiple Rab5 effectors. As one of the best studied Rab proteins to date, Rab5 
has been found to interacts with as many as 30 different effector proteins (Pfeffer, 
2005). For instance, EEA1, an important Rab5 effector that binds to Rab5-GTP 
form, is the only effector that is necessarily required by minimal fusion and 
mediates endosome docking (Christoforidis et al., 1999). Another Rab5 effector, 
Rabaptin-5, is initially identified as an GTP-bound Rab5 effector through a yeast 
2-hybrid screen (Stenmark et al., 1995). Rabaptin-5 is mostly found as a complex 
with Rabex-5 in the cell (Horiuchi et al., 1997). Rabex-5 and Rabaptin-5 recruit 
each other in a positive loop upon Rab5 activation and thus keep the membrane 
Rab5-postive until the loop is interrupted by other recruited compartments (Kalin 
et al., 2015). Deletion of the Rab5-binding domain of Rabaptin-5 results in giant 
endosomes as well as impaired endocytosis process (Kalin et al., 2015). 
In summary, the movement of intracellular vesicles mediated by RME is 
related with Rab5 and its effectors due to their roles in regulating vesicle formation 
and delivery.  
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CHAPTER II 
II. Role of Rab5 in the process of adipogenesis 
II. 1 Introduction 
As described in Chapter I, the in vitro differentiation of the mouse 3T3-L1 
pre-adipocytes into mature adipocytes is an insulin-dependent ten-days process 
that can be divided into a mitotic clonal expansion (MCE) phase and a terminal 
differentiation phase (Tang & Lane, 2012). The pre-adipocytes undergo two cycles 
of mitosis during the MCE phase maintaining their fibroblast-like cell characteristics. 
However, the cells exhibit distinct morphological changes in the terminal 
differentiation phase. Besides the alterations in the cell shape and size, the most 
noticeable feature of the mature adipocytes is the formation and accumulation of 
a large number of lipid droplets in the cytosol (Suzuki et al., 2011). The conversion 
from pre-adipocytes into adipocytes, along with the remarkable changes in cell 
morphology, is controlled by the insulin and IGF-1 signaling pathways and 
numerous transcription factors. Much of what is known about the adipogenic 
factors required for adipogenesis process is based on the in vitro studies of 
adipogenic cell lines, such as the mouse 3T3-L1 and 3T3-F442A cell lines. The 
essential transcription factors promoting the adipogenesis process are the 
peroxisome proliferator-activated receptor γ (PPARγ) and the CCAAT/enhancer-
binding protein (C/EBP) family (Rosen et al., 2002). These transcription factors 
regulate the expression of most genes that define mature adipocytes, including the 
insulin-sensitive glucose transporter isoform 4 (GLUT4), which is primarily 
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expressed on the plasma membrane of adipocytes (James et al., 1988; Tamori et 
al., 2002). The expression level of GLUT4 and the number of GLUT4 existing on 
the plasma membrane is regulated through the insulin and IGF-1R signaling 
pathways (Bryant et al., 2002; Czech & Buxton, 1993). Several Rab proteins are 
involved in the trafficking of GLUT4 by participating in the insulin signaling 
transduction process and the transportation of GLUT4 from intracellular GLUT4 
storage vesicles (GSVs) to the plasma membrane (Sadacca et al., 2013). In 
particular, three Rab proteins of the endosomal system (e.g., Rab5, Rab4, and 
Rab11) participate at different steps of the GLUT4 trafficking process. 
Rab5 is a key regulatory molecule directing in the early endocytic pathway 
(Barbieri et al., 2004; Barbieri et al., 2000; Hoffenberg et al., 2000). Rab5 is 
encoded as three differentially expressed isoforms, Rab5a, Rab5b, and Rab5c 
(Chen et al., 2009).  The mRNA expression profiling study shows distinct tissue 
distributions of the Rab5 isoforms (Gurkan et al., 2005). A study shows that the 
suppression of Rab5a or Rab5b undermines the degradation of EGFR, whereas 
Rab5c shows limited effect (Chen et al., 2009). Another study suggested the 
silencing of Rab5c, but not the other two isoforms, significantly reduced the focal 
adhesion foci of Hela cells, indicating a particular role of Rab5c in cell migration 
(Chen et al., 2014). However, the functional redundancy of the isoforms is 
suggested as only the simultaneous knockdown of all three isoforms results in an 
inhibition of the insulin-dependent Akt activation, whereas individual knockdown of 
any single isoform does not affect Akt activation (Su et al., 2006).  
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Mutational studies have shown that the Rab5:S34N, a Rab5 GTP-binding 
defective mutant, inhibits transferrin and EGF endocytosis displaying a dominant-
negative effect; whereas the Rab5:Q79L, a mutant with reduced GTPase activity, 
behaves as a constitutively active Rab5 mutant stimulating internalization of 
several ligands, such as EGF and insulin (Dinneen & Ceresa, 2004; Hunker et al., 
2006; Jozic et al., 2011; Jozic et al., 2012; Mendoza et al., 2013). The Q79 residue 
of Rab5 locates on the GTPase domain (residues 15-184) of Rab5. Structural 
study of Rab5 reveals that each GTPase domain of Rab5 binds to one GTP and 
one Mg2+ ion and contains a central six-strand β-sheet (β1- β6) flanked by five α-
helices (α1- α5) (Terzyan et al., 2003). Two switch regions, switch I (residues 44-
64) and switch II (residues 76-94) undergo structural changes between the GTP-
bound and GDP-bound forms (G Zhu et al., 2004). Several residues on Rab5 have 
been reported to be responsible for the interaction and recruitment of specific Rab5 
effectors. For instance, Y57A, W74A, Y82A, and Y89A based on the Rab5:Q79L 
mutant showed significant decreased binding affinity with Rabaptin-5, whereas 
K116E and R120E based on the Rab5:Q79L mutant had no effect on Rab5-
Rabaptin-5 binding (G Zhu et al., 2004). Moreover, Y57A, W74A, Y82A, and Y89A 
are also found to be effector binding epitopes for EEA1 and Rabenosyn-5 based 
on structural studies (Mishra et al., 2010).  
Like the other small GTPases, the Rab5 cycle is regulated by several Rab5 
GEFs (e.g., RIN1, Rabex-5, and Rinl) and Rab5 GAPs (e.g., RN-tre and RabGap-
5). Rab5 in its active form (the GTP-bound form) recruits several downstream 
effectors onto the endosome membrane to support the endosomal fusion in the 
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early endocytic pathway and the interaction of endosomes with microtubule 
networks (Balaji et al., 2012; Sandri et al., 2012). Rab5 is also implicated in other 
cellular processes such as receptor cell signaling and phagosome maturation 
(Mustafi et al., 2013). Recently, Rab5 is also proved to participate in several 
cellular functions, including endoplasmic reticulum (ER) reorganization, nuclear 
Lamin disassembly, spindle assembly and stability during mitosis (Audhya et al., 
2007; Capalbo et al., 2011; Das et al., 2014). Furthermore, up-regulation of the 
Rab5-GTP level upon addition of EGF requires the participation of one or more 
Rab5 GEFs (Hunker et al., 2006; Jozic et al., 2011; Jozic et al., 2012). Interesting, 
the addition of insulin to 3T3-L1 pre-adipocytes, but not the NIH-3T3 or the HepG2 
cell lines, induced inactivation of Rab5 (Huang et al., 2001; Tessneer et al., 2014). 
Thus, evidence regarding the regulation of Rab5 activity during adipogenesis 
process and the understanding of the cellular mechanisms by which Rab5 
modulates the differentiation of 3T3-L1 pre-adipocytes are lacking. 
Besides Rab5, several Rab proteins (e.g., Rab4, Rab7, Rab22, and Rab31) 
also have their particular roles in the endocytosis process. In vitro study of 3T3-L1 
cells reveals an increased cytosolic Rab4 level upon insulin stimulation (Shisheva 
& Czech, 1997). Rab4 is also proved to play a role in determining directional 
vesicle mobility (Potokar et al., 2012). Similar as Rab5, the overexpression of the 
dominant-negative mutant of Rab4 (Rab4:Q67L) results in enlarged endosomes 
and diminished vesicle mobility in terms of vesicle track length (the total length that 
the vesicle traveled during analysis), maximal displacement (maximal distance 
between two positions in the track that the vesicle traveled during analysis), and 
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speed (Potokar et al., 2012). Consistently, the overexpression of the dominant-
positive mutant of Rab4 (Rab4:S22N), leads to dysfunctional vesicle directionality 
(Potokar et al., 2012). If Rab5 is the key for homotypical early endosome fusion, 
then Rab7, which controls the net movement of late endocytic elements, is the star 
to govern the early to late endosome fusion (Lebrand et al., 2002). It is reported 
that Rab7 colocalizes with the insulin-responsive GLUT4-containing intracellular 
compartments, but its localization is not affected by the stimulation of insulin (Millar 
et al., 1999). The deletion of Rab7 in Hela cells does not affect the trafficking of 
the EGF-EGFR complex through the early endosome to the late endosome upon 
EGF stimulation. However, the EGF-EGFR complex is sequestrated in the late 
endosomes indicating a regulatory role of Rab7 in the receptor trafficking 
(Vanlandingham & Ceresa, 2009). Rab11 is a master regulator to mediate the 
transportation of intracellular vesicles towards the cell surface in the exocytosis 
process (Takahashi et al., 2012). Depletion of Rab11 results in tubulated recycling 
endosomes as well as the accumulation of recycling compartments containing 
endocytosed transferrin and transferrin receptor beneath the plasma membrane 
(Takahashi et al., 2012). Rab22 is from the same subfamily of small GTPases as 
Rab5 and thus displays high sequence homology to Rab5 (Kauppi et al., 2002). A 
previous study showed that Rab22 even perform a higher affinity to the Rab5 GEF, 
Rabex-5, interacted with Rabex-5 to recruit the Rab5 effector, EEA1, and 
promoted early endosome fusion (HP Zhu et al., 2009). The knockdown of Rab22 
abrogates the membrane targeting of Rabex-5 in the body hamster kidney (BHK)-
21 cells as well as the NGF-induced TrkA endocytosis in the PC12 cells (Wang et 
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al., 2011; HP Zhu et al., 2009). Rab31 is also a Rab5 subfamily GTPase that can 
be activated by the Rab5 GEF, RAP6, and perform its function in trans-Golgi 
Network-to-endosome trafficking (Lodhi et al., 2007). The overexpression of 
Rab31 impairs the GLUT4 translocation from the intracellular compartments to the 
cell surface whereas the knockdown of Rab31 potentiates both GLUT4 
translocation and glucose uptake upon insulin stimulation (Lodhi et al., 2007). 
Because of the essential role of Rab proteins in the regulation of 
endocytosis as well as in trafficking of glucose, I hypothesized that Rab5 and other 
Rab proteins participate in the 3T3-L1 pre-adipocytes adipogenesis process 
positively. 
 
II.2 Specific aims and research design 
II.2.1 Specific aim 1: To examine the key determinants of Rab5 that are 
required in adipogenesis. 
Rab5 is a small GTPase required for several cellular processes, including 
proliferation, migration, and invasion. It functions as a molecular switch as it cycles 
between its GTP-bound form (the active form) and GDP-bound form (the inactive 
form). The switch of Rab5 is controlled by guanine nucleotide exchange factors 
(GEFs), which activate Rab5 by increasing the nucleotide status of Rab5 in the 
GTP-bound form, and also by GTPase activating proteins (GAPs), which inactivate 
Rab5 by accelerating the hydrolysis of GTP to GDP. Preliminary observations 
indicated that the expression of Rab5-Wild-type (WT) affected adipogenesis. 
Therefore, I determined 
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1.a the effect of the Rab5 isoforms (Rab5A, Rab5B, and Rab5C) on adipogenesis. 
1.b the nucleotide status of Rab5 during adipogenesis 
1.c the effect of the deletion of the N-terminal or C-terminal of Rab5 on 
adipogenesis. 
1.d the effect of point mutants in the effector domain of Rab5 on adipogenesis. 
1.e the particular role of Rab5 in the differentiation process in comparison with 
other Rab5 family proteins. 
 
II.2.2 Research design 1 
Rab5 isoforms, and several point and deletion mutants of Rab5, as well as 
several selected Rab proteins, were inserted into the pMX-puro vector at the EcoRI 
and NotI restriction sites. Then the plasmid DNA were purified via the plasmid 
purification assay. The purified DNA was transfected into the Plat-A cells using 
Lipofectamine® 2000 reagent as specified by Invitrogen. After 48 hours, virus 
suspension from the Plat-A cells was applied to the 3T3-L1 mouse pre-adipocyte 
cell line for the expression of specific proteins. The transfected cells were then 
selected with puromycin. siRNA for the Rab5 isoforms were designed and 
synthesized by Ambion. The purchased specific siRNA was induced into the 3T3-
L1 cells by Lipofectamine® 2000 reagent as specified by Invitrogen. The siRNA-
transfected or the selected pMX-puro vector-transfected 3T3-L1 cells were utilized 
for several biological assays, including cell cycle testing, lipid accumulation testing 
(ORO assay, only for differentiated cells), microscopy, and western blotting.  
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Cell lysates of the 3T3-L1 cells that have been transfected with GFP, 
Rab5:WT, Rab5:Q79L, and Rab5:S34N were incubated with GST-labeled EEA1. 
The bonded proteins were eluted and be used for immunoprecipitation analysis. 
 
II.3 Material and Methods 
II.3.1 Materials 
The 3T3-L1 pre-adipocyte cell line was obtained from the Zen-Bio, Inc. (NC, 
USA). The Platinum A (Plat-A) retroviral packaging cell line and the pMX-puro 
retroviral vector were purchased from Cell Biolabs, Inc. (San Diego, CA, USA).  
Primary antibodies, including the insulin receptor (IR), GLUT4, Akt1, p-Akt 
(Ser473), PPARγ, C/EBPα, Erk1/2, p-Erk1/2, FABP4, FAS, ACC, GAPDH, and 
Rab5, and secondary antibodies, including the anti-Rabbit IgG and anti-Mouse IgG, 
were purchased from the Cell Signaling Technology (Boston, MA, USA). Fetal 
bovine serum (FBS) was purchased from the RMBIO, Inc. (Missoula, MT, USA). 
Other reagents and supplies, if not specifically described, were purchased from 
Thermo Fisher Scientific (Weston, FL, USA).  
 
II.3.2 cDNA Construction.  
Complementary DNAs (cDNA) of green fluorescent protein (GFP), Rab5 
isoforms, Rab4:wild-type (Rab4:WT), Rab7:WT, Rab11:WT, Rab22:WT, 
Rab31:WT, GFP-Rab5:WT, GFP-Rab5:S34N, and GFP-Rab5:Q79L were cloned 
into the pMX-puro vector at the EcoRI and NotI restriction sites (Onishi et al., 1998). 
GFP-Rab5:S34N, GFP-Rab5:Q79L, Rab5:S34N, Rab5:Q79L, Rab4:S22N, 
 
 
100 
Rab4:Q67L, Rab7:S22N, Rab7:Q67L, Rab11:S22N, Rab11:Q70L, Rab22:S19N, 
Rab11:Q64L, Rab31:S19N, and Rab31:Q64L on the pMX-puro vector were made 
via the Q5® Site-Directed Mutagenesis Kit purchased from New England Biolabs, 
Inc. (NEB, Ipswich, MA, USA). Rab5:Q79L-△C4, Rab5:Q79L-△N19, Rab5:S34N-
△C4, Rab5:S34N-△N19, and GFP-Rab5:Q79L double mutants (GFP-Rab5:Q79L-
W57A, Rab5:Q79L-W74A, Rab5:Q79L-Y82A, Rab5:Q79L-Y89A, Rab5:Q79L-
K116E, and Rab5:Q79L-R120E) on the pMX-puro vector were purchased from 
GenScript, Inc. (Piscataway, NJ, USA).   
 
II.3.3 Site-directed mutagenesis. 
5’ and 3’ primers for specific mutant were designed via the online NEB 
primer design software, NEBaseChangerTM, and obtained from Sigma-Aldrich, Inc. 
(Raleiga, NC, USA). The site-directed mutagenesis process was done following 
the protocol of the Q5® Site-Directed Mutagenesis Kit. Briefly, 0.5 μM of 5’ and 3’ 
primers were mixed with 25 ng of template vector DNA in the Q5 Hot Start High-
Fidelity 2X Master Mix reagent. 25 cycles of PCR were performed followed by the 
kinase, ligase, and DpnI treatment for 5 minutes. The treated PCR mixture was 
then used for bacteria transformation, which will be described later.  
 
II.3.4 Bacteria transformation 
The cDNA-containing vectors (either purchased or cloned) and the treated 
PCR mixture generated via the site-directed mutagenesis were transformed into 
the 5-alpha Competent E. coli purchased from NEB via the transformation protocol 
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described on the company website. Briefly, the competent cells were thawed on 
ice for 10 minutes. Then 100 ng of cDNA-containing vectors or 5 μl of the treated 
PCR mixture was mixed with 50 μl of the competent cells in an Eppendorf tube 
and incubated on ice for 30 minutes followed by a 30 seconds heat shock at 42°C. 
Then the Eppendorf tube was placed on ice for 5 minutes before mixing with 950 
μl of SOC media provided by the kit. After a one-hour incubation at 37°C with 
shaking (250 rpm), the transformed competent cells were spread on Lysogeny 
broth (LB) agar selection plates and incubated overnight at 37°C.  
 
II.3.5 Vector DNA purification assay.  
Colonies grown on the LB agar selection plates or the cDNA constructs 
were grown in the LB media overnight at 37°C. Then vectors containing specific 
cDNA constructs were collected according to the QIAprep Spin Miniprep Kit or 
Qiagen Plasmid Plus kits obtained from Qiagen Sciences, Inc. (Germantown, MD, 
USA). The optical density (OD) of vector DNA was tested and analyzed to ensure 
a high concentration and purity of DNA that can be used for mammalian cell 
transfection and yeast transformation. 
 
II.3.6 Generation of stable cell lines 
The cDNA containing vector was transfected into the Plat-A (80%~90% 
confluence) monolayer using Lipofectamine® 2000 Transfection Reagent. The 
Plat-A cells were grown in the Plat-A growth media (1% penicillin/streptomycin 
(P/S), 1 µg/mL puromycin, 10 µg/mL blasticidin, and 10% FBS in Dulbecco’s 
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modified Eagle’s medium (DMEM)) and incubated under a humid atmosphere 
containing 5% CO2 under 37°C before and after transfection. 48 hours after 
transfection, the supernatant of media from the transfected Plat-A cells was filtered 
with 0.2 nm filter and applied to 90% confluent 3T3-L1 cells grown in the 3T3-L1 
growth media (1% P/S, 1% L-glutamine, and 10% FBS in DMEM). After another 
24-hour incubation, transfected 3T3-L1 cells were selected with the 3T3-L1 
selection media (2µg/mL puromycin in 3T3-L1 growth media). 
 
II.3.7 Cell culture and 3T3-L1 cell differentiation.  
Non-transfected 3T3-L1 cells were grown to 100% confluence in the 3T3-
L1 growth media and incubated in a humid atmosphere containing 5% CO2 under 
37°C. The differentiation of the 3T3-L1 pre-adipocytes took a total of 10 days. The 
differentiation process was triggered by treatment of the 3T3-L1 differentiation 
media (10 µg/ml insulin, 1 µg/ml DEX and 1µg/ml IBMX in the 3T3-L1 growth media 
for day 1 to day 4 and 10 µg/ml insulin in the 3T3-L1 growth media for day 5 to day 
10). Media was changed every 48 hours. The pMX-puro cDNA-containing vector-
transfected 3T3-L1 cells were grown in the same conditions as the non-transfected 
3T3-L1 cells except with an addition of 2µg/mL puromycin in all types of media. 
 
II.3.8 Oil Red O (ORO) staining and quantification.  
On the tenth day of differentiation, the 3T3-L1 cells were washed and fixed 
with 10% formalin in phosphate buffer saline (PBS) for 5 minutes and 1 hour at 
room temperature, respectively. The ORO stock solution (0.5 g of ORO in 100 ml 
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of isopropanol) was diluted freshly with deionized (DI) water to make the ORO 
working solution (60% of stock solution with 40% of DI water). The working solution 
was filtered with a 0.2 nm filter before applying to the fixed 3T3-L1 cells. Then the 
3T3-L1 cells were stained with the filtered ORO working solution for 15 minutes at 
room temperature. Excessive ORO working solution was removed and the stained 
3T3-L1 cells were washed with DI water. At last, 100% of isopropanol was used to 
elute the ORO from fixed cells by incubating the cells in a 37°C water bath for 10 
minutes. The quantification of lipids was done by measuring OD of eluted ORO 
solution at 540 nm wavelength.  
 
II.3.9 Bright-field microscopy, confocal microscopy, and live-cell 
microscopy 
For bright-field and confocal microscopy, the normal 3T3-L1 cells and the 
transfected 3T3-L1 cells were seeded on glass coverslips at 1.0 × 105 per 3.8 cm2 
well. The cells were incubated with different types of media and treatments as 
required. After the ORO staining (as described above), the cells were observed 
and taken image of under an inverted microscope at a 20X magnification objective 
lens via the AmScopeX software for bright-field images. Or the cells were mounted 
with DAPI and observed under the Olympus BX61 confocal microscope.  
For live-cell microscopy, the normal/transfected 3T3-L1 cells were seeded 
in the µ-Slide 4 Well chamber purchased from ibidi, Inc. (Fitchburg, WI, USA) with 
required media and treatments. Then live-cell images were taken under the Delta 
Vision Elite microscope. 
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II.3.10 Lysate preparation, protein quantification, and Western blotting 
II.3.10.1 Lysate preparation 
To prepare whole cell lysates, 3T3-L1 cells were collected in ice-cold fresh 
lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM 
ethylenediaminetetraacetic acid (EDTA), 1% sodium deoxycholate (w/v), 0.1% 
SDS, 1 mM Na3VO4, 10 mM NaF, 2 mM phenylmethane sulfonyl fluoride (PMSF), 
and protease/phosphatase inhibitors purchased from Sigma-Aldrich, Inc.). 3T3-L1 
cell lysates were then mixed with the 4X loading dye and heat-shocked at 100°C 
for 10 minutes. Supernatant were collected after centrifugation (2 minutes in 
13,000 rpm) for western blotting. To prepare the whole yeast lysates, the yeast 
cells were first collected by centrifugation (5 minutes in 5000 rpm). After discarding 
the supernatant, 3 times of freeze-thaw cycles (3 minutes in -20°C ethanol then 3 
minutes in 37°C water bath) were applied. The cells were then mixed with the fresh 
lysis buffer with addition of 5 mM of DTT for 30 minutes.  
 
II.3.10.2 Protein quantification – the Pierce BCA Protein Assay 
Protein contents of the cell lysates were tested using the Pierce BCA 
Protein Assay Kit. Briefly, the working solution was made freshly by mixing the 
reagent A and the reagent B in a ratio of 1:20. Gradient volumes of the standard 
protein and same volume of sample proteins (preparation has been described 
above) were mixed thoroughly and incubated at 30°C for 30 minutes. The ODs of 
standards and samples were measured under an absorbance of 562 nm 
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wavelength. Then the concentrations of sample proteins were calculated based on 
the standard curve. 
 
II.3.10.3 Western blotting 
The tested cell lysates were mixed with the 4X loading dye and heat-
shocked in 95°C for 10 minutes. Supernatant was collected after centrifugation (2 
minutes in 13,000rpm). Same amount of cell lysate proteins (cased on the BCA 
assay) were resolved by 10% SDS-PAGE and transferred to nitrocellulose 
membranes. The membranes were blocked overnight with specific primary 
antibodies at 4°C in BSA-TBS-t (20 mM Tris-HCl, pH 7.4, 150mM NaCl, 0.1% 
Tween 20, and 5% bovine serum albumin (BSA)). After washing of the primary 
antibodies, specific secondary antibodies were applied and washed. Visualization 
of results was achieved by exposing. To determine relative protein amounts, three 
representative exposures for each sample were quantified using the Fiji software 
(National Institutes of Health). 
 
II.3.11 siRNA sequences and transfection.  
RNA interference (RNAi) directed against: 
mouse Rab5A [5'-AAGCACAGTCCTATGCAGATG-3'], 
mouse Rab5B [5'-AATCCGTGTGTTTAGATGACA-3'], or 
mouse Rab5C [5'-AAGCAGCCATTGTGGTCTATG-3'] were designed and 
synthesized by Ambion (Austin, TX). A scrambled siRNA sequence was designed 
as a control [5'-CACCUAAUCCGUGGUUCAA-3']. Prior to siRNA sequence 
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transfection, cells were plated in growth medium without antibiotics at 70-80% 
confluence. siRNA sequence (20 nM final concentration) transfection was 
performed using LipofectamineTM 2000 as specified by Invitrogen (Invitrogen, 
Carlsbad, CA). After transfection, cells were used for the indicated assay (e.g., for 
immunoblotting, differentiation or pull-down assays). 
 
II.3.12 Activation of Rab5 assay.  
Cells were lysed using a buffer containing 20 mM HEPES (pH 7.5), 100 mM 
NaCl, 1 mM DTT, 5 mM MgCl2, 5% glycerol and 1% Triton-X-100, supplemented 
with 1 mM PMSF. Lysates were incubated with 100 mL glutathione beads 
containing 10 μg of GST-EEA1, followed by rocking for 1 hour at 4°C.  After 
incubation, beads were washed three times with PBS. The pull-downs were 
subjected to SDS-PAGE and analyzed by immunoblotting using Rab5 antibodies. 
Relative levels of Rab5-GTP were determined using the ratio of Rab5- to total-
Rab5. 
 
II.3.13 Statistical analysis 
All experiments presented were repeated a minimum of three times. Normal 
distributed data were represented in mean ± standard deviation (S.E.M.). The 
difference between groups were determined by the Student t-test. Tests were 
considered statistically significant if p-value were less than 0.05. 
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II.4 Results 
II.4.1 Nucleotide status of Rab5 is critical for the differentiation of 3T3-L1 
pre-adipocytes 
Rab5 is known to regulate membrane fusion during vesicular trafficking 
where the Rab5:Q79L mutant, which has preferential affinity for GTP showed a 
dominant-positive effect and promotes early endosome fusion (Barbieri et al., 
1996). In contrast, the Rab5:S34N mutant, which has preferential affinity for GDP 
and shows a dominant-negative effect, induced the accumulation of very small 
endocytic profile and inhibited transferrin endocytosis (Stenmark et al., 1994).  
 
II.4.1.1 The induction of pMX-puro retroviral vector expression-system 
did not alter the differentiation process 
To access whether Rab5 plays a regulatory role in the 3T3-L1 pre-
adipocytes differentiation, I used the pMX-puro retroviral vector expression-system 
to induce the expression of a specific protein. The retroviral system is designed to 
express a specific exogenous protein in mammalian cells permanently. To 
establish that the transfection system will not affect the normal differentiation 
process, I induced the green fluorescent protein (GFP) into the 3T3-L1 cells as a 
control. In Figure 9.A, the overexpression of GFP alone did not affect the 
accumulation of lipids as compared with the un-transfected 3T3-L1 cells. As 
expected, the expression level of GAPDH, which served as the whole cell lysate 
loading control, was similar in both GFP-transfected and un-transfected cells 
before (day 1) and after (day 9) differentiation, respectively (Figure 9.B). Both cells 
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expressed similar amount of PPARγ at day 9, suggesting that the usage of the 
pMX-puro retroviral vector expression-system did not significantly alter the 
differentiation process of the 3T3-L1 pre-adipocytes. Bright-field images of ORO 
stained cells were taken at day 1 and day 9 after differentiation (Figure 9.C).  
 
 
Figure 9. Differentiation of un-transfected and GFP-overexpressing 3T3-L1 
pre-adipocytes.  
The un-transfected (3T3-L1) or GFP-overexpressing (GFP) 3T3-L1 pre-adipocytes 
were differentiated into adipocytes in the absence or in the presence of induction 
media, and the accumulation of lipid droplets was measured by the incorporation 
of Oil Red O as described in Material and Methods. A. Relative lipid content of 
3T3-L1 and GFP 3T3-L1 cells. Results were represented as relative lipid contents. 
Data represent the mean ± S.E.M. of three independent experiments. B. 
Representative Western blot of the content of GFP, PPARγ, and GAPDH proteins. 
C. Bright-field images of ORO stained day 1 and day 9 cells under 20X objective 
lens. ORO stained lipid droplets were shown as red color under the microscope. 
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II.4.1.2 The overexpression or deletion of individual Rab5 isoforms 
inhibited the differentiation of 3T3-L1 pre-adipocytes 
For the purpose of understanding the role of different Rab5 isoforms during 
adipogenesis, individual overexpression of the Rab5 isoforms (Rab5A, Rab5B, 
and Rab5C) was prepared. As shown in Figure 10.A, all the Rab5 isoforms, Rab5A, 
Rab5B, and Rab5C, showed a statistically inhibitory effect on the lipids 
accumulation. Specifically, the overexpression of Rab5A inhibited the 
accumulation of lipids by 32±6%, while Rab5B and Rab5C inhibited the 
accumulation by 25±6% and 21±5%, respectively. Then the depletion effect of 
each Rab5 isoforms was done via the RNA interference to individually or 
simultaneously knockdown the Rab5 isoforms. The accumulation of lipids in 
differentiated 3T3-L1 cells was examined under the knockdown of Rab5 isoforms 
by inducing specific siRNA. According to Figure 10.B, depletion of Rab5 was 
accompanied by a reduction of the accumulation of lipids. Importantly, individual 
removal of Rab5A isoform produced a small but statistically significant (24±6%) 
inhibition on the accumulation of lipids as compared with scrambled siRNA-
induced and siRNA-uninduced cells. Rab5B and Rab5C siRNA were also able to 
block the accumulation of lipids, though not as noticeable as Rab5A, by 14±2% 
and 16±4%, respectively, as compared with scrambled siRNA and non-siRNA 
induced cells. Remarkably, combined depletion of all the Rab5 isoforms strongly 
inhibited (84±5%) the accumulation of ORO (Figure 10.B).  
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Figure 10. Selective effect of Rab5 isoforms on the differentiation of 3T3-L1 
pre-adipocytes.  
Results were represented as relative lipid contents. Data represent the mean ± 
S.E.M. of three independent experiments. (*P<0.05 by Student's t-test). A. Relative 
lipid content of cells expressing GFP or Rab isoforms. GFP or Rab5 isoforms-
transfected 3T3-L1 cells were differentiated into adipocytes in the presence of 
induction media. B. Relative lipid content of differentiated 3T3-L1 cells with 
depletion of the Rab5 isoforms. Non-transfected cells (Ctl), or cells transfected with 
scramble RNAi  (Scr), or individually RNAi against the Rab5 isoforms (siRab5a/b/c), 
or RNAi’s against all Rab5 isoforms (siRab5abc) were differentiated as described 
in Material and Methods. 
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Since the Rab5A exhibited the most remarkable results in lipid formation 
during adipogenesis of the 3T3-L1 pre-adipocytes, the rest of the experiments 
were designed based on the Rab5A isoform. And in the rest of this section, Rab5 
represents the Rab5A isoform if not specifically stated.  
 
II.4.1.3 The GTP-bound Rab5 decreased during adipogenesis 
As described above, Rab5 functions as a molecular switch that cycles 
between the active GTP-bound form and the inactive GDP-bound form. The 
overexpression and depletion of the three Rab5 isoforms individually exhibited 
inhibitory role in the adipogenesis process of 3T3-L1 pre-adipocytes (Figure 10). 
Thus, it is hypothesized that the nucleotide states of Rab5 may change during the 
differentiation process and the states of Rab5 may play a regulatory role in 
governing the adipogenesis process of 3T3-L1 cells. 
In order to detect the endogenous nucleotide states of Rab5 during the 
differentiation of 3T3-L1 pre-adipocytes, the 3T3-L1 cells overexpressing GFP 
were differentiated into adipocytes in the absence (as the negative control) or in 
the presence (as the positive control) of induction media. Endogenous GTP-bound 
activated Rab5 was analyzed by Rab5 GST pull-down assay followed by 
immunoblotting at specific days during the differentiation. In Figure 11, along with 
the progression of adipogenic differentiation, the expression level of the adipocyte-
specific transcription factor, PPARγ, gradually elevated (Figure 11.A&B). In 
contrast, the relative Rab5-GTP level gradually decreased over time during the 
differentiation process (Figure 11.C&D).  
 
 
112 
 
Figure 11. GTP levels of endogenous Rab5 in comparison with expression 
of PPARγ during the differentiation of 3T3-L1 pre-adipocytes.  
3T3-L1 pre-adipocytes overexpressing GFP were differentiated into adipocytes in 
presence of induction media, and the endogenous GTP-bound activated Rab5 was 
analyzed by GST pull-down assay followed by immunoblotting at specific day of 
the differentiation as described in Material and Methods. A. Relative PPARγ 
expression levels in comparison with GAPDH during differentiation. Data represent 
the mean ± S.E.M. of three independent experiments. (*P<0.05 by Student's t-test). 
B. Representative Western blot of the content of PPARγ and GAPDH. C. Relative 
Rab5 GTP-bound levels as compared with total Rab5 loaded. Data represent the 
mean ± S.E.M. of three independent experiments. (*P<0.05 by Student's t-test). D. 
Representative immunoblots of samples probed with anti-Rab5 antibodies for total 
Rab5 (T-Rab5) and active Rab5 (GTP-Rab5). 
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II.4.1.4 Increase the Rab5-GTP level hampered the differentiation of 
3T3-L1 pre-adipocytes 
In order to address the role of Rab5 in the differentiation of 3T3-L1 pre-
adipocytes, cell lines overexpressing GFP, Rab5:wild-type (WT), the GTP-bound 
defective Rab5 mutant (Rab5:S34N), or the GTPase-defective, constitutively 
activated Rab5 mutant (Rab5:Q79L) were prepared, and the accumulation of lipids 
was measured via the oil red O (ORO) assay. To observe the localization of Rab5 
and the two Rab5 mutants, the GFP conjugated Rab5:WT, Rab5:S34N, and 
Rab5:Q79L were transfected into the 3T3-L1 cells. Then the day 1 and day 9 cells 
were fixed for confocal microscopy and observed under the Olympus BX61 
confocal microscope (Figure 13). As shown in Figure 12, the overexpression of 
Rab5:Q79L mutant decreased the accumulation of lipids in 3T3-L1 pre-adipocytes 
at day 9 of differentiation. Moreover, Rab5:WT decreased the accumulation of 
lipids in less extent as compared with the Rab5:Q79L mutant but is statistically 
significant in comparison with the GFP cells (Figure 12.A). Surprisingly, the 
expression of Rab5:S34N mutant stimulated this differentiation process as the lipid 
content increased by about 28% in comparison with the GFP cells (Figure 12). The 
observation suggests that Rab5 inactivation improves the differentiation of 3T3-L1 
pre-adipocytes, whereas constitutively activating Rab5 resulted in decreased lipid 
accumulation.  
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Figure 12. Selective effect of Rab5 constructs on the differentiation of 3T3-
L1 pre-adipocytes.  
3T3-L1 pre-adipocytes expressing GFP or Rab5 constructs (Rab5:WT, Rab5S34N, 
and Rab5:Q79L) were differentiated as described in Material and Methods. A. 
Relative lipid content of 3T3-L1 cells overexpressing  GFP, Rab5:WT, Rab5:Q79L, 
and Rab5:S34N. Results were represented as relative lipid contents. Data 
represent the mean ± S.E.M. of three independent experiments. (*P<0.05 by 
Student's t-test). B. Representative Western blot of the content of GFP, Rab5, and 
GAPDH proteins.  
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Adipocyte differentiation can be also monitored by formation of intracellular 
lipid droplets (Qi et al., 2017). Thus, with the overexpression of GFP-conjugated 
Rab5 and Rab5 mutants, combining with the ORO staining assay, morphological 
experiments were carried out to visualize the lipid droplets and the localization of 
Rab5 or Rab5 mutants. Under the microscope, GFP and GFP-conjugated 
constructs were visualized as green, ORO stained lipid droplets were observed as 
red, whereas nucleus were stained with DAPI, which gave a color of blue under 
the microscope. As described above, 3T3-L1 pre-adipocytes expressing GFP and 
Rab5 constructs were cultivated and induced to differentiate into adipocytes with 
induction media. At day 9, Oil Red O staining showed an abundant red round 
structures in GFP- and Rab5:S34N-overexpressed 3T3-L1 cells, which suggested 
a significant lipid accumulation in the GFP-control and the Rab5:S34N mutant cells. 
However, lipid droplets were not observed in untreated non-differentiated day 1 
cells (images in the left column of Figure 13). More importantly, formation of lipid 
droplets was inhibited in the Rab5:Q79L mutant cells (Figure 13). In cells 
overexpressing the Rab5:WT, lipid droplets were observed but in less amount in 
comparison with the GFP-control cells (Figure 13). These observations were 
further supported with the quantitative measurement of lipid content (Figure 12). 
In addition, the overexpression of Rab5:Q79L mutant significantly inhibited 
adipogenic morphology (e.g., the transition from a fibroblast-like shape to an 
increasingly rounded-up appearance with an accumulation of cytoplasmic lipid 
droplets), which can be confirmed by comparing the GFP-expressing cells with the 
Rab5:Q79L-expressing cells at day 9 of differentiation.   
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Figure 13. Confocal images of 3T3-L1 cells overexpressing GFP and GFP-
conjugated Rab5 constructs.  
GFP, lipid droplets, and nucleus were represented in green, red, and blue, 
respectively. Morphological changes of 3T3-L1 pre-adipocytes were monitored by 
a Olympus BX61 and photographed before (day 1) after 9 days from the onset of 
differentiation. 
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Figure 14. Effect of Rab5 constructs on the expression of PPARγ and CEB/Pα.  
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs were 
differentiated as described in Material and Methods, and the endogenous levels of 
PPARγ, GEB/Pα and GAPDH proteins were analyzed with specific antibodies by 
immunoblotting. Data represent the mean ± S.E.M. of three independent 
experiments. (*P<0.05 by Student's t-test).  
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Next, the 3T3-L1 pre-adipocytes overexpressing GFP, Rab5:WT and the 
Rab5 mutants were differentiated and then harvested for immunoblotting analysis 
with specific antibodies. With the overexpression of Rab5:S34N mutant, but not 
the Rab5:Q79L mutant, the protein expression of the adipogenesis-associated 
transcription factors, PPARγ and C/EBPα, were up-regulated as compared with 
the GFP-overexpressing cells (Figure 14). The Rab5:WT affected the expression 
of the two transcription factors in less extent in comparison with the Rab5:Q79L 
mutant. Thus, these observations suggest that the nucleotide status of Rab5 is 
critical for the differentiation process of 3T3-L1 pre-adipocytes. The effect of Rab5 
nucleotide status on adipogenesis relies, at least partially, on its regulatory role 
towards the two adipogenic transcription factors, PPARγ and C/EBPα. 
 
II.4.2 The determinants of Rab5 in promoting adipogenesis. 
In the previous section, Rab5:Q79L, the dominant-positive mutant of Rab5, 
has demonstrated an inhibitory role in adipogenesis process. Since specific 
residues, especially the Y57A, W74A, Y82A, and Y89A residues on the Rab5 
GTPase domain affect the binding affinity of Rab5 with Rab5 effectors (e.g. 
Rabaptin-5, Ranenosyn-5, and EEA1), several additional mutants (Y57A, W74A, 
Y82A, Y89A, K116E, and R120E) were made based on the Rab5:Q79L mutant. 
Then the Rab5:Q79L double mutants were transfected into the 3T3-L1 cells 
through the pMX-puro vector system, respectively. Surprisingly, the Rab5:Q79L-
K116E double mutant, not the other mutants that showed positive role in effector 
binding, advanced the lipid formation of differentiated 3T3-L1 cells, whereas the 
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other double mutants exhibited similar inhibitory role in adipogenesis as the 
Rab5:Q79L single mutant (Figure 15). 
Figure 15. Selective effects of Rab5:Q79L double mutants on the 
differentiation of  3T3-L1 pre-adipocytes.  
3T3-L1 pre-adipocytes overexpressing GFP, Rab5:Q79L, or Rab5:Q79L double 
mutants were differentiated into adipocytes in the presence of induction media, 
and the accumulation of lipid droplets was measured by the incorporation of ORO 
as described in Material and Methods. A. Relative lipid content of differentiated 
3T3-L1 cells overespression GFP, Rab5:Q79L mutant, and Rab5:Q79L double 
mutants. Data represent the mean ± S.E.M. of three independent experiments. 
*P<0.05 by Student's t-test. B. Representative Western blot of the content of GFP, 
Rab5 constructs, and GAPDH proteins. 
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Figure 16. Bright-field images of 3T3-L1 cells overexpressing GFP, 
Rab5:Q79L, or Rab5:Q79L double mutants.  
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Bright-field images of the 3T3-L1 cells overexpressing GFP, Rab5:Q79L, or 
Rab5:Q79L double mutants revealed parallel results in comparison with the 
quantitative ORO results (Figure 15 &16). 
To further examine the specific molecular requirement for the effect of Rab5 
on the differentiation of 3T3-L1 pre-adipocytes, I investigated the effect of deletion 
of the N-/C-terminal of Rab5 or the Rab5 mutants. These N-/C-terminal residues 
are essential for Rab5 function. The N-terminal is critical for efficient 
geranylgeranylation of the C-terminal of Rab5 (Sanford et al., 1995). The C-
terminal contains a CCXX motif that is responsible for the post-transcriptional 
modification, geranylgeranylation, of Rab5 (Farnsworth et al., 1994). The biological 
activity of Rab5: △N19 and Rab5: △C4 deletion mutants were examined (Figure 
17.A). In comparison with Rab5:S34N, the mutant Rab5:S34N-△N19 resulted in a 
partial, though not significant, loss of differentiation of the 3T3-L1 pre-adipocytes. 
For the C-terminal deletion, the elimination of the entire CCXX motif (Rab5:S34N-
△C4) completely abolished the effect of Rab5:S34N on the differentiation of 3T3-
L1 pre-adipocytes. In Figure 17, the introduction of the C-terminal deletion in 
Rab5:Q79L mutant (Rab5:Q79L-△C4), but not the introduction of the N-terminal 
deletion (Rab5:Q79L-△N19), reversed the inhibitory effect of Rab5:Q79L mutant 
on differentiation of 3T3-L1 pre-adipocytes. These data suggest that post-
translational isoprenylation modifications of Rab5 are essential for its biological 
function during differentiation of 3T3-L1 pre-adipocytes. 
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Figure 17. Selective effect of Rab5 constructs on the differentiation of 3T3-
L1 pre-adipocytes.  
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs (Rab5:S34N, 
Rab5:S34N-△C4/△N19, Rab5:Q79L and Rab5:Q79L-△C4/△N19) were 
differentiated as described in Material and Methods. A. Relative lipid content of 
differentiated 3T3-L1 cells overespression GFP or Rab5 constructs. Results were 
represented as relative lipid contents. Data represent the mean ± S.E.M. of three 
independent experiments. (*P<0.05 by Student's t-test). B. Representative 
Western blot of the content of GFP, Rab5 proteins. 
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II.4.3 Rab5 plays an irreplaceable role in the regulation of adipogenesis 
Based on the results collected so far, Rab5 played a regulatory role in 
adipogenesis. Since the primary role of Rab5 is to promote early endosome fusion 
in the membrane trafficking process and receptor-mediated endocytosis, I 
questioned if the other Rab family proteins had their particular roles in the process 
of adipogenesis. Thus, several small GTPases, including Rab4, Rab7, Rab11, 
Rab22, and Rab31, as well as the dominant-negative forms (e.g., Rab4:Q67L, 
Rab7:Q67L, Rab11:Q70L, Rab22:Q64L, Rab31:Q64L) and the dominant-positive 
forms (e.g., Rab4:S22N, Rab7:S22N, Rab11:S25N, Rab22:S19N, Rab31:S19N) 
were transfected into the 3T3-L1 pre-adipocytes, respectively. As introduced 
above, each of these Rab GTPase proteins exhibits particular function in the 
endocytic pathway, and the active/inactive form of these Rab proteins affect the 
endocytic pathway in different manners.  
In Figure 18, unlike the Rab5:Q79L, none of the Rab GTP-hydrolysis 
defective mutants (the Rab:QL mutants) tested here inhibited the differentiation of 
3T3-L1 pre-adipocytes. Furthermore, none of the Rab GTP-binding defective 
mutant (the Rab:SN mutants) increased the accumulation of lipids. In addition, the 
overexpression of Rab:WT proteins did not affect the differentiation process. 
However, it is also important to note that the overexpression of Rab4:Q67L mutant 
showed a modest but statistically significant increased accumulation of lipids, while 
the overexpression of Rab4:S22N decreased it. These data suggest that 
increasing the levels of Rab5 in the GTP-bound form by overexpressing the 
Rab5:Q79L mutant and to some extent, overexpressing of Rab5:WT, has a 
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detrimental and non-substitutable role on the differentiation of 3T3-L1 pre-
adipocytes. Furthermore, the data suggest that the Rab5 GDP-bound form plays 
a particular and significant role in the differentiation process. 
Figure 18. A. Selective effect of Rab proteins on the differentiation of 3T3-L1 
pre-adipocytes.  
3T3-L1 pre-adipocytes overexpression different Rab:WT, Rab:SN, and Rab:QL 
were differentiated into adipocytes in the presence of induction media, and the 
accumulation of lipid droplets was measured by the incorporation of ORO as 
described in Material and Methods. Data represent the mean ± S.E.M. of three 
independent experiments. (*P<0.05 by Student's t-test). B. Representative 
Western blot of the content of GFP, Rab p, and GAPDH proteins. 
A 
* 
* 
  WT    S22N  Q56L     WT   S22N    Q67L 
               Rab4                       Rab7 
Rabs 
GAPDH 
  WT    S22N   Q70L     WT     S19N    Q64L         WT   S19N    Q64L 
             Rab11                      Rab22                                Rab31 
Rabs 
GAPDH 
B 
 
 
125 
II.4.4 Rab5 performs its function via the insulin signaling pathway during 
the adipogenesis process 
Based on the observations above, Rab5, not the other Rab proteins (e.g., 
Rab7, Rab11, Rab22, and Rab 31), uniquely affects the expression of 
adipogenesis-associated transcription factors. Then, I wondered what effect of 
Rab5 constructs overexpression on the expression of other factors (e.g., insulin 
receptor, GLUT4 and Akt) during adipogenesis would be. This is because the IR, 
GLUT4, and Akt (the key protein in the PI3K/Akt signaling pathway triggered upon 
insulin stimulation) have been showed to play a key role during the differentiation 
of 3T3-L1 pre-adipocytes. Not surprisingly, the expression of the IR, GLUT4, and 
Akt exhibited an increase in cells overexpressing the Rab5:S34N mutant (Figure 
19, Figure 20, and Figure 21). These data further supported the increase of lipids 
formation observed in this Rab5 mutant cell line (Figure 12). It is important to note 
that not only the expression level of IR and GLUT4 were increased in Rab5:S34N 
cell lines, but also the relative phosphorylated IR level was enhanced at day 9 of 
differentiation (Figure 19, Figure 21). An increase in the phosphorylation of Akt, 
but not the phosphorylation of Erk1/2 was also observed upon insulin stimulation 
(Figure 20). Taken together, the data suggest that the overexpression of the 
Rab5:S34N mutant, which constitutively inhibited the biological function of Rab5 
selectively contribute to the up-regulation of expression as well as phosphorylation 
of the IR by diminishing the internalization of the receptor. This impaired 
internalization in turn augment the level of phosphorylated Akt and enhance the 
translocation of GLUT4 to the plasma membrane. Therefore, it is possible to 
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speculate that Rab5 GTP/GDP ratio has an essential role on differentiation of 3T3-
L1 pre-adipocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Effect of Rab5 and the Rab5 mutations on the expression and 
phosphorylation of the IR.  
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs were 
differentiated as described in Material and Methods. The endogenous levels of IR, 
phosphorylated-IR (p-IR), and GAPDH proteins were analyzed with specific 
antibodies by immunoblotting as indicated in the figure upon insulin stimulation. 
Data represent the mean ± S.E.M. of three independent experiments. Inset: 
Representative Western blot of the content of IR, phospho-IR, and GAPDH 
proteins. *P<0.05 by Student's t-test. A. Relative IR expression level (as compared 
with GAPDH) of GFP- or Rab5 constructs-overexpressed 3T3-L1 cells. B. Relative 
p-IR expression level (in comparison with IR) of GFP- or Rab5 constructs-
overexpressed 3T3-L1 cells. C. Representative Western blot of the content of IR, 
phospho-IR, and GAPDH proteins.  
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Figure 20. Effect of Rab5 constructs on the activation of Akt and Erk1/2.  
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs were 
differentiated as described in Material and Methods. The activation of Akt and 
Erk1/2 were analyzed with specific antibodies by immunoblotting as indicated in 
the figure upon insulin stimulation. GAPDH served as loading control. Data 
represent the mean ± S.E.M. of three independent experiments. *P<0.05 by 
Student's t-test. A. Relative p-Akt level of 3T3-L1 cells expressing GFP or Rab5 
constructs. B. Representative Western blot of the content of total Akt, phosphor 
Akt (p-Akt), and GAPDH. C. Relative p-Erk1/2 level of 3T3-L1 cells expressing 
GFP or Rab5 constructs. D. Representative Western blot of the content of total 
Erk1/2, phosphor Erk1/2 (p-Erk1/2), and GAPDH. 
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Figure 21. Effect of Rab5 and the Rab5 mutants on the expression of GLUT4.  
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs were 
differentiated as described in Material and Methods and the endogenous levels of 
GLUT4 and GAPDH were analyzed with specific antibodies by immunoblotting as 
indicated in the figure. A. Relative GLUT4 level in comparison with GFP cells. Data 
represent the mean ± S.E.M. of three independent experiments. *P<0.05 by 
Student's t-test.  B. Representative Western blot of the content of GLUT4 and 
GAPDH. 
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individual Rab5 isoforms, as well as all three isoforms via RNA interference also 
resulted in a decrease of lipids accumulation. The Rab5 isoforms exhibit different 
roles in different cell types. For instance, the overexpression of Rab5B or Rab5A 
hampered the degradation of EGFR as well as the progression of EGFR from early 
to late endosomes upon EGF stimulation in Hela cells (Chen et al., 2009). Rab5A 
is also found to regulate autophagosome formation in the U2OS cells (human bone 
osteosarcoma epithelial cells). And Rab5C has been shown to enhance β-integrin 
recycling in EGF-induced cancer cell invasion (Onodera et al., 2012). Since the 
insulin receptor and the EGFR are both a member of the receptor tyrosine kinases, 
these data suggest that Rab5 may affect the process of differentiation by impairing 
the endocytosis process of the IR. 
Second, the activated GTP-bound Rab5 has been demonstrated to undergo 
a graduated decrease over the differentiation of 3T3-L1 cells (Figure 11). The 
reduction of Rab5 GTP-bound form exhibited a negative relationship with the 
accumulation of adipogenesis-associated transcription factor, PPARγ, which 
served as the marker of adipogenesis process (Figure 11). In addition, the 
decrease of Rab5 GTP-bound level during adipogenesis happened without any 
changes in the total endogenous expression level of Rab5 (Figure 11.D).  These 
data suggest that the ratio of Rab5-GTP over total Rab5 may be important for the 
differentiation of 3T3-L1 pre-adipocytes. 
Third, two Rab5 mutants, the dominant-negative Rab5:S34N and the 
dominant-positive Rab5:Q79L, exhibited opposite roles in the differentiation of 
3T3-L1 cells, where the Rab5:Q79L inhibited this process whereas the Rab5:S34N 
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promoted the process. In addition, the expression of the Rab5:Q79L mutant, but 
not the Rab5:S34N mutant, blocked this process by inhibiting the expression of 
PPARγ and C/EBPα in the 3T3-L1 pre-adipocytes. In previous studies, the 
expression of Rab5:Q79L mutant results in enlarged endosomes in multiple cell 
types, whereas the expression of Rab5:S34N inhibited the internalization of the 
EGFR in Hela cells as well as phagosome formation and T. cruzi internalization in 
the Raw 264.7 mouse macrophage cells (Dinneen & Ceresa, 2004; Galperin & 
Sorkin, 2003; Li et al., 1994; Maganto-Garcia et al., 2008; Stenmark et al., 1994). 
In the confocal images, enlarged endosomes can be observed in the Rab5-Q79L-
overexpressed cells, which suggests that GTP-Rab5 may diminish the 
accumulation of lipids by impairing the endocytosis process. Furthermore, 
Rab5:Q79L-△C4, a mutant lacking CCXX (X refers to any amino acid) motif that is 
required for isoprenylation, completely reversed the inhibitory effect of Rab5. 
Previously, researchers show that the N-terminal is critical for efficient 
geranylgeranylation of the C-terminal of Rab5, whereas the C-terminal contains a 
CCXX motif that is responsible for the post-transcriptional modification of Rab5 
(Farnsworth et al., 1994) (Sanford et al., 1995). My data suggest that the C-
terminal is essential for the function of Rab5 in regulating the differentiation 
process. Though the N-terminal supports the function of the C-terminal, deletion 
of the N-terminal alone does not have a significant effect on the differentiation of 
3T3-L1 pre-adipocytes. 
Fourth, the overexpression of Rab5:Q79L-K116E, but not the other 
Rab5:Q79L double mutants (Rab5:Q79L-Y57A, Rab5:Q79L-W74A, Rab5:Q79L-
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Y82A, Rab5:Q79L-Y89A, or Rab5:Q79L-R120E), significantly promoted the 
accumulation of lipids in the differentiated 3T3-L1 cells (Figure 15). Previously, the 
Y57A, W74A, Y82A, and Y89A were predicted to be decisive binding epitopes for 
EEA1 and Rabenosyn-5, and the Rab5:Q79L-Y57A, Rab5:Q79L-W74A, 
Rab5:Q79L-Y82A, and Rab5:Q79L-Y89A mutants all showed reduced binding 
affinity to Rab5 effector Rabaptin-5 (G Zhu et al., 2004; Mishra et al., 2010). The 
K116 serves as a mono-ubiquitination site of Rab5 (Wagner et al., 2011). But the 
Rab5:K116R mutant did not affect the recruitment of Rab5 effectors or alter the 
GTP loading/GDP release activities of Rab5 (Shin et al., 2017). My data suggested 
a novel role of the K116 residue in regulating the function of Rab5 in adipogenesis 
process. 
Fifth, several small GTPases (e.g., Rab4, Rab7, Rab11, Rab22, and Rab31) 
were unable to affect this differentiation process as compared with Rab5. Though 
each of the tested Rab proteins exhibits particular functions in different steps of 
endocytosis (Frittoli et al., 2014; Lodhi et al., 2007; Takahashi et al., 2012; 
Vanlandingham & Ceresa, 2009; HP Zhu et al., 2009). None of the chosen Rab5 
proteins displayed a similar role as Rab5 in the differentiation process. 
Sixth, both the expression levels of insulin receptor and GLUT4 were up-
regulated under the overexpression of Rab5:S34N and down-regulated under the 
overexpression of Rab5:Q79L. Besides, the levels of phosphorylated Akt and 
phosphorylated insulin receptor were increased in the Rab:S34N cells. 
These observations can be explained, at least in part, by the fact that 
Rab5:Q79L, but not Rab5:S34N mutant, increased internalization of the insulin 
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receptor, thus, decreasing both cell surface localization as well as tyrosine 
autophosphorylation of the insulin receptor at day 9 day of the differentiation 
process. Consistent with this idea, internalized and less active insulin receptor will 
not be able to fully activate Akt, a key molecule required for the activation of GLUT4. 
These molecules have been implicated in the differentiation of 3T3-L1 pre-
adipocytes.  
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CHAPTER III 
III. Role of Rab5 regulators and effectors in the process of adipogenesis 
III.1 Introduction 
Adipogenesis is a complicated process triggered by hormones and 
governed by corresponding signaling pathways (Chi et al., 2017; Hinoi et al., 2014; 
Nam et al., 2015; Wu et al., 2015). The insulin signaling pathway plays an essential 
role in multiple cellular processes, including cell proliferation, cell migration, and 
cell differentiation, in a wide range of cell types (Huttala et al., 2016; Shukla et al., 
2009; Yen et al., 2015). Specifically, insulin is proved to be the most potent 
hormone to trigger the differentiation of the pre-adipocytes (Klemm et al., 2001). 
The dominant effects of insulin on the pre-adipocytes coincide with the high 
expression of IR on the plasma membrane of the pre-adipocytes, with a number 
of about 200~300 × 103 per pre-adipocyte compared to ~40 per erythrocyte 
(Watanabe et al., 1998). The binding of insulin to the IR triggers 
autophosphorylation of several tyrosine sites on the intracellular portion of the IR 
β-subunit (Saltiel & Kahn, 2001). The insulin signaling pathway activated upon 
insulin stimulation governs the body metabolism by affecting the rates of glucose 
transport, glycogen synthesis, fatty acid synthesis, and enzyme/protein synthesis, 
and the expression of adipocyte differentiation-associated proteins (Dimitriadis et 
al., 2011). Under the stimulation of insulin, the IR undergoes a rapid internalization 
process (t1/2 < 3 min) through the receptor-mediated endocytosis (RME), in which 
the insulin-IR complex is engulfed into the cell with a region of the plasma 
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membrane as a clathrin-coated pit (CCP) in an insulin concentration-dependent 
manner (Jochen et al., 1989; Marshall, 1985). Internalized CCP is then delivered 
through the intracellular membrane trafficking system, in which the CCP is 
transport to the early endosome, the late endosome, and eventually the lysosome 
to be degraded or the plasma membrane to be reused (Scheidel et al., 2015). 
The small GTPase Rab5 is dynamically involved in several cellular 
trafficking and signaling events, including receptor internalization, fusion of 
endocytic vesicles with early endosomes, and signaling to the nucleus (Barbieri et 
al., 2000; Bucci et al., 1992; GP Li et al., 1994). As is described in Chapter II, Rab5 
regulate the adipogenic differentiation of the pre-adipocytes through the insulin 
signaling pathway. Specifically, the overexpression of the GTP-binding defective 
mutant of Rab5 (Rab5:S34N) increases differentiation of the 3T3-L1 pre-
adipocytes, whereas the overexpression of the GTPase-defective mutant of Rab5 
(Rab5:Q79L) improves differentiation of 3T3-L1 pre-adipocyte. Besides, previous 
study shows that the formation of Rab5-positive endosomes and the activation of 
Rab5 upon insulin in intact cells were both blocked by the treatment of a receptor 
tyrosine kinase inhibitor (Jozic et al., 2011). In addition, the impaired Rab5 
activation can be rescued by the overexpression of Rab5:Q79L, which parallels 
with the fact that the formation of Rab5:Q79L mutant-positive endosomes is not 
affected by the receptor tyrosine kinase inhibitor (Jozic et al., 2011). 
 Rab5 cycles between the active GTP-bound form and the inactive GDP-
bound form to serve as the molecular switch in the early endosome fusion process 
(G Li, 2015). The activation of Rab5 is regulated by a number of guanine nucleotide 
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exchange factors (GEFs). All these proteins contain a highly conserved VPS9 
domain that catalyzes nucleotide exchange on GTP-bound form Rab5. The Rab5 
GEFs include Rabex-5, Alsin, the RIN family proteins, RAP6 (which is also known 
as RME-6 and GAPex-5), and Rinl (Han & Colicelli, 1995; Horiuchi et al., 1997; 
Hunker, Galvis, et al., 2006; Kajiho et al., 2003; Otomo et al., 2003; Saito et al., 
2002; Woller et al., 2011). Furthermore, it seems that these Rab5 GEFs also 
interact with several receptors via diverse mechanisms (Barbieri et al., 2003; 
Deininger et al., 2008; Penengo et al., 2006; Su et al., 2007; Tall et al., 2001). The 
GTPase activating proteins (GAPs) convert Rab5 to its GDP-bound form. Two 
well-characterized Rab5 GAPs are RabGAP-5 and RN-tre. The deletion of 
RabGAP-5 or RN-tre increase the level of active Rab5 in vitro (Haas et al., 2005; 
Palamidessi et al., 2013). 
One of the best-characterized Rab5 GEFs is RIN1 (Ras interference 1), a 
multifunctional protein composed of several functional domains, including an SRC 
homology 2 (SH2) domain, a proline-rich (PR) domain, a vacuolar protein sorting 
9 (VPS9) domain, and a Ras association (RA) domain (Balaji et al., 2014). 
Previous work suggested that RIN1 is an exchange factor for the small GTPase 
Rab5, whose overexpression stimulates IR-mediated endocytosis. And it has 
shown that deletion of the RIN1 N-terminal, which contains the SH2 domain and 
PR domain of RIN1, blocked the insulin stimulated receptor-mediated endocytosis 
(Hunker, Giambini, et al., 2006). Specific residues, such as RIN1:D537A and 
RIN1:Y561F on the RIN1-VPS9 domain are critical for Rab5 activation, whereas 
RIN1-R94A on the RIN1-SH2 domain is crucial for the interaction between EGFR 
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and RIN1 upon EGF stimulation (Barbieri et al., 2003; Galvis, Balmaceda, et al., 
2009; Galvis, Giambini, et al., 2009). Thus, relationship of key residues required 
for optimal RIN1 functionality is critical in order to understand the connection 
between receptor signaling and trafficking. 
The Rabex-5 protein structure is identified to be made up of an N-terminal 
domain, a membrane binding domain, a helical bundle (HB) domain, a VPS9 
domain, a coiled-coil (CC) domain, and a PR domain (Shin et al., 2012). Besides 
the well-studied VPS9 domain to interact and activate Rab5, the HB domain has 
been found to play a role in the association with early endosomes and activating 
Rab5 in vivo (Zhu et al., 2007). The GEF activity of Rabex-5 is initially autoinhibited 
by its CC domain, which binds weakly to the substrate-binding site of the VPS9 
domain (Zhang et al., 2014). When the Rabex-5 activates Rab5 and recruits 
Rabaptin-5 (a Rab5 effector), Rabaptin-5 will in turn bind to the GTP-bound Rab5 
and recruits Rabex-5 in a positive loop. The binding with Rabaptin-5 displaces the 
CC domain of Rabex-5 thus exposes a larger substrate-binding site for Rab5, 
causing the release of the GEF activity (Zhang et al., 2014). The autoinhibition of 
Rabex-5 explains why in comparison to other well-characterized small GTPases 
and their corresponded GEFs, Rabex-5 exhibits a relatively lower affinity to Rab5  
(Esters et al., 2001). The autoinhibition also gives a clue to why the GTP exchange 
activity of Rabex-5 is much higher when in the Rabex-5-Rabaptin5 complex 
(Delprato et al., 2004). Besides, the VPS9 domain of Rabex-5 alone also shows a 
higher GTP exchange activity than the full-length Rabex-5 (Delprato et al., 2004). 
Thus, Rabex-5 is involved in early endosome fusion as a Rab5 activator with 
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regulated activity. Thus, the GTP exchange activity of Rabex-5 is much higher 
when in the Rabex-5-Rabaptin5 complex (Delprato et al., 2004). A study has 
shown that the Ras ubiquitination been mediated by Rabex-5 promoted Ras 
endosomal localization and led to the suppression of Erk activation (Xu et al., 
2010). Interestingly, the VPS9 domain of Rabex-5 alone shows a higher GTP 
exchange activity than the full-length Rabex-5 (Delprato et al., 2004).  
In the processes of vesicle formation and delivery, Rab5 is also regulated 
by multiple Rab5 effectors. As one of the best studied Rab proteins to date, Rab5 
has been found to interacts with as many as 30 different effector proteins (Pfeffer, 
2005). For instance, a novel Rab5 effector, VPS34, is classified as the Class III 
enzyme of the phosphoinositide 3 kinase (PI3K) family and only uses 
phosphatidylinositol as substrate to generate phosphoinositide (PI) at the 3-
position of the inositol ring, which is named the phosphatidylinositol 3-phosphate 
(PI3P) (Backer, 2008). Since PI3P is required for the recruitment of EEA1 and 
Rabenosyn-5 to the active form of Rab5, VPS34 plays a positive role in early 
endosome fusion and the endocytosis process (Siddhanta et al., 1998) 
(Christoforidis, Miaczynska, et al., 1999). EEA1, an important Rab5 effector that 
binds to Rab5-GTP form, is the only effector that is necessarily required by minimal 
fusion and mediates endosome docking (Christoforidis, McBride, et al., 1999). 
Though Rabenosyn-5 is also recruited to the early endosome in a PI3P-dependent 
manner, it does not bind to GTP-bound Rab5 directly but is required for fusion of 
the plasma membrane-derived CCVs with early endosomes, as well as for 
homotypical early endosome fusion (Nielsen et al., 2000). Another Rab5 effector, 
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Rabaptin-5, was initially identified as an GTP-bound Rab5 effector through a yeast 
2-hybrid screen (Stenmark et al., 1995). Rabaptin-5 is mostly found as a complex 
with Rabex-5 in the cell (Horiuchi et al., 1997). Rabex-5 and Rabaptin-5 recruit 
each other in a positive loop upon Rab5 activation and thus keep the membrane 
Rab5-postive until the loop is interrupted by other recruited compartments (Kalin 
et al., 2015). Deletion of the Rab5-binding domain of Rabaptin-5 results in giant 
endosomes as well as impaired endocytosis process (Kalin et al., 2015). 
In this project, I examined the effect of Rab5 GEFs (e.g., Rabex-5 and RIN1), 
Rab5 GAPs (e.g., RN-tre), and Rab5 effector (e.g., VPS34) on adipogenesis. In 
addition, I also elucidated the determinant residues and domains of RIN1 during 
adipogenesis process. Based on the determined specific residues and domains of 
RIN1 that are required for signal transduction during adipogenesis, and the in silico 
docking analysis between the IR and RIN1, a model of RIN1 function on the insulin 
signaling pathway during adipogenesis is proposed. 
 
III.2 Specific aims and research design 
III.2.1 Specific aim 2: To determine the effect of Rab5 regulators on 
adipogenesis. 
Rab5 effectors denote a set of proteins that interact with the GTP-bonded 
Rab5. Each effector mediates a feature of Rab5 function and thus affects different 
aspects of downstream signaling. For example, Rabaptin-5 is involved in 
membrane fusion, it interacts with GTP-bonded Rab5 and stabilizes Rab5 in its 
active form. VPS34 generates PI3P, which is required for the recruitment of EEA1 
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and Rabenosyn-5 to the active form of Rab5. These recruitments allow both EEA1 
and Rabenosyn-5 then take part in the molecular machinery of regulating 
endosome fusion. The function of Rab5 dramatically depends on the recruitment 
of different effectors to clear several downstream trafficking and signaling events.  
One of the best-characterized Rab5 GEF is RIN1, which is required for the 
activation of Rab5 upon ligand stimulation in several cellular processes. The 
expression of RIN1:Wild-type, but not its depletion, affects the nucleotide status of 
Rab5. Preliminary results indicated that RIN1 interacted with the activated insulin 
receptor. Thus, I elucidated 
2.a. whether the expression (or depletion) of Rab5 GAPs (RN-tre, RabGAP-5), 
Rab5 GEFs (RIN1, Rabex-5, and RAP6), or Rab5 effector (VPS34) affected 
adipogenesis. 
2.b. the domains of Rab5 regulators required for adipogenesis. 
2.c. the specific effect of the expression of RIN1 and its mutants on adipogenesis. 
2.d. the key residues on RIN1 and the insulin receptor in the IR – RIN1 interaction. 
2.e. a 3-dimensional model of the interaction between the VPS9-HB domain of 
RIN1 and the IR cytoplasmic tail. 
 
III.2.2 Research design 2 
Cell lysates of the 3T3-L1 cells that have been transfected with GFP, RIN1, 
Rabex-5, RAP6, RabGAP-5, and RN-tre were incubated with GST-labeled EEA1. 
The bonded proteins were eluted and be used for immunoprecipitation analysis. 
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Then the cDNA of RIN1:WT and RIN1 mutants were cloned into the pMX-
puro vector at EcoRI and NotI restriction sites and plasmid DNA were purified via 
the plasmid purification assay. The purified DNA was then transfected into the Plat-
A cells using Lipofectamine® 2000. After 48 hours, virus suspension from the Plat-
A cells were applied to the 3T3-L1 mouse pre-adipocyte cell line for the expression 
of RIN1 or RIN1 mutants. The transfected cells were then selected with puromycin, 
and used for several biological assays, including cell cycle testing, lipid 
accumulation testing (ORO assay, only for differentiated cells) or western blotting.  
The RIN1:WT, RIN1:VPS9, RIN1 mutants and RIN1:VPS9 mutants were 
cloned into the pB42AD vector at the EcoRI and Xhol restriction sites. The insulin 
receptor tail (IR-β) and the catalytic defective mutant of the insulin receptor were 
cloned into the pLex-A vector at the EcoRI and BamHI restriction sites. All plasmids 
were purified and transfected into the yeast EGY48 stain. One pLex-A plasmid was 
combined with one pB42AD plasmid and co-transfected into the yeast cells. The 
co-transfected yeast was used for yeast β-Galactosidase Assay to test the intensity 
of protein-protein interaction. At last, the data were input into the software, i.e., the 
SWISS MODEL serve and the PyMOL, to build the 3-dimensional structural model 
of the interaction between the RIN1:VPS9 and the IR-tail. 
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III.3 Materials and Methods 
Methods that have been described in the previous chapter are not shown in 
this section. 
 
III.3.1 Materials 
The 3T3-L1 pre-adipocyte cell line was obtained from the Zen-Bio, Inc. (NC, 
USA). The Platinum A (Plat-A) retroviral packaging cell line and the pMX-puro 
retroviral vector were purchased from Cell Biolabs, Inc. (San Diego, CA, USA).  
The yeast Saccharomyces cerevisiae strain EGY48 was obtained from American 
Type Culture Collection (ATCC, Manassas, CA, USA). The pLex-A and pB42AD 
control vectors were purchased from Addgene (Cambridge, MA, USA). Yeast 
minimal SD Agar base, yeast minimal SD base, yeast dropout supplements were 
purchased from Takara Bio, Inc. (Mounting View, CA, USA). Primary antibodies, 
including the Akt1, p-Akt (Ser473), PPARγ, C/EBPα, Erk1/2, p-Erk1/2, FABP4, 
FAS, ACC, GAPDH, and Rab5, and secondary antibodies, including the anti-
Rabbit IgG AND anti-Mouse IgG, were purchased from the Cell Signaling 
Technology (Boston, MA, USA). Fetal bovine serum (FBS) was purchased from 
the RMBIO, Inc. (Missoula, MT, USA). Other reagents and supplies, if not 
specifically described, were purchased from Thermo Fisher Scientific (Weston, FL, 
USA).  
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III.3.2 cDNA Construction.  
Complementary DNAs (cDNA) of green fluorescent protein (GFP), GFP-
Rab5:wild-type (GFP-Rab5:WT), and RIN1:WT were cloned into the pMX-puro 
vector at the EcoRI and NotI restriction sites (Onishi et al., 1998). cDNA of IR β-
subunit intracellular tail (IR-β) was cloned into the pLex-A vector at the EcoRI and 
BamHI restriction sites. cDNA of RIN1:WT and the C-terminal of RIN1 containing 
both the VPS9 and RA domains (R3:WT) were cloned into the pB42AD vector at 
the EcoRI and XhoI sites. RIN1-SH2 mutants (RIN1:W69F, RIN1:A76F, 
RIN1:R94A, RIN1:H120F, RIN1:121F, RIN1:Y148F) conjugated the pB42AD 
vector were purchased from GenScript, Inc. (Piscataway, NJ, USA).  IR-kinase 
dead (IR:KD, IR:K1030A) and IR-β mutants (IR:Y972F, IR:Y1158F, IR:Y1328F, 
and IR:Y1334F) on the pLex-A vector, RIN1-SH2 mutants and RIN1-VPS9 
mutants (RIN1:Y537F, RIN1:Y561F, RIN1:T580A) on the pMX-puro vector, and 
R3 mutants (R3:Y506F, R3:Y523F, R3:Y537F, R3:P541A, R3:Y561F, R3:Y572F, 
R3:Y577F, R3:Y578F, R3:T580A, R3Y:Y629F) on the pB42AD vector were made 
via the Q5® Site-Directed Mutagenesis Kit purchased from New England Biolabs, 
Inc. (NEB, Ipswich, MA, USA). 
 
III.3.3 siRNA sequences and transfection.  
RNA interference (RNAi) directed against: 
mouse RIN1 [5'-UUAUACAUUUGCUUCACACCUAAGC-3'], 
mouse Rabex-5 [5’-UUUAUAGAGACGCGUCAUGAUGUGC-3'], 
mouse RAP6 [5'-AAGAATCGATTACCTATAGCA-3'], 
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mouse Rn-tre [5'-TAGACAGTATAATCACGCA-3'], 
or mouse RabGAP-5 [5'-GGACGACTCTGTGACAGAAGGAGTA-3'] and [5’ 
GAACATCAAGCAAACAGAGCTGGTA-3’] were designed and synthesized by 
Ambion (Austin, TX). A scrambled siRNA sequence was designed as a control [5'-
CACCUAAUCCGUGGUUCAA-3']. Prior to siRNA sequence transfection, cells 
were plated in growth medium without antibiotics at 70-80% confluence. siRNA 
sequence (20 nM final concentration) transfection was performed using 
Lipofectamine-2000 as specified by Invitrogen (Invitrogen, Carlsbad, CA). After 
transfection, cells were used for the indicated assay (e.g., for immunoblotting, 
diffenrentiation or pull-down assays). 
 
III.3.4 Cell counting assay.  
The 3T3-L1 pre-adipocytes under different treatment (e.g., with or without 
treatment of the differentiation media) and at different time points during 
differentiation (e.g., 0 h time point before the treatment of differentiation media, 15 
minutes/24 hours/48 hours time points after the treatment of differentiation media) 
were detached by trypsin and diluted with DMEM. 100 μl of the cell suspension will 
be mixed with 100 μl of the Trypan Blue solution. 10μl of the mixture was applied 
to a hemocytometer or a TC20™ Automated Cell Counter (Bio-Rad, Inc.) to be 
counted.  
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III.3.5 Yeast 2 hybrid system.  
III.3.5.1 Yeast transformation 
Protein-protein interactions were tested and analyzed by the yeast 2-hybrid 
system (Y2H). The generation of cDNA-containing vectors were described above. 
These pvectors were transformed into the yeast stain EGY48 containing a pSH18-
34 reporter vector. A cDNA-containing pB42AD vector and a cDNA-containing 
pLexA vector were co-transformed into yeast cells by the Yeast Transformation Kit. 
Transformed yeast cells were selected by SD agar plates that lack leucine (for 
selection of pSH18-34), histidine (for selection of pLexA), tryptophan (for selection 
of pB42AD) and uracil (for selection of yeast stain EGY48).  
 
III.3.3.2 Yeast β-galactosidase Assay 
The protein-protein interaction was quantified by the Yeast β-galactosidase 
(β-gal) Assay. Yeast cells were collected in the log phase followed by three freeze-
thaw cycles and lyased in 70 μl of Y-PER buffer (50 mM Tris-HCl, pH 8; 50 mM 
NaCl; 5 mM MgCl2·6H2O; 5 mM DTT). The β-gal reaction was triggered by adding 
70 μl of 2*β-gal buffer. Then samples were incubated in 37°C until an obvious 
yellow color showed up. At last, 56 μl of stop solution was added and samples 
were tested under 420 nm wavelength. The β-gal activity can be calculated by the 
formula below: 
β-Gal activity=#$$$∗&'()*
+∗,∗&'--*
 (t=total incubation time, V=0.196 ml) 
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III.3.6 In silico Studies 
The homology model of the VPS9 domain with N-terminal helical bundle of 
RIN1 was built by the SWISS-MODEL (Arnold et al., 2006) using the crystal 
structure of the VPS9 domain of Rabex-5 (Pdb Id:1TXU) as a template (Delprato 
et al., 2004). The model was built from residue M350 to L612 of RIN1. The 
sequence identity between the VPS9 domain of RIN1 and Rabex-5 is 30.0%. The 
coordinate of Rab5 (1R2Q) was taken from the protein data bank (Terzyan et al., 
2003; Zhang et al., 2014). The RIN1:VPS9-Rab5 complex was built using the 
crystal structure of the complex of Rab5 and Rabex-5 (Pdb Id: 4Q9U) (Zhang et 
al., 2014). The RIN1:VPS9-Rab5 complex was minimized by using NAMED and 
VMD (Humphrey et al., 1996; Phillips et al., 2005). The whole RIN1 model was 
built by using RaptorX structure prediction server (Kallberg et al., 2012). The server 
used the SH2 domain of human carboxyl-terminal Src kinase (Pdb Id: 3EAC) (Liu 
& Cowburn, 2016), Rabex-5 (Pdb Id: 2OT3) (Delprato & Lambright, 2007) and the 
RA domain (Pdb Id: 4K81) (Qamra & Hubbard, 2013) as templates. The molecular 
model was drawn with PYMOL (Delano, 2001).  
 
III.3.7 Statistical analysis 
All experiments presented were repeated a minimum of three times. Normal 
distributed data were represented in mean ± standard deviation (Wilfling et al.). 
The difference between groups were determined by the Student t-test. Tests were 
considered statistically significant if p-value were less than 0.05. 
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III.4 Results  
In chapter II, Rab5 has been established to play a detrimental role in the 
process of adipogenesis with a decreased GTP-bound Rab5 level. However, the 
total expression of Rab5 in the 3T3-L1 pre-adipocytes was not affected. The 
overexpression of the Rab5:Q79L mutant, which increased GTP-bound Rab5 level 
due to its low GTP hydrolysis rate, impaired the accumulation of cytosolic lipid 
droplets in the 3T3-L1 differentiated cells. Whereas the overexpression of 
Rab5:S34N, the GTP-binding defective mutant that maintained Rab5 in its inactive 
form, promoted the formation of lipid droplets in the differentiated 3T3-L1 cells. 
Besides, a gradient decrease of GTP-bound Rab5 was observed during the 3T3-
L1 cell differentiation process in a time-dependent manner. Thus, I questioned if 
the Rab5 GEFs, Rab5 GAPs, and Rab5 effectors participate in the regulation of 
Rab5 during the adipogenesis process. 
 
III.4.1 Rab5 GEFs were down-regulated during the differentiation of 3T3-
L1 pre-adipocytes 
In order to address whether the Rab5 GEFs participate in the differentiation 
of adipocytes, cell lysates collected from 3T3-L1 pre-adipocytes at before (day 1) 
and after (day 9) differentiation were prepared and utilized for immunoblotting, The 
expression of several Rab5 GEFs, such as RAP6 and Rabex-5, and Rab5 GAPs, 
such as RabGAP-5 and RN-tre, were analyzed. As described early, GAPDH 
served as the whole cell lysate loading control. PPARγ , C/EBPα, acetyl-CoA 
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carboxylase (ACC), fatty acid synthase (Kralisch & Fasshauer), GLUT4, and IR 
were adipogenic markers indicating the extent of differentiation.  
 
 
Figure 22. Representative Western blot of the content of Rab5 GEPs, Rab5 
GAPs, typical adipogenic markers, and GAPDH.  
3T3-L1 pre-adipocytes expressing GFP were lysed before (day1) and after (day9) 
of differentiation as described in Material and Methods. 
 
In Figure 22, all adipogenic markers, including PPARγ, C/EBPα, ACC, FAS, 
GLUT4, and IR exhibited an increased expression level at day 9 after 
differentiation in comparison with day 1. The two Rab5 GEFs tested, Rabex-5 and 
RAP6, showed a decreased expression in mature adipocytes (day 9). However, 
the two Rab5 GAPs, RabGAP-5 and RN-tre, did not exhibit obvious changes 
between day 1 and day 9 during differentiation. The results suggest an essential 
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role of Rab5 GEFs in the regulation of Rab5 nucleotide states during the 
differentiation process. 
 
III.4.2 The Rab5 GEFs downregulated the accumulation of lipids in the 
differentiated 3T3-L1 cells. 
In order to address the specific role of different Rab5 GEFs (e.g., RIN1, 
Rabex-5, and RAP6) and Rab5 GAPs (RN-tre and RabGAP-5) in the differentiation 
of 3T3-L1 cells, the individual overexpression of specific Rab5 GEFs/GAPs in 3T3-
L1 cells was accomplished via the pMX-puro retroviral vector system that has been 
described in the Materials and Methods. And to further explain the role of a specific 
Rab5 GEF/GAP in regulating the Rab5 nucleotide states, I lysed the 3T3-L1 cells 
overexpressing RIN1, Rabex-5, RAP6, RN-tre, or RabGAP-5 before (day1) and 
after (day 9) differentiation. The cell lysates were incubated with GST-EEA1 
(glutathione-S-transferase-EEA1) followed by GTP-Rab5 pull-down assay, and the 
pull-downs were subjected to immunoblotting analysis to determine the ratio of 
GTP-Rab5 (G-Rab5) to total Rab5 (T-Rab5). Besides, siRNA targeting specific 
Rab5 GFF and Rab5 GAP, as well as scrambled siRNA as control, were designed 
and induced into the 3T3-L1 cells to selectively silence a particular Rab5 GEF/GAP. 
At last, 3T3-L1 cells overexpressing GFP or a specific Rab5 GEF/Rab5 GAP, and 
3T3-L1 cells induced with scrambled siRNA or Rab5 GEF/GAP siRNA, were 
stained with ORO followed by quantification of lipid content. 
In Figure 23, I show that the overexpression of RabGAP-5 affected the 
differentiation of 3T3-L1 pre-adipocytes as evidenced by the increase in the 
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accumulation of cytosolic lipids. This increase in the accumulation of lipid droplets 
was consistent with the decreased Rab5-GTP level in cells overexpressing 
RabGAP-5 as compared with the GFP cells (Figure 23). Specifically, I also 
observed statistically significant inhibition of the Rab5-GTP level in cell lines 
expressing RabGAP-5 at both day 1 and 9 as compared with GFP-control cells. 
Similarly, the overexpression of RN-tre increased adipogenesis (Figure 23). More 
importantly, RabGAP-5 (137±4%) is more active than RN-tre (121±4%) during the 
differentiation process (compare Figure 23.A with Figure 24.A) as well as in the 
levels of GTP-bound Rab5 (compare Figure 23.C with Figure 24.C). Moreover, the 
Rab5-GTP level was dramatically reduced in cells expressing Rab5 GAPs, and no 
further reduction of the Rab5-GTP level was observed at day 9 of differentiation 
(Figure 23.C and Figure 24.C). To further uncover the role of Rab5 GAPs in the 
differentiation of 3T3-L1 pre-adipocytes, I utilized specific siRNA to induce the 
deletion of specific Rab5 GAP in the 3T3-L1 pre-adipocytes. Individual removal of 
Rab5 GAPs produced a significant inhibition on the accumulation of lipids (Figure 
23.B and Figure 24.B). These observations suggest that the decrease of the GTP-
bound Rab5 induced by the two Rab5 GAPs has a positive effect on the 
differentiation of 3T3-L1 pre-adipocytes. 
 
 
 
155 
 Figure 23. Selective effect of RabGAP-5 on the differentiation of 3T3-L1 pre-
adipocytes.  
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1 
cells expressing GFP and RabGAP-5 were differentiated. The accumulation of lipid 
droplets quantified via ORO assay and were represented as relative lipid contents. 
Inset: Representative Western blot of content of RabGAP-5 and GAPDH proteins. 
B. Non-transfected cells (Ctl), and cells transfected with scramble RNAi (Scr) or 
RNAi against RabGAP-5 were differentiated as described. Results were 
represented as relative lipid contents. Inset: Representative Western blot of 
content of RabGAP-5, RIN1 and GAPDH proteins. C. Cell lysates of 3T3-L1 pre-
adipocytes expressing GFP and RabGAP-5 were prepared at specific day (Day 1 
and Day 9) of the differentiation, and the endogenous GTP-bound Rab5 was 
analyzed by immunoblotting as indicated in the figure. 
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Figure 24. Selective effect of RN-tre on the differentiation of 3T3-L1 pre-
adipocytes.  
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1 
pre-adipocytes expressing GFP and RN-tre were differentiated. The accumulation 
of lipid droplets quantified via ORO assay and were represented as relative lipid 
contents. Inset: Representative Western blot of content of RN-tre and GAPDH 
proteins. B. Non-transfected cells (Ctl), and cells transfected with scramble RNAi 
(Scr) or RNAi against RN-tre were differentiated as described. Results were 
represented as relative lipid contents. C. Cell lysates of 3T3-L1 pre-adipocytes 
expressing GFP and RN-tre were prepared at specific day (Day 1 and Day 9) of 
the differentiation, and the endogenous GTP-bound Rab5 was analyzed by 
immunoblotting as indicated in the figure.  
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To gain more information about the regulation of Rab5 cycle during 
adipogenesis, I analyzed the effect of the expression of Rab5 GEFs (RIN1, Rabex-
6, and RAP6) on the differentiation of 3T3-L1 pre-adipocytes (Figure 25~27). In 
Figure 25, the overexpression of RIN1 blocked the accumulation of lipids. 
Consistent with this observation, the overexpression of RIN1 increased the Rab5-
GTP level as compared with GFP-control pre-adipocytes at day 1 and 9 of 
differentiation (Figure 25.C). Interestingly, a decrease of the level of Rab5-GTP 
was observed in RIN1-overexpressed cells at day 9 as compared with day 1 of 
differentiation, but this reduction in the Rab5-GTP level was less significant as 
compared with the GFP-control cells (e.g., Rab5-GTP level in GFP-control 
exhibited a reduction of 75% whereas reduced by only 50% in the RIN1-
overexpressed cells) (Figure 25.C).  
The effect of the overexpression of Rabex-5 and RAP6 on the differentiation 
of 3T3-L1 pre-adipocytes were also examined (results are shown in Figure 26 and 
Figure 27). In Figure 26.A and Figure 27.A, similar to the effect of RIN1-
overexpression, the individual overexpression of Rabex-5 and RAP6 blocked the 
accumulation of ORO by 63±7% and 56±4%, respectively. Consistent with these 
results, I observed that the individual overexpression of wither Rabex-5 or RAP6 
statistically significant increased the Rab5-GTP level as compared with GFP-
control pre-adipocytes at day 1 and 9 (Figure 26.C and Figure 27.C). Furthermore, 
a statistically significant decrease in the level of Rab5-GTP was also observed in 
the GFP-overexpressing cells when day 9 was compared with day 1 (a ~75% 
reduction can be observed). A decrease of the level of Rab5-GTP can also be 
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detected in Rabex-5- and RAP6-overexpressing cell lines at day 9 as compared 
with day 1 of the differentiation process. But this reduction between day 9 and day 
1 in the Rab5-GTP level was less significant as compared with GFP-control cells 
(e.g., Rabex-5-cells showed a ~70% decrease whereas the RAP6-cells showed a 
~50% decrease) (Figure 26.C and Figure 27.C). 
Then the depletion effect of these Rab5 GEFs was examined by inducing 
specific siRNA on the 3T3-L1 pre-adipocytes during the differentiation process. 
The down-regulation of each one of the Rab5 GEFs was accompanied by an 
increase of the accumulation of ORO as compared with control siRNA-induced 
cells. Specifically, cells overexpressing RIN1 promoted the lipid formation by 26%, 
Rabex-5 increased lipids accumulation by 20, while the overexpression of RAP6 
increased lipids accumulation by 25 (Figure 26.A and Figure 27.A). 3T3-L1 pre-
adipocytes differentiation process and also increased the levels of Rab5-GTP as 
compared with GFP-control cells (data not shown). Taken together, these data 
suggest that the overexpression or deletion of the specific Rab5 GFE (or the Rab5 
GAPs) have essential effects on differentiation of 3T3-L1 pre-adipocytes. The 
affected differentiation process by these Rab5 GEFs/GAPs were because, at least 
partially, of their role in regulating the Rab5 nucleotide states. 
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Figure 25. Selective effect of RIN1 on the differentiation of 3T3-L1 pre-
adipocytes.  
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1 
pre-adipocytes expressing GFP and RIN1 were differentiated. The accumulation 
of lipid droplets quantified via ORO assay and were represented as relative lipid 
contents. Inset: Representative Western blot of content of RIN1 and GAPDH 
proteins. B. Non-transfected cells (Ctl), and cells transfected with scramble RNAi 
(Scr) or RNAi against RabGAP-5 were differentiated as described. Results were 
represented as relative lipid contents. Inset: Representative Western blot of 
content of RIN1, RIN1 and GAPDH proteins. C. Cell lysates of 3T3-L1 pre-
adipocytes expressing GFP and RIN1 were prepared at specific day (Day 1 and 
Day 9) of the differentiation, and the endogenous GTP-bound Rab5 was analyzed 
by immunoblotting as indicated in the figure. Inset: Representative immunoblots of 
samples probed with anti-Rab5 antibodies for total Rab5 (T-Rab5) and active Rab5 
(G-Rab5) respectively. 
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Figure 26. Selective effect of Rabex-5 on the differentiation of 3T3-L1 pre-
adipocytes.  
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1 
pre-adipocytes expressing GFP and Rabex-5 were differentiated. The 
accumulation of lipid droplets quantified via ORO assay and were represented as 
relative lipid contents. Inset: Representative Western blot of content of Rabex-5 
and GAPDH proteins. B. Non-transfected cells (Ctl), and cells transfected with 
scramble RNAi (Scr) or RNAi against Rabex-5 were differentiated as described. 
Results were represented as relative lipid contents. C. Cell lysates of 3T3-L1 pre-
adipocytes expressing GFP and Rabex-5 were prepared at specific day (Day 1 
and Day 9) of the differentiation, and the endogenous GTP-bound Rab5 was 
analyzed by immunoblotting as indicated in the figure.  
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Figure 27. Selective effect of RAP6 on the differentiation of 3T3-L1 pre-
adipocytes.  
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1 
pre-adipocytes expressing GFP and RAP6 were differentiated. The accumulation 
of lipid droplets quantified via ORO assay and were represented as relative lipid 
contents. Inset: Representative Western blot of content of RAP6 and GAPDH 
proteins. B. Non-transfected cells (Ctl), and cells transfected with scramble RNAi 
(Scr) or RNAi against RAP6 were differentiated as described. Results were 
represented as relative lipid contents. Inset: Representative Western blot of 
content of RabGAP-5, RIN1 and GAPDH proteins. C. Cell lysates of 3T3-L1 pre-
adipocytes expressing GFP and RAP6 were prepared at specific day (Day 1 and 
Day 9) of the differentiation, and the endogenous GTP-bound Rab5 was analyzed 
by immunoblotting as indicated in the figure. Inset: Representative immunoblots of 
samples probed with anti-Rab5 antibodies for total Rab5 (T-Rab5) and active Rab5 
(G-Rab5) respectively. 
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III.4.3 Selective effect of RIN1 and its mutants on insulin signaling during 
pre-adipocyte differentiation 
III.4.3.1 RIN1 overexpression inhibited adipogenesis in vitro 
Previous results showed that the adipogenic differentiation of Rab5-
overexpressed 3T3-L1 cells was promoted. Also, GTP-bound Rab5 were 
progressively down-regulated over the process of differentiation. In addition, in the 
previous section, I showed a regulatory role of Rab GEFs in the adipogenesis 
process. Here, to further examine the effect of RIN1 on the differentiation of 3T3-
L1 pre-adipocytes, I overexpressed RIN1:wild-type (RIN1:WT) in the 3T3-L1 cells 
and tested the effect of RIN1 overexpression on the adipogenic markers (results 
shown in Figure 28 and Figure 29). 
 
Figure 28. RIN1 effect on the differentiation of 3T3-L1 pre-adipocytes.  
A. Relative lipid content of GFP (C+/C-, represent positive control and negative 
control, respectively) or RIN1:WT transfected 3T3-L1 cells. Cells that were not 
treated with hormone cocktail served as negative control. Data represent the mean 
± S.E.M. of three independent experiments. *P<0.001 by Student's t-test compared 
to differentiated GFP-overexpressed cells. S.E.M. = Standard error of the mean. 
B. Representative Western blot results of RIN1:WT and GFP overexpressed cells.  
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I used the Plat-A cells to transfer the RIN1:WT or the GFP-containing 
retrovirus into 3T3-L1 pre-adipocytes. The transfected cells were treated with or 
without hormone cocktail as was described in Materials and Methods. Then the 
ORO staining and spectroscopy was used to quantify lipid accumulation in the 
cytosol (Figure 28). Then the expression of adipogenic transcription factors, 
PPARγ and C/EBPα, and adipogenic markers, ACC, FABP4 and FAS in 
differentiated cells were tested to confirm the ORO results (Figure 29).  
 
 
 
 
 
 
 
 
 
 
Figure 29. Effect of RIN1:WT on transcription factors.  
3T3-L3 cells overexpressing GFP or RIN1:WT were differentiated with (positive 
control) or without hormone inducers.  
 
 
In Figure 29, the expression level of PPARγ, C/EBPα, ACC, and FAS in 
GFP- (cells were treated with or without hormone inducers, which represent the 
positive control and the negative control, respectively) and RIN1:WT- (cells were 
hormone treated) overexpressed 3T3-L1 cells were tested via Western blotting. 
The differentiated GFP-overexpressed cells showed a significantly higher 
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expression of the two adipogenic transcription factors, PPARγ and C/EBPα, and 
the two adipogenic markers, ACC and FAS. However, the differentiated RIN1:WT-
overexpressed cells showed a decreased expression of all tested proteins (Figure 
29). 
These results, showing that RIN1:WT played an inhibitory role in pre-
adipocyte differentiation, lead me to further examine the mechanism by which 
RIN1 affects the adipogenesis process. 
 
III.4.3.2 Two RIN1 selective mutants rescued the inhibitory effects of 
RIN1 on adipogenesis 
RIN1 performs multiple functions in cell metabolism due to its availability of 
interacting with numerous proteins through different domains. Through its Src 
homology 2 (SH2) domain, RIN1 interacts with several receptor tyrosine kinases, 
such as epidermal growth factor receptor (EGFR) and insulin receptor (IR) 
(Barbieri et al., 2003; Hunker et al., 2006b). Through its VPS9 domain, RIN1 can 
activate Rab5, a small GTPase that is essential in early endosome fusion process 
(Tall et al., 2001). Thus, I used two selective mutants, the RIN1:R94A and the 
RIN1:Y561, to examine the inhibitory role of RIN1 in adipogenesis process. The 
R94A mutation locates in the SH2 domain of RIN1 and leads a diminished 
interaction between RIN1 and the IR (Barbieri et al., 2003). The Y561F mutant, 
however, interferes with the activation of Rab5, resides in the VPS9 domain 
(Mustafi and Barbieri, 2016).  
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Again, the ORO staining and spectroscopy assay and the western blot 
assay were used to quantify the lipid content and to qualify the maturity of 
differentiated adipocytes, respectively. Interestingly, the overexpression of either 
mutant could rescue the prohibited effects on adipogenesis caused by RIN1:WT 
overexpression. In Figure 30, the ORO results presented that the RIN-R94A and 
RIN1:Y561F mutant increased lipid content from 53% to 77% and 64%, 
respectively in comparison to the RIN1:WT. The western blot analysis convinced 
the ORO results where the cells overexpressing either RIN1:R94A or RIN1:Y561F 
showed a higher expression of the adipogenic transcription factors, PPARγ and 
C/EBPα, and two adipogenic markers, ACC and FAS (Figure 30).  
Due to the fact that the function-declined RIN1 mutants, either in the SH2 
domain or the VPS9 domain, could extricate adipogenesis of 3T3-L1 cells from 
obstructed effects of RIN1:WT, I suspected that both the SH2 domain and the 
VPS9 domain are necessary for RIN1 to complete its molecular function in 
adipogenesis process. As described above, the two mutants are from different 
domains of RIN1. Thus, the data here suggested that RIN1 affected the 
adipogenesis process through at least two cellular processes, the endosome 
pathway and the insulin signaling pathway. 
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Figure 30. Effect of RIN1 selective mutants on adipogenesis.  
A. Relative lipid content of GFP or RIN1:WT transfected 3T3-L1 cells. 3T3-L1 cells 
overexpressing GFP, RIN1:WT, and RIN1 mutants were treated with or without 
hormone cocktail as described in Materials and Methods. Cells that were not 
treated with hormone cocktail served as negative control (C-). (Data represent the 
mean ± S.E.M. of three independent experiments. *P<0.01 by Student's t-test 
compared to differentiated RIN1:WT-overexpressed cells). S.E.M. = Standard 
error of the mean. B. C. Western blot result of RIN1:WT, RIN1:R94A, RIN1:Y561F 
and GFP overexpressed cells. 
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III.4.3.3 RIN1 mutants recovered both Erk1/2 and Akt signaling in 
compare with RIN1-WT 
In the previous study, RIN1 showed co-localization with the IR on both cell 
membrane and endosomes upon insulin stimulation, and the expression of RIN1-
WT blocks the activation of both Erk1/2 and Akt signaling pathway in cancer cells 
in vitro (Hunker, Giambini, et al., 2006). Evidence also showed that both Akt and 
Erk1/2 signaling reached their maximal level at 15 minutes upon insulin stimulation 
in vitro (Zecchin et al., 2007). Because of the glaring effects of RIN1 and its 
mutants on the process of adipogenesis and the regulatory role of RIN1 in insulin 
signaling pathway, I examined the activation of Erk1/2 and Akt, two important 
proteins in the MAPK and PI3K signaling pathways, respectively, at 15 minutes 
after hormone treatment (Figure 31). The western blot analysis revealed that both 
the MAPK and the PI3K signaling pathways were activated upon a 15-minutes 
hormone treatment in all cell lines (Figure 31). Both activated Akt and Erk1/2 
appeared to be downregulated in the RIN1-WT overexpressed cells upon hormone 
treatment (Fig. 5A) However, the RIN1-R94A overexpressed cells attended to 
reach a significantly higher signal than the RIN1-WT overexpressed cells at 15 
minutes after and even before hormone treatment (Figure 31). Simultaneously, the 
RIN1-Y561F overexpressed cells presented higher signal of activated Akt (p-Akt) 
both before and 15 minutes after hormone treatment (Figure 31). The RIN-Y561F 
mutant increased the Erk1/2 signal before hormone treatment and slightly higher 
signal after hormone treatment (Figure 31).  
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Figure 31. The activity of Akt and Erk1/2 before (0) and 15 minutes after 
hormone treatment.   
3T3-L1 cells overexpressing GFP, RIN1:WT, and RIN1 mutants were treated with 
or without hormone cocktail as described in Materials and Methods. Cells that were 
not treated with hormone cocktail served as negative control (C-). (Data represent 
the mean ± S.E.M. of three independent experiments. *P<0.01 by Student's t-test 
compared to differentiated RIN1:WT-overexpressed cells). S.E.M. = Standard 
error of the mean. Representative Western blot of the content of p-Akt and p-
Erk1/2 in comparison with GAPDH were shown. 
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III.4.3.4 RIN1 mutants promote cell proliferation in clonal expansion 
phase during adipogenesis 
Proliferative 3T3-L1 pre-adipocytes were growth-arrested upon contact 
inhibition before hormone treatment. Prior to terminal differentiation, the hormone 
triggered growth-arrested cells re-entered cell cycle to perform 2 rounds of post-
confluence mitosis, which is named as the clonal expansion phase. Establishing 
that the RIN1:WT and RIN1 mutants had noticeable effects on the MAPK and PI3K 
signaling pathways upon hormone treatment in the previous unit, I hypothesized 
that the ultimate consequences of the protein overexpression would cause notable 
effects on the clonal expansion phase. proliferation in the early stage of 
adipogenesis.  
 
 
Figure 32. Cell proliferation of GFP-, RIN1-, RIN1:R94A-, or RIN1:Y561F-
overexpressed cells in the first 48h after hormone induction.  
The results indicated a depressed cell growth rate of RIN1 expressed cells while 
a rescue of cell proliferation when expressing the two selective mutants. 
 
* 
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Figure 33. Bright-field images of GFP-, RIN1-, RIN1:R94A-, or RIN1:Y561F-
overexpressed cells in the first 48h after hormone induction.  
Images were taken under bright-field microscope at 0h (before differentiation) and 
48h (after differentiation) with the same magnification of 20X objective lens. The 
results indicated a depressed cell growth rate of RIN1 expressed cells while a 
rescue of cell proliferation when expressing the two selective mutants. 
 
To address the effect of RIN1 and its mutants on adipogenesis, I used cell 
counting assay, both manually and automatically, to intuitively investigate the 
growth of transfected cells in the first 48 hours upon hormone treatment. In Figure 
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32 and 33, RIN1 inhibited cell proliferation whereas the two mutants of RIN1 
rescued it during the clonal expansion phase of adipogenesis. The results suggest 
that RIN1 plays an inhibitory role in adipogenesis by, at least partially, impairing 
the cell mitotic clonal expansion phase of adipogenesis. 
 
III.4.4 The expression of Rab5 effector, VPS34, impaired the 
differentiation of 3T3-L1 preadipocytes.  
Rab5 is regulated by Rab5 GAPs and GEFs, and eventually perform its 
function by recruiting different Rab5 effectors. In order to investigate the effect of 
VPS34, a Class III PI3K to generate PI3P upon recruitment by Rab5, I transfected 
the 3T3-L1 pre-adipocytes with GFP-VPS34 via the pMX-puro retroviral vector 
system. The transfected cells were treated with or without hormone cocktail as was 
described in Materials and Methods. Then the ORO staining and spectroscopy 
was used to quantify lipid accumulation in the cytosol (Figure 34). Then I tested 
the effect of VPS34 on the insulin signaling pathway by analyzing the 
phosphorylation levels of Akt and Erk1/2 in the cell lysates. The VPS34- and GFP-
transfected cell lysates were collected before differentiation (0h) and 15 minutes 
after hormone treatment (Figure 35). At last, live cell images were taken under the 
inverted microscope at the same field of view to analyze the proliferation rate of 
transfected cells (Figure 36 & 37). Bright-field images were taken at either before 
differentiation(0h), 15 minutes, 24 hours, and 48 hours (48 hour time point is 
considered as the end of the mitotic clonal expansion phase) after hormone 
treatment. 
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Figure 34. Differentiation of GFP and VPS34 overexpressed cells.  
A. Relative lipid content of cells expressing GFP or GFP-VPS34. Data represent 
the mean ± S.E.M. of three independent experiments. *P<0.05 by Student's t-
test.B. Bright-field images of 3T3-L1 cells overexpressing GFP or GFP-VPS34. C. 
Confocal images of 3T3-L1 cells overexpressing GFP or GFP-VPS4 before 
differentiation. 
 
A 
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In Figure 34.A and B, the ORO quantification assay revealed a significant 
decreased lipid content of VPS34 overexpressed cells as compared with the GFP 
positive control (GFP+, cells were treated with hormone inducers during the 10-
day differentiation). Interestingly, the VPS34-transfected cells exhibited similar 
lipid content as the GFP negative control cells which were not treated with 
hormone inducers during the differentiation process. To my surprise, the size of 
the VPS34-transfected cells was much bigger than the GFP-transfected cells, 
which can be observed through both bright-field images and confocal images taken 
under the same magnification (Figure 34.B & C).  
 
 
 
Figure 35. The activity of Akt and Erk1/2 at 0h, 15 min 24h, and 48h after 
hormone treatment.   
3T3-L1 cells overexpressing GFP or GFP-VPS34 were treated with or without 
hormone cocktail as described in Materials and Methods. Cells that were not 
treated with hormone cocktail served as negative control. Representative Western 
blot of the content of p-Akt and p-Erk1/2 in comparison with GAPDH were shown. 
 
 
 
 
174 
In Figure 35, phosphorylated Akt and Erk1/2 were tested at 0h, 15min, 25h, 
and 48h time points. Surprisingly, the VPS34-transfected cells had an increased 
activity of both Akt and Erk1/2 as compared with the GFP cells at the same time 
points. What is more, the VPS34 transfected cells even exhibited a higher 
phosphorylation base line (compare the activity of both Akt and Erk1/2) and 
experienced a higher increase at 15min after hormone induction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. The activity of Akt and Erk1/2 at 0h, 15 min 24h, and 48h after 
hormone treatment.   
3T3-L1 cells overexpressing GFP or GFP-VPS34 were treated with or without 
hormone cocktail as described in Materials and Methods. Cells that were not 
treated with hormone cocktail served as negative control. Representative Western 
blot of the content of p-Akt and p-Erk1/2 in comparison with GAPDH were shown. 
 
 
 
* 
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Figure 37. Bright-field images of GFP and GFP-VPS34 overexpressed cells 
in the first 48h after hormone induction.  
Images were taken under bright-field microscope at 0h (before differentiation) and 
48h (after differentiation) with the same magnification of 20X objective lens. The 
results indicated a depressed cell growth rate of VPS34 expressed cells while a 
rescue of cell proliferation when expressing the two selective mutants. 
 
As described above, the Akt signaling pathway governs cell metabolism and 
plays a positive role in 3T3-L1 pre-adipocyte differentiation whereas the Erk1/2 
signaling pathway controls gene expression, protein translation, and plays a 
negative role in promoting the adipogenesis process. Thus, it will be interesting to 
investigate how the clonal expansion phase is affected during the differentiation 
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process. In Figure 36 and 37, cell counting data revealed that the expression of 
VPS34 in the 3T3-L1 cells not only enlarge the size of the pre-adipocytes, but also 
decreased the cell proliferation rate in the first 48 hours of differentiation.  
 
III.4.5 Selective association of IR with Rab5 GEFs 
Based on my observations where the diminishing of the Rab5-GTP levels 
during the differentiation process is linked to insulin stimulation together with the 
differential effect of Rab5 GEFs, Rab5 GAPs, and Rab5 constructs on 
differentiation of 3T3-L1 pre-adipocytes, I concluded that decreasing the Rab5-
GTP levels could be related to the inability of Rab5 GEFs and Rab5 GAPs to 
regulate and/or access to Rab5 proteins during differentiation of 3T3-L1 pre-
adipocytes.  
To determine the possible cellular mechanism under the regulation of Rab5, 
I examined whether the IR was associated with specific Rab5 GEFs and/or Rab5 
GAPs. 3T3-L1 pre-adipocytes individually expressing each Rab5 GEF and Rab5 
GAP were differentiated, and then cells at day 9 of the differentiation process were 
incubated in the absence or in the presence of insulin for 5 min at 37°C. After the 
incubation, cells were lysed, and IR was immunoprecipitated followed with 
immunoblotting analysis with specific anti-Rab5 GEFs antibodies. In Figure 38, I 
show that RIN1 (Figure 38.A), Rabex5 (Figure 38.B) and RAP6 (Figure 38.C) are 
able to interact with the IR in the presence of insulin. Results were tested via 
immunoprecipitation with anti-IR antibodies. In contrast, it was not possible to 
immunoprecipitate these Rab5 GEFs with IR in the absence of insulin (Figure 38.A, 
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B, and C). The SH2 domain of RIN1 has been established previously to interact 
with activated insulin receptor tyrosine kinase domain, which is also confirmed in 
Figure 38.D. The SH2 domain of RIN1 alone was able to interact with the activated 
insulin receptor, whereas this domain was not able to interact with the catalytic 
inactive mutant of the insulin receptor (IR:KD). Interestingly, besides the well-
established SH2 domain, another domain of RIN1, the VPS9 domain showed 
strong interaction with the IR-tail in the yeast two-hybrid system (Figure 38.D). 
However, the domains that showed higher affinity to the activated IR did not show 
any binding affinity to the catalytic inactive IR-tail. Taken together, these 
observations suggest that, IR interacts with Rab5 GEFs only upon the stimulation 
of insulin. These observations were not surprising for RIN1 since it contains an 
SH2 domain. However, Rabex5 and RAP6 do not have an SH2 domain, even the 
association of the latter molecules can be attributed to the requirement of 
additional factors as it has been shown in the case of the interaction with EGFR. 
Thus, is reasonable to consider that the VPS9 domain, which is a common domain 
between these Rab5 GEFs, may be responsible for this interaction with the IR 
upon insulin stimulation. 
 
 
 
 
 
178 
Figure 38. Interaction of the IR-cytoplasmic tail and VPS9 containing proteins. 
3T3-L1 preadipocytes expressing GFP, RIN1 (A), Rabex-5 (B), and RAP6 (C) were 
differentiated into adipocytes in the absence (Control) or in the presence of insulin 
at 37°C for 5 min. After the incubation, cells were lysed and analyzed by 
immunoprecipitation followed by immunoblotting as described in the figure. 
Results were represented as relative lipid contents. Data represent the mean ± 
S.E.M. of three independent experiments. A./B./C. Representative Western blot of 
the content of Rabex-5, RAP6, RIN1 constructs, IR, and phospho-IR proteins. 
*P<0.05 by Student's t-test. D. Yeast cells were co-transformed with plasmids 
pB42AD fused with Rab5 GEF constructs and plasmids pLexA fused with IR-
tail:WT/KD. Co-transformed cells were selected as described in Material and 
Methods. Liquid cultures in selective media were also assayed for β-Galactosidase 
(β-Gal) to verify and quantify two-hybrid interactions. The data are presented as 
means ± SD of five independent experiments, n=5 *P<0.005. Each independent 
experiment was performed in quintuplicate. 
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To further investigate the specificity of the interaction between Rab5 GEFs 
and IR, I then asked whether a specific domain of Rab5 GEFs was involved in the 
interaction with the cytoplasmic tail of IR. To address this, I utilized a yeast two-
hybrid system to analyze the interaction of the cytoplasmic tail of IR:WT with the 
following Rab5 GEFs constructs: a) RIN1:SH2, RIN1:VPS9 and RIN1:RA;                 
b) Rabex-5:Z-M (Z: zinc-finger, which displays Ub protein ligase (E3) activity and 
binds Ub; M: MIU, a motif interacts with ubiquitin), Rabex-5:VPS9, Rabex-5:C-P 
(Lee et al., 2006); c) RAP6:VPS9, RAP6:PH and RAP6:RGD (Figure 38). The 
cytoplasmic tail of IR kinase-dead (IR:K1077M), as well as blank vectors that were 
not conjugated with Rab5 GEF constructs, were used as negative controls. 
Consistent with previous observations, I found that RIN1:SH2 domain interacted 
with the cytoplasmic tail of IR (Figure 38.A). However, I also noticed that 
RIN1:VPS9 domain, but not RIN1:RA domain, interacted with the cytoplasmic tail 
of IR. Interestingly, the VPS9 domain of RAP6 and Rabex-5, but not other domains 
from these Rab5 GEFs, also interacted with the cytoplasmic tail of IR (Figure 38.D). 
These observations, indicates Rab5 GEFs interact with the cytoplasmic tail of IR 
via VPS9 domain. For additional examination of this novel interaction between the 
RIN1:VPS9 domain and with the cytoplasmic tail of IR, I built the in silico model of 
the complex of RIN1:VPS9-HB and the cytoplasmic tail of IR using the X-ray crystal 
structure of the IR and VPS9-HB of Rabex-5. In Figure 34, I show the model of the 
interaction of VPS9-HB domain and IR-cytoplasmic tail. The molecular analysis of 
the RIN1:VPS9-HB:IR cytoplasmic tail complex shows that there are 24 residues 
in RIN1 VPS9-HB and 28 residues in IR-cytoplasmic tail are placed in the interface 
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between them (Table 4). This complex is being stabilized by hydrogen bonds, van 
der Walls, hydrophobic and ionic interactions at the interface, and it also predicts 
that a number of exposed residues in the RIN1; VPS9-HB (Asp537, Pro541, 
Tyr561, and Thr580) domain. Thr580 places in the αV6 helix on the VPS9 domain 
and is conserved in hRabex-5, hRIN1, hAlsin, hVarp, but not in hRAP6 proteins. It 
is placed in the interface, where the side chain of the Thr580 is almost buried into 
the interface. The side chain of Thr580 in VPS9 domain makes the hydrogen bond 
interaction with the backbone of Ser1096 of IR cytoplasmic tail. The distance 
between OG1 atom of Thr580 and OG atom of Ser1096 of IR cytoplasmic tail is 
nearly 4.5 Å, and it could also form the hydrogen bond between them (Figure 39).  
 
Table 4. In silico analysis of the interaction between the VPS9-HB1 domain 
of RIN1 and the IR-tail2 
1 The numbering of amino acids of corresponds to the protein of Han and Colicelli 
(Han & Colicelli, 1995).    
2 The numbering of amino acids of IR-B differs from that of the receptor of Ebina 
et al. by being 47 amino acids greater (Ebina et al., 1985).  
 
Table 4.A Hydrophobic interactions between the VPS9-HB domain of RIN1 
and the IR-tail 
 
VPS9-HB Domain IR-tail 
Leu571 Trp1036 
Pro599 Leu1085 
Leu540 Ile1089, Leu1092 
Pro541 Ile1089 
Leu588 Ile1089, Leu1092 
Ala584 Leu1092 
Trp577 Val1097, Phe1175 
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Table 4.B Cation-Pi interactions between the VPS9-HB domain of RIN1 and 
the IR-tail within 6 Å 
VPS9-HB Domain IR-tail 
Lys520 Tyr1205 
 
Table 4.C Aromatic-aromatic Interactions between VPS9-HB and IR-tail 
within 4.5 and 7 Å 
VPS9-HB Domain IR-tail 
Tyr577 Phe1175 
 
Table 4.D Ionic interactions between VPS9-HB and IR-tail within 6 Å  
VPS9-HB Domain IR-tail 
Glu564 Lys1067 
Asp537 Arg1086, Glu1090 
Lys520 Asp1203, Glu1206 
Glu532 Arg1211, Lys1212 
Glu530 Lys1212 
Glu538 Lys1212, Lys1215 
Lys426 Glu1327 
Glu574 Glu1328 
 
 Table 4.E Hydrogen bond interactions between VPS9-HB and IR-tail.  
 
VPS9-HB 
Domain IR-tail 
VPS9-HB 
Domain IR-tail 
Leu571 Phe1101 Asp537 Arg1086, Arg1202 
Ala536 Asn1093 Glu530 Lys1212, Lys 1215 
Thr572 Lys1173 Glu538 Lys1212, Lys 1215 
Glu532 Arg1211, Lys1212, Lyr1209 Lys426 Glu1327 
Gly533 Lys1212 Lys520 Asp1203, Glu1206 
Thr580 Ser1096 Ser563 Glu1035 
Arg403 Lys1067, Thr1207 Tyr577 Asp1203 
Tyr523 Asp1203   
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Figure 39. Analysis of the interaction between the IR-cytoplasmic tail and the 
RIN1:VPS9 mutants.  
In silico docking analysis of the IR-cytoplasmic tail and the VPS9-HB domain of 
RIN1.  RIN1:VPS9 domain’s residues studied above are shown in magenta sticks 
and their interactions are shown in separate panels (Inserts).  The polar distance 
less than 4.0 Å are shown in dotted lines. Residues Pro541 and Thr580 of the 
VPS9 domain are buried in the interface of the complex. The Pro541 makes 
hydrophobic interaction with Ile1089 of IR-cytoplasmic tail. The side chain of 
Thr580 makes interaction with the main chain of Ser1096. These mutations of 
Pro541 and Thr580 to alanine destabilize this complex. The activated IR-
cytoplasmic tail structure is taken from the protein data bank (Pdb Id: 4XLV) for 
docking (Cabail et al., 2015). The homology model of VPS9-HB domain of RIN1 
was built by SWISS-MODEL (Arnold et al., 2006) using the crystal structure of 
Rabex-5 (Pdb id:1TXU) as a template (Delprato et al., 2004). The docking of the 
IR-cytoplasmic tail and the VPA9-HB domain was done by the ZDOCK online 
server. The docked model was minimized by using NAMED (Phillips et al., 2005) 
and VMD (Humphrey et al., 1996). The molecular model was drawn with PYMOL 
(Delano, 2001). 
 
 
 
183 
 
Tyr561 is also conserved in hRabex-5, hRIN1, hGAPVD1, hVarp but not in 
hAlsin proteins. It is placed in the αV5 helix, and the side chain is fully buried into 
the interface between VPS9 and HB domain of RIN1. The hydroxyl group of Tyr561 
makes hydrogen bonds with the backbone atom of Tyr506 and Arg455, placed in 
αH4 (Figure 34). Tyr506 is only present in hRIN1 and it can make a hydrogen bond 
with the backbone atom of tyr561. The mutation of Tyr561 and Tyr506 to 
phenylalanine may lose the hydrogen bond. Based on these observations, I utilized 
a two-hybrid system to analyze the interaction of the cytoplasmic tail of IR-WT with 
the following Rab5:VPS9-HB mutants: (Y506F, Y523F, Y537F, P5431A, Y561F, 
T572A, Y577F, Y578F, T580A) (Figure 39). I found that residues (Tyr506, P541, 
Y561, and T580) play an important role in the interaction of RIN1:VPS9-HB with 
the cytoplasmic tail of IR. As expected, the cytoplasmic tail of IR kinase-dead was 
used as negative control. These observations indicate selective residues of the 
VPS9-HB domain are required for the interaction of the cytoplasmic tail of IR, which 
may represent a distinctive and original protein-protein interaction. Taken together, 
these findings indicate that (a) Rab5 GEFs interact with the cytoplasmic tail of IR, 
but not with its catalytic inactive mutant, (b) the Rab5 GEFs VPS9 domain is 
sufficient for this interaction, and (c) Rab5 GAPs do not interact with the 
cytoplasmic tail of IR. Furthermore, these results also strengthen the possibility 
that interaction between VPS9 domain of Rab5 GEFs and the cytoplasmic tail of 
IR, defining a novel and selective interaction between VPS9 domain and the IR 
cytoplasmic tail. 
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Figure 40. Analysis of interaction between the IR-cytoplasmic tail (IR-β) and 
RIN1:VPS9 mutants or IR-β mutants and the RIN1:VPS9 domain.  
Yeast cells were co-transformed with plasmids pLexA fused to the IR-β:WT/KD or 
IR-β mutants (Y972F, IR:Y1158F, IR:Y1328F, and IR:Y1334F) and pB42AD fused 
to the RIN1:VPS9 or RIN1:VPS9 mutant (Y506F, Y523F, D537A, P541A, Y561F, 
Y572F, Y577F, Y578F, T580A). Co-transformed cells were spotted onto plates 
containing selected media and incubated at 30°C as described in Material and 
Methods. Liquid cultures in selective media were also assayed for β-Galactosidase 
(β-Gal) to verify and quantify two-hybrid interactions. The data are presented as 
means ± SD of five independent experiments, n=5 *P<0.05. Each independent 
experiment was performed in quintuplicate. 
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Figure 41. Analysis of interaction between the IR-cytoplasmic tail (IR-β) and 
RIN1:SH2 domain.  
Yeast cells were co-transformed with plasmids pLexA fused to the IR-β:WT/KD 
and pB42AD fused to the RIN1:SH2 or RIN1:SH2 mutants (RIN1:W69F, 
RIN1:A76F, RIN1:R94A, RIN1:H120F, RIN1:121F, RIN1:Y148F). Co-transformed 
cells were spotted onto plates containing selected media and incubated at 30°C 
as described in Material and Methods. Liquid cultures in selective media were also 
assayed for β-Galactosidase (β-Gal) to verify and quantify two-hybrid interactions. 
The data are presented as means ± SD of five independent experiments, n=5 
*P<0.05. Each independent experiment was performed in quintuplicate. 
 
In order to further investigate the interaction between the IR and RIN1, I 
insert RIN1-SH2:WT, RIN1:VPS9:WT, several RIN1-SH2/VPS9 mutants into the 
pB42AD vector, and insert the IR-β and IR-β mutants into the pLex-A vector. Figure 
40 showed the interaction between IR-cytoplasmic tail (IR-β) and RIN1:VPS9 
mutants or IR-β mutants and RIN1:VPS9 domain whereas Figure 41 showed the 
interaction between the IR-β and RIN1:SH2. 
RIN1 
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III.5 Discussion 
In this section, I show the cellular mechanism of the Rab GEFs and the Rab 
GAPs in regulating Rab5 function during the differentiation of 3T3-L1 pre-
adipocytes. My data indicate that Rab5 inactivation upon insulin stimulation is 
directly linked to the interaction between the activated insulin receptor and the 
VPS9 domain of the Rab5 GEFs. The interaction probably affects the availability 
of Rab5 GEFs to activate Rab5. In addition, the VPS9-IR-tail interaction also 
affected the recruitment of IRS-1 to the activated insulin receptor cytoplasmic tail. 
The expression of Rab5 GEFs, which increased the Rab5-GTP levels, 
reduced the differentiation of 3T3-L1 pre-adipocytes, while the expression of Rab5 
GAPs, which decreased Rab5-GTP levels, improved adipogenesis. I also show 
that the exposure of 3T3-L1 pre-adipocytes to insulin can stimulate the association 
of Rab5 GEF via its VPS9 domain to the activated insulin receptor. This 
observation strongly suggests a direct link between the Rab5 inactivation and the 
insulin receptor trafficking and signaling. 
Analysis of the Rab5-GTP levels reveals a significant decrease in the GTP 
levels in an insulin-sensitive manner during 3T3-L1 pre-adipocytes differentiation 
without any significant decrease of the total level of Rab5 (Figures 11). One striking 
feature of the Rab5-GTP levels in cells expressing Rab5 GEFs is that not only an 
increase of the GTP levels can be observed, but also a statistically significant 
decrease in the Rab5-GTP levels is displayed by comparing the Rab5-GTP levels 
between day 1 and day 9 during differentiation. In contrast, in cells expressing the 
Rab5 GAPs, the Rab5-GTP levels were not further affected by the addition of 
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insulin during the differentiation process. In this context, depletion of Rab5 GEFs 
or Rab5 GAPs by siRNA showed a remarkable characteristic; silencing of Rab5 
GEFs decrease Rab5-GTP levels, while depletion of Rab5 GAPs increase it. 
These data suggest that regulation of these factors is critical to ensure and 
maintain the Rab5-GTP level during the differentiation process. Taken together, 
these results suggest a possible cellular mechanism of the regulation of Rab5 
inactivation during adipogenesis, which is directly linked to the interaction of 
activated insulin receptor with the Rab5 GEFs. 
It is reasonable to propose that association of activated insulin receptor with 
the Rab5 GEFs is specific and selective and will also affect the activation of Rab5. 
In support of this possibility, it has been shown that RIN1 interacts with activated 
insulin receptor via its SH2 domain (Hunker, Giambini, et al., 2006). Interestingly, 
Rabex-5 and RIN1 are recruited by activated EGF-receptor tail via two different 
mechanisms: RIN1 require tyrosine phosphorylation of the EGF-receptor, while 
Rabex-5 requires ubiquitination. In addition, it has been also shown that a deletion 
mutant of Rabex-5 containing the VPS9 domain is targeted to membrane without 
Rabaptin-5 and the ubiquitination domain (Aikawa, 2012). Together, these data 
suggest that Rab5 GEFs utilize several mechanisms to interact with the activated 
receptor. However, in this study, I found that these Rab5 GEFs utilize one common 
domain (the VPS9 domain) to interact with the activated insulin receptor, with the 
exception of RIN1 that also utilizes the RIN1:SH2 domain to interact with the 
activated insulin receptor (Figure 34). 
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In addition, the VPS9 domain does not interact with insulin receptor catalytic 
inactive mutant or with other receptors (e.g., EGF-, transferrin- and LDL-receptor 
[data not shown]). However, the finding that the Rab5 GEFs VPS9 domain also 
interacts with the IGF-1R (data not shown) further support the idea that Rab5 GEFs 
VPS9 domain plays a critical function during the differentiation of pre-adipocytes 
since both the IR and IGF-1R have been implicated in the regulation of adipocyte 
differentiation and lipid accumulation in vitro (Boucher et al., 2010). It is also 
important to mention that beside the VPS9 domain, other domains of the Rab5 
GEFs may also play critical roles in the differentiation of pre-adipocytes. For 
example, the Ras-binding domain found in both RIN1 and Rabex-5, as well as the 
Ras-GAP domain described in RAP6, may also be involved in the differentiation of 
pre-adipocytes since the expression of Ras GTP-hydrolysis defective mutant 
(Ras:V12G) increases the differentiation of pre-adipocytes (Murholm et al., 2010). 
These data suggest that Rab5 inactivation is a key and specific factor, yet not the 
only one, that is crucial to trigger the differentiation of 3T3-L1 pre-adipocytes. 
In summary, my data show that the exposure of 3T3-L1 pre-adipocytes to 
insulin can stimulate the inactivation of Rab5, which strongly suggests a direct link 
between the inactivation of Rab5 and the activation of the insulin receptor. One 
explanation for this mechanism is lay on the association of Rab5 GEFs with the 
activated insulin receptor and IGF-1R. In either case, the VPS9 domain of Rab5 
GEFs mediates this interaction with the activated receptor, indicating a novel 
cellular mechanism to regulate the activity of Rab5. This hypothesis is further 
supported by the observation that only tyrosine-phosphorylated insulin receptor 
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interacted with more than one Rab5 GEFs. Therefore, Rab5 cannot be activated 
once the Rab4 GEFs were sequestered by the activated IR or IGF-1R. In 
agreement with these observations, the addition of insulin down-regulates Rab5 
activity in the initial phase, but Rab5 activity could be recovered later, which 
coincides with activation and inactivation phases of the insulin receptor during the 
receptor-mediated endocytosis. This lack of Rab5 activation will block insulin 
receptor internalization allowing an increase of the tyrosine autophosphorylation 
of the insulin receptor and activation of Akt followed by translocation of GLUT4 to 
the plasma membrane. Another possibility is that decreasing the level of Rab5-
GTP is associated with diminishing the amount of Rab5 proteins during the 
differentiation process. Thus, inadequate level of Rab5 proteins would affect their 
activation by Rab5 GEFs. Moreover, it seems that it could be a case since the 
expression of Rab5 is differentially altered during the 3T3-L1 pre-adipocytes 
differentiation. However, it has been shown that the expression of Rab5 is not 
altered during the 3T3-L1 pre-adipocytes differentiation (Figure 22 and Figure 11). 
Additionally, secondary modification on Rab5 and/or Rab5 GEFs (e.g., 
phosphorylation, ubiquitination) would also be involved. Further investigation will 
be needed to define the potential requirements of specific modifications of Rab5. 
Additional explanations, such as how an increased GLUT4 internalization could be 
induced by an inhibitory effect of the Rab5 activity cannot be ruled out (Figure 13).  
Here, I provided function and cellular evidence that Rab5 may be 
considered as a molecular switch on the cell fate determination of 3T3-L1 pre-
adipocytes. Interestingly, Rab5 inactivation has been found to associate with 
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neurite outgrowth and differentiation, where RabGAP-5 interacts with NGF-TrkA 
receptor and regulates the NGF-TrkA receptor signaling (Tam et al., 2015). 
Nevertheless, my studies indicate a finely orchestrated balance between 
GTP/GDP ratio of Rab5, Rab5 GEFs, and tyrosine autophosphorylation of the 
insulin receptor, and more importantly, demonstrate a fundamental role of Rab5 
inactivation during the differentiation of 3T3-L1 pre-adipocytes. 
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